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Abstract 
Image-guided medical interventions are diagnostic and therapeutic procedures that focus 
on minimizing surgical incisions for improving disease management and reducing patient 
burden relative to conventional techniques. Interventional approaches, such as biopsy, 
brachytherapy, and ablation procedures, have been used in the management of cancer for 
many anatomical regions, including the prostate and liver. Needles and needle-like tools 
are often used for achieving planned clinical outcomes, but the increased dependency on 
accurate targeting, guidance, and verification can limit the widespread adoption and 
clinical scope of these procedures. Image-guided interventions that incorporate 3D 
information intraoperatively have been shown to improve the accuracy and feasibility of 
these procedures, but clinical needs still exist for improving workflow and reducing 
physician variability with widely applicable cost-conscience approaches. The objective of 
this thesis was to incorporate 3D ultrasound (US) imaging and image processing methods 
during image-guided cancer interventions in the prostate and liver to provide accessible, 
fast, and accurate approaches for clinical improvements.  
An automatic 2D-3D transrectal ultrasound (TRUS) registration algorithm was optimized 
and implemented in a 3D TRUS-guided system to provide continuous prostate motion 
corrections with sub-millimeter and sub-degree error in 36 ± 4 ms. An automatic and 
generalizable 3D TRUS prostate segmentation method was developed on a diverse clinical 
dataset of patient images from biopsy and brachytherapy procedures, resulting in errors at 
gold standard accuracy with a computation time of 0.62 s. After validation of mechanical 
and image reconstruction accuracy, a novel 3D US system for focal liver tumor therapy 
was developed to guide therapy applicators with 4.27 ± 2.47 mm error. The verification of 
applicators post-insertion motivated the development of a 3D US applicator segmentation 
approach, which was demonstrated to provide clinically feasible assessments in 0.246 ± 
0.007 s. Lastly, a general needle and applicator tool segmentation algorithm was developed 
to provide accurate intraoperative and real-time insertion feedback for multiple anatomical 
locations during a variety of clinical interventional procedures. Clinical translation of these 
developed approaches has the potential to extend the overall patient quality of life and 
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outcomes by improving detection rates and reducing local cancer recurrence in patients 
with prostate and liver cancer. 
Keywords 
Image-guided interventions, prostate cancer, liver cancer, three-dimensional ultrasound, 
2D-3D image registration, 2D image segmentation, 3D image segmentation, real-time 
image processing 
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Summary for Lay Audience 
Medical procedures that use imaging are useful for diagnosis or treatment of patients as 
open surgery is often avoided, reducing the side-effects and time needed for healing. 
Needle-like tools are often used for managing diseases, like prostate and liver cancer, by 
taking samples for testing, bringing radiation directly into a tumor for treatment or heating 
small regions in the body to kill the cancer cells. Although the small tool sizes are helpful, 
higher physician skills are needed to read 2D images for understanding the 3D body while 
guiding these tools, which can lead to missed cancer diagnoses and treatments that have 
cancer recurrence. 3D information has been shown to reduce the occurrence of these poor 
procedure outcomes, but systems that generate 3D information are often expensive and 
make procedures longer. The goal of this work was to use 3D ultrasound (US) imaging 
with the software during image-guided prostate and liver cancer procedures.  
One software approach was created to correct for prostate motion and performed with small 
errors at more than 15 times per second when installed in our 3D US system. Another 
software approach was made to automatically recognize the prostate in 3D US images. This 
method performed in less than one second and had the same error as humans when tested 
on images from different procedures, demonstrating the multi-purpose potential of the 
software. A new 3D US system was made for guiding liver cancer therapy by controlling 
three motors to create new types of images and a clinical navigation procedure that guided 
therapy needles to targets identified in the images. The software was made for this system 
to recognize needles in 3D US images in less than one second, improving the speed that 
needle placements could be checked. Lastly, the software was made to automatically 
recognize needles in 2D US images from a large range of clinical procedures and areas in 
the body. We believe that this research will increase the use of image-guided needle 
procedures to help patients with cancer while taking advantage of the reduced side-effects 
and time for healing.  
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Chapter 1  
1 Introduction 
Image-guided medical interventions is a growing field that has many clinical applications 
from neurosurgery to cancer diagnosis and therapy.1 Recent advancements in hardware and 
software have benefitted this field from intra-operative tools in the form of tracking, 
visualization, and advanced image processing technologies, which provide easier and 
enhanced image guidance. Utilities such as image segmentation and registration are 
becoming necessities for physicians as they “potentially lead to shortened operation time, 
reduced radiation dose, minimized contrast medium, and most importantly, increased 
accuracy.”2 As the interest in minimally invasive procedures continues to rise, increasing 
image guidance accuracy will lead to increased dissemination and success of current 
approaches.  
Diagnosis and therapy of prostate and liver cancer can be pursued with image-guided 
interventional approaches, but currently suffer from undesirable limitations, such as high 
false-negative rates3 and local cancer recurrence.4 Accordingly, the focus of this thesis is 
to improve the accuracy and reduce user variability of image-guided interventions using 
lower-cost solutions that incorporate three-dimensional (3D) ultrasound (US) and 
advanced image processing techniques. This thesis is mainly focused on applications in 
prostate and liver cancer diagnoses and therapies, but applications to other relevant 
anatomies, such as gynecologic and kidney cancer, are provided to demonstrate the 
potential widespread impact of the investigated solutions. This work has the potential to 
detect clinically significant tumors earlier, result in fewer diagnostic and therapeutic 
sessions, determine appropriate treatment selection, reduce the local cancer recurrence 
after focal tumor ablation, and treat more complex tumor locations. The remainder of this 
chapter describes the current status of prostate and liver cancer prevalence (1.1), 
therapeutic options for patients with these disease sites (1.2), image-guided interventions 
(1.3) with selected image processing techniques (0) as alternatives to conventional therapy, 
and the unmet needs, hypothesis, and specific objectives of the thesis (1.5). 
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1.1 Motivation 
1.1.1 Prostate cancer 
Prostate cancer is the most commonly diagnosed non-skin cancer in Canadian men with 1 
in 9 males expected to be diagnosed with the disease in their lifetimes.5 This disease site 
accounted for 20.3% (22,900) of all new cancer cases, with 99% of cases occurring in men 
over the age of 50. Prostate cancer was projected to be the third most common cause of 
cancer deaths in Canadian males in 2019, but the mortality rate has been declining by 2.8% 
per year since 1994 and has the third-highest five-year net survival rate (93%) in most 
recent predictions.5 Although the disease is most often highly treatable, prostate cancer has 
a wide range of clinical presentation from slow-growing to fatally aggressive, which is 
characterized by a standardized numerical scoring system (i.e., Gleason score).6 
 
Figure 1.1 Local anatomy in the male pelvis surrounding the prostate. 
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The prostate is a gland of the male reproductive system located in the pelvis inferiorly to 
the bladder, posterior to the pubic symphysis, and anterior to the rectum (Fig. 1).7 This 
non-vital gland surrounds the urethra and contributes secretions in the formation of semen. 
The presence of disease can lead to symptoms such as frequent urination, blood in the urine 
and semen, as well as discomfort from an enlarged prostate.8 Although these symptoms 
can be difficult and sometimes intolerable, metastatic disease that spreads through the body 
is the primary concern as five-year survival rates are approximately 30% relative to almost 
100% for local or regional prostate cancer.9 This variability in survival correlating with 
disease aggressiveness stresses the need for earlier cancer detection before late-stage 
disease development and more aggressive treatments for high-risk disease.  
1.1.2 Liver cancer 
Liver cancer is one of the fastest rising cancers in Canada. While it only represents less 
than 2% of all new cancer cases, liver cancer incidence in Canada has been increasing in 
males (3.3%) and females (2.7%), second only to thyroid cancer, based on the average 
annual percent change between 1984 and 2015.5 More concerning are the annual changes 
in mortality rates since 1984, which shows that liver cancer is the highest statistically 
significant (p < 0.001) increasing change in males (3.1%) and females (2.2%).5 Once 
diagnosed with the disease, the prognosis is poor as liver cancer has the fourth-lowest five-
year net survival rate (19%). This rate is also an underestimate relative to other sources as 
it does not consider cancers of the intrahepatic bile duct or the large number of unspecified 
cases based on primary or metastatic classifications, which would increase the number of 
cases by 45.9%.5 
These statistics get worse on a global scale as liver cancer accounts for the fifth and ninth-
highest incidence rates for cancer and the second and sixth-highest mortality rates, for men 
and women respectively.10 One major cause for the high mortality rate is the asymptomatic 
nature of most primary liver cancers with very few to nonexistent traditional cancer 
markers, like bleeding and palpable lesions. This leads to large and late-stage tumor 
diagnoses that are less treatable with curative intent. However, improvements in early 
detection of liver cancer have been observed more recently, partially attributed to the 
widespread use of ultrasound screening for individuals at risk for liver cancer.11 
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Figure 1.2 Local anatomy in the abdomen surrounding the liver. 
The liver is the largest solid organ in the body located inferiorly to the diaphragm and 
normally resting against the lateral and anterior abdominal walls. It is predominantly 
divided into two lobes (i.e., right and left) by the falciform ligament, but it is often more 
finely divided into eight segments unequally distributed between the two lobes and in 
relation to the hepatic arterial, portal, and biliary drainage.7 The primary functions of the 
liver are to produce bile for digestion, process nutrients and drugs, and filter blood from 
the stomach and intestines. 
The most common subtype of liver cancer is hepatocellular carcinoma (HCC) and is highly 
prevalent in low-income and developing countries.11 Liver cancer is predominantly due to 
the incidence of hepatitis B and C viruses12,13 and is often preceded by cirrhosis (scarring), 
but includes other risk factors like excessive alcohol consumption, smoking, fatty liver 
disease, diabetes, obesity, and aflatoxin (produced by some fungi on crops, like corn and 
peanuts14) exposure.5,12 Although increases in mortality rates have been mostly attributed 
to hepatitis and alcohol consumption,12 universal vaccinations against hepatitis B have 
been shown to reduce the incidence of HCC with statistical significance.15 The liver is also 
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a frequent site for metastatic cancer originating from other parts of the body, such as the 
lung, breast, pancreas, gastrointestinal tract and lymphatic system.12 
1.2 Conventional therapeutic options 
1.2.1 Prostate cancer 
Over-diagnoses of prostate cancer has been a concern with the increased use of prostate-
specific antigen (PSA) for screening as many prostate cancers would not affect quality or 
quantity of life if left undetected.16 Recent Canadian guidelines in 2014 have mirrored the 
decisions from the United States Preventive Services Task Force to decrease PSA 
screening in men over 75 and asymptomatic men, which has resulted in a 9% decrease in 
the annual percent change for prostate cancer incidence since 2011.17 Although surgery, 
radiation, and drug-based therapies are effective in the management of prostate cancer, 
recent motivation has been focused towards conservative management techniques and 
focal methods of treatment.18 
1.2.1.1 Active surveillance 
Active surveillance refers to deferring treatment and observing patients with serial PSA 
assessments, repeated biopsies, and other recurring diagnostic exams to wait until low-risk 
disease shows signs of higher-risk and likely well within the window of opportunity for 
cure.19 Concerns with overtreatment of low-risk prostate cancer have led to increases in the 
number of patients recommended for active surveillance; for example, the percentage of 
patients with low-risk disease in the United States on active surveillance increased from 
15% to 42% in 2015,20 with the majority of increases in patients over age 75.9  
1.2.1.2 Radical prostatectomy 
Radical prostatectomy is a surgical procedure that completely removes the prostate gland 
and its attachments around the base of the bladder.7 This procedure is considered an 
excellent treatment option for patients with early prostate cancer;21 however, side effects 
include incontinence, impotence, and altered bowel habits with approximately 35% of 
patients experiencing biochemical recurrence within ten years.22 Following recent 
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guidelines to reduce overtreatment of low-risk disease, prostatectomies have declined from 
47% to 31% as of 2015.20 
1.2.1.3 Systemic treatments 
Advanced prostate cancer that has metastasized beyond the prostate is most often treated 
using androgen deprivation or chemotherapy.9 Androgens like testosterone and 
dihydrotestosterone are essential for the prostate and overexpression of the androgen 
signaling pathways are often observed in proliferating prostate tumor cells.23 Suppressing 
these hormones in the body is a foundational and mainstay treatment for advanced prostate 
cancer; however, not all prostate cancers respond to this form of therapy and many can 
develop into castration-resistant prostate cancer.24 The remaining treatment option is often 
chemotherapy with palliative intent,25 but the utility of involving chemotherapy at different 
stages of disease progression have been investigated.26  
1.2.1.4 External beam radiation therapy 
External beam radiation is a well-established form of therapy for low to intermediate-risk 
prostate cancer, with application to high-risk in some cases, and is often treated alone or in 
combination with androgen deprivation therapy.27 Radiation therapy is associated with 
improved long-term sexual function and urinary continence relative to prostatectomy, but 
patients have been observed to have worse bowel function and treatments are often long, 
typically requiring multiple weeks of treatment sessions.28 Recent evidence suggests that 
there is an increased risk of overall and prostate cancer-specific mortality compared to 
surgery for clinically-localized prostate cancer,29 but new techniques incorporating 
accurate imaging such as intensity-modulated and stereotactic radiation therapy have 
focused on increasing the dose-per-fraction to the prostate (reducing the overall physical 
dose), improving coverage of tumor volumes, and reducing adverse side effects through 
the use of smaller and more conformal fields.27,30 
1.2.1.5 Prostate brachytherapy 
Prostate brachytherapy refers to procedures where radioactive sources are implanted or 
brought within the prostate using needles, typically guided by a rigid template with 
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regularly spaced holes every 5 mm in a grid-like system. Prostate brachytherapy is most 
often used as a monotherapy to treat early, localized prostate cancer tumors31 and in 
combination with external beam therapy for intermediate and high-risk patients. This 
procedure involves either permanently implanting low-dose-rate (LDR) radioactive seeds 
or temporarily holding a high-dose-rate (HDR) radioactive source at specified positions in 
hollow needles based on calculated dwell time durations. Since the radioactive sources are 
implanted or temporarily held within the prostate, highly conformal dose distributions can 
be achieved with improved healthy tissue sparing of organs-at-risk, such as the bladder, 
urethra, and rectum, compared to external beam radiation.32 For intermediate and high-risk 
prostate cancer, brachytherapy can also be used to boost radiation dose to the tumor 
following external beam radiation therapy for a statistically significant benefit in 5-year 
biochemical-progression-free survival, but a complete understanding of long-term 
toxicities is still unknown.31 
1.2.2 Liver cancer 
Liver cancer is typically diagnosed using a combination of health history, physical and 
imaging examination, blood tests, and biopsy.33 Since the liver rests on the lateral and 
anterior abdominal walls, the liver is easily accessible and can be treated using open 
surgery or percutaneous (through the skin) approaches. Although it is generally understood 
that early detection of cancer can lead to improved survival outcomes, early-stage HCC is 
currently difficult to diagnose because it is usually a single, asymptomatic lesion measuring 
less than two centimeters in diameter, with no vascular or distant metastases.34 
1.2.2.1 Transplantation or resection 
Resection and transplantation have conventionally been the curative surgical options of 
choice for treating patients with HCC.35 This is either the removal of some of the liver 
segments or the entire organ, depending on the number, location, and spread of the 
disease.36 Surgical resection is usually considered for early-stage HCC with a single lesion 
less than three centimeters,35 sometimes with up to three lesions,12 as sufficient remaining 
liver function is necessary for survival.36 The presence of comorbidities, such as cirrhosis, 
8 
 
can increase the risk of HCC recurrence after liver resection and typically motivates the 
need for other treatment options, like transplantation.  
Transplantation is a desirable method for curing liver cancer as it has the potential to 
remove localized tumors and underlying cirrhosis, which presents as complications in other 
forms for therapy. Although transplantation is the preferred treatment modality for patients 
with solitary HCC, poor liver function, or multifocal HCC, patient eligibility is low, 
complications can be frequent and severe, and the lack of consistent donors leads to long 
waiting times.37 Both resection and transplantation are limited to approximately 10% to 
20% of patients36 and even if the patient is eligible for this type of procedure, complications 
rates have been observed to be approximately 26% in resection and 33% in 
transplantation.38 Also, conventional techniques to treat and manage individuals with liver 
cancer have been typically associated with high costs, both clinically and financially, with 
the scarcity of liver donors often leading to a preferential selection of other alternatives, 
such as liver ablation.12 
1.2.2.2 Chemotherapy 
Advanced-stage liver cancer that has spread beyond the organ to local nodes and distant 
sites or has invaded the portal or hepatic veins typically have very few options for therapy. 
Standard chemotherapy is not tolerated well and has not been shown to be effective in 
treating advanced HCC.12 The most recognized treatment option for advanced-stage liver 
cancer with well-preserved liver function is chemotherapy treatment with a molecular 
target agent, sorafenib, to slow tumor proliferation and angiogenesis, but overall survival 
is usually only extended by two to seven months.39,40 
1.2.2.3 External beam radiation therapy  
External beam radiation has been used increasingly in the treatment of liver cancer due to 
advances in planning and delivery that have improved sparing of the radiosensitive healthy 
tissue.12 Radiation therapy is most often ideal for early to intermediate-stage liver cancer 
and is most often recommended when other techniques are not possible or as a bridge to 
transplantation.41 Breathing motion and liver position changes can make it difficult for 
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radiation therapy, but advances in imaging and liver motion tracking have led to more 
investigation into conformal radiation delivery, dose-escalation, and fewer fractions of 
therapy.42 
1.2.2.4 Embolization 
Intermediate stage liver cancer typically refers to a multinodular disease that has either 
more than three lesions or two to three lesions with at least one greater than five 
centimeters.37 Patients showing signs of this stage are often treated with embolization,43 
with the most common form being transarterial chemoembolization (TACE), which 
focuses on inducing tumor necrosis by acute arterial occlusion with the addition of 
chemotherapeutic drugs.36 These are typically salvage or bridge therapies for patients with 
preserved liver function and do not usually have curative intent as complete necrosis is not 
typically achieved for larger tumors due to incomplete embolization and tumor 
angiogenesis.35 Approaches that combine TACE with other procedures have been 
investigated for tumors larger than three centimeters to make patients eligible for other 
curative approaches,44 with the use of TACE post-resection showing benefits compared to 
other anti-recurrence therapies.45 Embolization can also be performed using radiation 
sources, such as Yttrium-90, with evidence suggesting potential benefits for patients with 
advanced tumor stages and few treatment options.46 
1.2.2.5 Ablation 
Ablation techniques are considered the best treatment alternatives for HCC patients who 
are not eligible for surgical techniques.36 Tumor ablation is defined as the direct application 
of therapies to eradicate or substantially destroy focal tumors, either using chemicals or 
energy-based (i.e., thermal or non-thermal) approaches.47 These ablation approaches can 
include the use of ethanol, radiofrequency, microwave, freezing (cryo), laser, high-
frequency ultrasound, and irreversible electroporation.48 Therapy is applied through the use 
of applicators, such as electrodes in radiofrequency ablation (RFA), antennas in microwave 
ablation, or fibres in laser ablation, to provide a focal region of therapy. These procedures 
can be used in a palliative setting for pain management, but also has the potential for 
curative intent on early-stage or small tumors. For example, RFA is considered a first-line 
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treatment option for HCC in the liver49 and has been shown to have similar survival as a 
resection for solitary lesions less than five centimeters with well-preserved liver function.50 
Since these procedures have small incision sites, these minimally or less-invasive 
procedures have been observed to result in procedures with a rate of complications of less 
than 2%.51 In addition, these procedures are often associated with lower costs as treatment 
times, hospital stays, and the need for blood transfusions are reduced.34 
The most common treatment approaches for tumor ablation in the abdomen are either RFA 
or microwave ablation (MWA). These thermal methods both focus on the production of 
heat for tissue ablation but have different mechanisms of heat production that require 
different equipment and application techniques. RFA techniques use applicators that are 
needle-like and typically use a single monopolar active applicator, occasionally separating 
at the tip into multiple tines for a larger ablation volume, with a 375-500 kHz alternating 
current dissipating at one or more grounding pads to produce resistive heat.47,52 MWA uses 
needle-like applicators without the need for grounding pads and generates microwaves with 
a frequency between 915 MHz and 2.45 GHz to produce frictional heat from oscillating 
water molecules.52 Both techniques allow for multiple applicators to be placed, depending 
on the size and geometry of the lesion being targeted for therapy, but MWA can also allow 
for simultaneous activation of applicators to exploit electromagnetic field overlap. Aside 
from the current size of the MWA applicators, this method has the potential to offer 
improved performance over RFA.52 Although both methods have numerous benefits, one 
limitation is the proximity of lesions to large vessels as sufficient heating cannot be 
achieved due to the heat sink effect, which requires other forms of therapy. The placement 
accuracy of the therapeutic applicators is also critical for procedure success due to the 
percutaneous nature of these procedures and the focal volume of therapy. Unfortunately, 
current approaches have been observed to show a range of local cancer recurrence rates 
between 6-39% of patients treated for HCC or colorectal liver metastases.4,41,50,53 
1.3 3D Image-guided interventions 
Medical imaging can have an impact on nearly every aspect of interventions to achieve 
successful diagnostic or therapeutic outcomes. Classification for the use of medical images 
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throughout a procedure is most often separated based on five separate categories: planning, 
targeting, monitoring, modification, and assessment.54 With the wide use of digital images, 
recent advancements have focused on merging or fusing 3D images in different 
combinations from these categories, alongside image processing for clinical workflow 
improvements, for improving patient side-effects and outcomes in various image-guided 
interventions related to prostate and liver cancer.  
1.3.1 MR-TRUS fusion biopsy 
 
Figure 1.3 Image-guidance pipeline for MR-TRUS fusion-guided prostate biopsy. The 
prostate (yellow) and regions suspicious of cancer (red) identified in MRI can be targeted 
using real-time 2D US guidance for biopsy sampling after two image registration steps. 
Concerns of prostate cancer over-diagnosis with over-treatment and missed diagnoses 
using conventional biopsy techniques have led to the development of a targeted magnetic 
resonance (MR)-transrectal ultrasound (TRUS) fusion biopsy approach.55 The 
conventional technique for definitive diagnosis of prostate cancer is a template biopsy 
method that typically samples six to twelve tissue regions using biopsy cores guided by 2D 
US, which are processed and examined histologically for prostate cancer.56 In contrast, 
fusion biopsy uses preoperative multi-parametric MR images, including T1-weighted, T2-
weighted, diffusion-weighted, and dynamic contrast-enhanced imaging,57 fused with 
intraoperative US images to perform sampling of suspicious cancer regions determined 
using both image modalities. This forms an imaging pipeline where the preoperative MR 
3D MRI 3D TRUS 2D TRUS 
Preoperative Intraoperative 
Registration Registration 
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image is registered to an intraoperative 3D TRUS image, followed by a subsequent 
registration between the 3D TRUS image and live 2D TRUS images.58 Although MR-
guided systems without TRUS have been developed,59 this combination of imaging 
modalities allows for an outpatient procedure without costly interventional suites. The 
combination of US with multiple MR imaging sequences enables the physician to perform 
targeted biopsies based on the superior soft-tissue contrast and functional information from 
MR images, while still using real-time and lower cost image guidance provided from US 
imaging.  
One of the main factors contributing to the success of an MR-TRUS guided procedure is 
the detection of clinically significant prostate cancer. Clinically significant prostate cancer 
has been defined60 as a tumor with a volume greater than 0.5 cm3, which is comparable to 
a sphere with a radius of 5 mm. When using an MR-TRUS fusion approach, evidence has 
been shown that clinically significant prostate cancer is sampled more frequently and with 
fewer biopsy cores, leading to less detection of clinically insignificant cancer.61 Results 
from the Prostate MR Imaging Study (PROMIS) showed that primary biopsy can also be 
avoided in approximately 27% of patients and MR images can also be used to direct TRUS 
biopsy to detect 18% more cases with clinically significant prostate cancer,62 potentially 
reducing the misdiagnosis and overtreatment of prostate cancer. 
1.3.2 3D US-guided brachytherapy 
Brachytherapy approaches rely on the accurate guidance of needles to place radiation 
sources at planned locations to achieve sufficient therapy while sparing healthy organs at 
risk. Prostate cancer applications typically use 2D US as the standard of care for guiding 
approximately 10-20 needles to planned locations as it is portable, inexpensive, real-time, 
and does not use ionizing radiation.63 Based on an accurate volume and shape of the 
prostate relative to the inserted needles, radiation plans can be computed and optimized to 
produce 3D patient-specific therapies.64 Methods have been investigated to incorporate 
CT65 or MR66 images for planning, but the widespread use of US has many practical 
advantages as the entire procedure can be completed without moving the patient, which 
saves time, resources, and clinical costs.67 However, 2D US images rely on the subjectivity 
of the physician to mentally form an impression of the 3D anatomical space, which can 
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introduce variability when determining needle positions relative to their intended targets 
for therapy and away from organs at risk, such as the rectum and urethra.68 These images 
also do not inherently allow for the required accurate 3D prostate volume and shape for 
gland dose calculation, requiring interpolation and approximations based on limited fields-
of-view.  
Generating 3D US images for prostate brachytherapy can provide a solution for the 
limitations of conventional 2D US techniques and can be acquired using different 
geometries depending on the transducers available and structures of interest. End-fire 
transrectal ultrasound (TRUS) probes are often used for biopsy procedures as they can 
allow for improved sampling in the sagittal and transverse sections of the prostate,69 but 
are often difficult to use during brachytherapy when inserting multiple needles at a time 
and correlating the US images relative to the guidance template. Side-fire TRUS probes 
can take advantage of sagittal transducer elements, which generate submillimeter spatial 
resolution in the needle insertion directions that can lead to <1 mm tip localization 
uncertainty during prostate brachytherapy.70 Side-fire probes can also be combined with 
transverse US elements to form biplane probes for accurately identifying the central cross-
section of the needles for determining 3D needle trajectories and offer simple pull-back 3D 
US image reconstruction with the use of commercial steppers (Civco Medical Instruments, 
Iowa, United States). 
Motorized 3D US systems have been developed for prostate brachytherapy applications to 
provide consistent and repeatable image reconstructions while enabling approaches to 
return the US probe to implants at later time points.71,72 3D US systems have also been 
developed for brachytherapy applications treating breast73 and gynecologic cancers,74 
which similarly requires the precise placement and identification of needles for sufficient 
therapy and avoiding organs-at-risk. Regardless of the anatomical location being treated 
with 3D US-guided brachytherapy or the chosen dose-rate approach, localizing needle tips 
and trajectories accurately is necessary for correct computation of dose plans. 
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1.3.3 Image-guided ablation 
The use of CT, MR, and 2D US imaging for the five main categories of image-guided 
interventions have been investigated for increasing the feasibility and scope of focal 
ablation procedures in the liver. CT images provide a versatile utility for ablation 
procedures as they are used preoperatively to identify the presence of cancer (typically 
using intravenous contrast material),54 intraoperatively for intermittent images with partial 
access during applicator insertions and verification of placement,75 and postoperatively for 
follow-up.76 CT fluoroscopy can be used for near real-time intraoperative imaging, but 
radiation exposure to the patient and personnel is a major consideration.77  
MR images have also been used as they offer advantages such as improved soft-tissue 
contrast, nonionizing radiation, and the potential for real-time treatment monitoring,78 but 
intraoperative access to the patient is often limited and the need for real-time images 
typically reduces the achievable image resolution and contrast,79 all with higher associated 
costs. The use of 2D US for real-time image feedback is beneficial when placing 
therapeutic ablation applicators intraoperatively in the treatment of liver cancer and also 
does not use ionizing radiation. However, similar to issues experienced in biopsy and 
brachytherapy, these images can increase the burden on the physician as they need to 
mentally reconstruct the complex anatomy, which can introduce subjective image guidance 
variability. These 2D US-guided insertions also require extensive training to interpret the 
US images, perform image and applicator alignment for real-time tracking of the applicator 
insertion, and verification of the final placement to assess expected therapeutic margins. 
CT, MR, and 2D US images all have aspects that make them advantageous for image-
guided ablation procedures, but variability in therapy applicator image-guidance still 
remains, which leads to the insufficient placement of therapeutic applicators, contributing 
to the local cancer recurrence rates as discussed in Sec. 1.2.2.5. 
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1.4 Image processing in image-guided interventions 
1.4.1 Image-based registration 
Image registration is an image processing technique that spatially aligns two or more 
images of the same scene taken from different times, viewpoints, and/or image 
modalities.80 Use of the image signal intensity information to perform spatial alignment 
refers to image-based registration techniques, which can be performed in multiple ways 
and is dependent on the choices made on four main components: image similarity metric, 
optimization approach, transformation degrees-of-freedom (DoF), and interpolator.81 In 
general, the image similarity metric provides the quantitative measure for comparing 
different transformations sampled using an optimization approach, with voxel interpolation 
to resample the image in the new coordinate system. Transformations can be performed 
simply using image translations and rotations, as in a rigid approach, up to complex 
operations like pixel-wise deformations, as in a non-rigid deformable approach.82 These 
choices not only influence the accuracy of an image-based registration approach but also 
the computer computation time required to perform the operations, which can be an 
important factor for practical implementation during procedures with intraoperative image-
guidance. 
1.4.2 Image-based segmentation 
Image segmentation, labeling, or contouring refers to the process of classifying image 
pixels or identifying boundaries corresponding to image regions that share relevant 
characteristics, like an organ or an interventional tool.83 This can be done manually by 
drawing regions in the image or identifying points that are later joined using defined 
assumptions, which is often the gold-standard method for an image segmentation task. 
However, due to the user-required effort, this is often a time-consuming process that can 
be a limiting factor for clinical workflow, as is the case for some intraoperative 
interventions like MR-TRUS fusion biopsy. Since this limitation can occasionally prevent 
the clinical adoption of image-guided interventions, the frequent investigation into semi-
automated and fully automated methods are performed to ease the burden on the user.84 
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Artificial intelligence is a broad umbrella term that is defined as any device that perceives 
its environment and takes actions that maximize its chance of success at some goal.85 
Recent efforts into fully automated segmentation methods have focused on data-driven 
approaches, such as convolutional neural networks (CNNs), which reduce the amount of 
user selection when determining relevant image features for discriminating image regions, 
referred to as hand-crafted features in traditional machine learning.86 Data-driven 
approaches are performed by supplying an algorithm with previously acquired data and 
allowing optimization methods to determine the relevant image characteristics through 
training of model parameters. This approach is often referred to as deep learning, which 
can be either performed using a supervised approach, where images with previously 
identified regions are provided for training, or an unsupervised approach, where only the 
images are given and the algorithm tries to automatically determine inferences without 
training labels. The development of graphics processing units (GPUs) has made deep 
learning approaches more feasible as they allow for highly parallel and simultaneous 
computational processing, unlike more traditional central processing units.87 While 
supervised learning requires more effort to produce a large enough dataset with required 
annotations, typically performed manually, unsupervised learning is more challenging and 
often requires larger datasets to determine reliable inferences. However, providing 
annotations for supervised deep learning tasks is often performed manually, which can 
incorporate errors and biases into the trained deep learning network.88 
1.5 Challenges in image-guided interventions 
1.5.1 Previous work and unmet needs 
1.5.1.1 Motion compensation during MR-TRUS fusion biopsy 
Performing image-based registration during MR-TRUS guided biopsy has been 
investigated previously to correct for intraoperative patient and prostate motion for 
accurate needle delivery. Accurate needle sampling during fusion biopsy is typically 
achieved when errors from four main sources throughout the workflow are minimal, 
namely (1) the mechanical guidance system,55 (2) MR-3D TRUS multi-modal 
registration,89 (3) 3D-3D TRUS preprocedural initialization and intraoperative 
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correction,90 and (4) 2D-3D TRUS motion compensation.58 In the last form of correction, 
real-time image guidance is performed using live 2D TRUS images, typically on a US 
system with an image refresh rate of approximately 15 frames-per-second, providing the 
information needed for an image-based registration.  
Since the patient is awake and not constrained or intubated during the MR-TRUS fusion 
biopsy, prostate motion arises due to sources including the respiratory cycle, the cardiac 
cycle, and general patient motion from discomfort and response to audible feedback from 
the spring-driven biopsy gun. TRUS transducer pressure caused by the physician can also 
change throughout the image-guided procedure, potentially leading to prostate 
deformations. These sources of motion can cause target misalignment,90 which increases 
needle targeting errors and the chance of missing cancer suspicious regions based on the 
registered MR image. To accurately sample a target, recent work has shown that a needle 
delivery system, including hardware and image-guidance software, requires an overall 
delivery error of 1.6 mm to sample a tumor of 1 cm3 with 95% probability.91 
2D-3D TRUS registration has been performed with promising results using a normalized 
cross-correlation (NCC) similarity metric and a Powell optimization to determine rigid 
registration corrections.58 The choice to use an NCC similarity metric is beneficial for 
single modality registration problems as it does not rely on the computation of derivatives, 
which can be time-intensive and often unknown, while also inherently being suitable for 
computational parallelization on simultaneous threads provided by GPU hardware. These 
advantages allow for faster processing and lower overall computation times, with the 
potential to be performed throughout the course of a fusion biopsy. However, computation 
times must be less than or equal to the displayed images to provide a seamless appearance 
without lag, which is often necessary for usability. In addition to physician usability, a 
continuous and automatic approach has the potential to compound errors throughout the 
procedure based on previous misalignments and has not been investigated. 
1.5.1.2 Prostate segmentation in 3D TRUS 
3D image-guided procedures in the prostate, such as MR-TRUS fusion biopsy and 
brachytherapy, rely on the identification of the pixels and boundary of the prostate gland 
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in 3D TRUS images for performing necessary workflow tasks like accurate needle 
guidance, gland volume computation, and dose calculations. Conventional workflows 
typically rely on the gold standard manual identification of the prostate in these images, 
but this process is time-consuming and can be variable due to physician subjectivity, which 
can increase the risk to patients during procedures that use anesthesia.92 Therefore, the 
investigation into automatic approaches for prostate segmentation in 3D TRUS images 
potentially provides an effective solution for providing a fast and objective method to 
improve clinical workflow during 3D US-guided prostate procedures. 
3D TRUS prostate segmentation that is partial or fully automatic has been previously 
investigated and has been shown to be feasible in numerous publications.93–96 
Unfortunately, 3D TRUS prostate segmentation still remains a clinically unmet need as 
investigated methods have lacked clinical translation due to computation complexity and 
time. Most recently, the data-driven approach of CNNs have been investigated to address 
these issues,97,98 but minimal evidence of robustness to variable clinical datasets has been 
shown as these methods have been applied to specific and limited dataset sizes. 3D TRUS 
images previously investigated are typically from a single US machine and one acquisition 
geometry with matched voxel dimensions and sizes, which can limit understanding of 
performance, especially when pursuing cross-validation approaches. Additionally, 
comparison between previous publications can be challenging when not assessed on the 
same dataset and when reported evaluation metrics are not consistent. 
1.5.1.3 Image-guidance during focal liver tumor therapies 
Focal liver tumor therapies rely on the accurate guidance of ablation applicators to provide 
sufficient cancer therapy. Procedures that incorporate 3D information, such as CT 
imaging,99 MR imaging,78 and electromagnetic tool tracking,100 have been shown to 
improve targeting accuracy that leads to higher clinical success rates on first ablation 
attempts and fewer sessions overall when compared to conventional techniques.101,102 
However, these methods can be limited in widespread adoption as factors like increased 
procedure times, patient radiation dose, sophisticated and costly interventional suites, and 
environmental limitations can make these approaches less feasible. Therefore, a clinical 
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need exists for a cost-effective intraoperative approach that can help physicians improve 
the image guidance to lesions for sufficient cancer therapy without local recurrence. 
3D US is an alternative method for image guidance that can provide real-time 
intraoperative imaging that is portable and able to provide multiplanar images for 
visualizing complex anatomy and focal therapy ablation applicators.103,104 Similar to a 
prostate fusion biopsy or brachytherapy workflow, a mechanical 3D US system has been 
previously developed that has the potential to provide a lower-cost guidance system for 
accurately targeting lesions based on targets derived in 3D US or other image modalities if 
registered.105 While this system provided sufficient proof-of-concept information on 
clinical feasibility and validation of needle positions within 3D US images, clinical 
usability was limited due to factors like manual locking components, scanner bulkiness, 
and a lack of tracking information for guidance, and was never investigated for performing 
active navigation to prospective targets. 
1.5.1.4 Segmentation of therapy applicators in 3D US liver images 
3D US imaging and systems like the one described in Sec. 1.5.1.3 have the potential to 
improve focal liver tumor therapies by increasing visualization of anatomy, reducing the 
mental burden and complexity for physicians, and enabling accurate localization of therapy 
needle-like applicators. Although 3D US has the potential to provide benefits to these 
procedures, increasing the visual information presented to the physician could add time to 
the procedure and visibility of the needle applicators can change depending on factors such 
as insertion angle, depth, applicator diameter, and choice of US transducer.106 Providing 
automation to applicator identification based on image information may provide a low-cost 
solution to reduce the time required for verifying applicator positions, especially during 
multi-applicator insertions, increasing the feasibility of incorporating 3D US into focal 
liver tumor ablation therapies. 
Existing methods for image-based 3D US applicator segmentation have primarily focused 
on other needle applications for the prostate,107 breast,108 heart,109 and anesthetic 
administration,110 where factors affecting needle visibility are drastically different. Deep 
applicator insertions up to 30 cm and steep insertion angles relative to the US transducer 
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result in challenging images for determining tip and trajectory information necessary for 
assessing the expected therapeutic volumes in focal liver ablation therapies. A clinical 
dataset on liver patients has also not been investigated and could present unexpected issues 
relative to current work on other applications and benchtop experiments. 
1.5.1.5 Segmentation of tools during 2D US interventions 
Identifying and localizing needle-like tools intraoperatively is a common need in image-
guided interventions that conventionally use 2D US imaging, such as biopsy, 
brachytherapy, and ablation, for guiding these tools to perform accurate diagnoses and 
therapies. Although technology like 3D US imaging has the potential to improve tool 
localization and verification, as described in Sec. 1.5.1.4, 2D US is still the clinical standard 
at most institutions for image-guided interventions. Thus, clinical needs for improving 
guidance still exist for providing optimal therapy while minimizing risks to healthy tissue 
and to avoid adverse events like local cancer recurrence.111 By using technology like 
image-based segmentation for automatic tool segmentation, a low-cost solution with the 
potential for widespread accessibility could be provided in these situations without the need 
for additional equipment, signal processing, and operating room set-up. Once tools are 
accurately identified, additional information can also be displayed, such as providing 
ablation volumes relative to the tip location in focal liver ablation therapies to predict 
therapeutic margins during applicator insertion, which could potentially improve clinical 
workflow and reduce the need for repeated adjustments and reinsertions.  
Recent efforts focusing on automatic image-based tool segmentation in 2D US images have 
investigated the use of data-driven approaches, like CNNs, to provide robust methods with 
fast computation times for image-guided interventions.112,113 Using annotated datasets for 
training deep learning networks, applications in procedures with steep needles112 and 
kidney biopsy113 have shown promising results for using CNN approaches. Although tools 
in many interventional procedures have similar needle-like appearances, most approaches 
for image-based tool segmentation in 2D US images are application-specific and lack 
evidence for generalizability, such as evaluation on other anatomical applications, US 
systems and acquisition settings, and variable tool visibility. 
21 
 
1.5.2 Hypothesis 
The central hypothesis of this thesis is that the incorporation of 3D US and advanced image 
processing techniques will increase the accuracy and reduce the user variability of image-
guided interventions in the management of prostate and liver cancer. 
1.5.3 Objectives 
The objectives of this thesis are to: 
1. Develop an automatic motion correction algorithm approaching the frame rate of 
an US system to be used in fusion-based 3D TRUS prostate biopsy systems. 
2. Develop a pre-insertion automatic deep learning-based approach to segment the 
prostate for biopsy and brachytherapy applications in 3D TRUS images. 
3. Develop a geometrically variable 3D US mechanically assisted system to guide and 
verify the placement of therapy needle applicators in focal liver tumor therapy. 
4. Develop a semi-automatic approach for identifying therapy needle applicators in 
3D US images from focal liver tumor therapies. 
5. Develop a general and automatic deep learning-based approach for identifying 
needle-like tools in 2D US images from various image-guided interventional 
procedures. 
1.6 Thesis outline 
The overarching goal of this thesis is to address the specific thesis objectives in five 
manuscripts (Chapters 2 to 6). 
Chapter 2: Real-time registration of 3D to 2D ultrasound images for image-guided 
prostate biopsy 
Patient motion can be continuous or intermittent throughout MR-TRUS prostate biopsy 
procedures and causes misalignment of the MR-derived targets during targeted biopsy 
workflows. This chapter describes our work to develop a real-time and continuous motion 
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compensation algorithm for automatic registration of 2D and 3D TRUS images. 
Retrospective patient images were used for adapting, developing, and optimizing the real-
time capabilities of a previously published approach58 through the use of a GPU, image 
downsampling, 2D area-of-interest cropping, and optimization search space direction 
initialization. The optimized algorithm was implemented on a 3D TRUS-guided system 
and evaluated on a tissue-mimicking prostate phantom with embedded spheres. This 
phantom was mounted on a translation and rotation stage to compare the real-time 
registration method against a single user-initiated correction for known displacements. 
The optimized continuous registration method was shown to significantly reduce 
registration times compared to a user-initiated method and resulted in sub-millimeter and 
sub-degree registration errors for both approaches. By continually registering images, 
optimization search spaces are often small between subsequent image frames and led to 
reduced iterations for convergence. This work was novel as it developed the first approach 
to achieve 2D to 3D TRUS image registrations that resulted in computation times 
approximately at the frame rate of an US system. This provided an approach to improve 
clinical workflow during image-guided prostate biopsy procedures. 
Chapter 3: Automatic prostate segmentation using deep-learning on clinically diverse 
3D transrectal ultrasound images 
3D TRUS imaging has been shown to benefit needle-based procedures for diagnosing and 
treating prostate cancer (i.e., biopsy and brachytherapy); however, these images require the 
physician to manually or semi-automatically segment the prostate, which is time-
consuming and difficult, often occurring while the patient is under sedation or anesthesia. 
This novelty and literature contributions of this chapter focuses on the development of a 
new deep learning-based approach to automatically segment the prostate in a clinically 
diverse 3D TRUS dataset. Modifications were made to a previously published deep 
learning U-Net architecture114 and 3D TRUS images were acquired from different 
procedures (biopsy and brachytherapy), acquisition geometries (end-fire and side-fire), and 
ultrasound systems. We developed a 3D segmentation method involving deep-learning 
predictions on 2D radial slices, followed by reconstruction into a 3D surface, to exploit the 
utility of the 3D TRUS dataset and take advantage of the approximately spherical nature 
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of the prostate. This method was compared to fully 3D approaches and evaluations were 
performed on an extensive variety of metrics to provide a comparison to other published 
methods and a baseline for future comparisons. 
The automatic prostate segmentation method performed with significant improvement over 
fully 3D approaches and other recently published methods. The automatic prostate 
segmentation method on 3D TRUS images was shown to be fast, accurate, and 
generalizable, providing promising results for clinical translation and application to other 
3D TRUS geometries (i.e., pull-back 3D TRUS images). This method has the potential to 
decrease overall clinical procedure times and anesthesia risks during prostate biopsy and 
brachytherapy. 
Chapter 4: Geometrically variable three-dimensional ultrasound for mechanically 
assisted image-guided therapy of focal liver cancer tumors 
Image-guided focal liver ablation procedures provide numerous benefits compared to other 
liver cancer therapeutic techniques, such as reduced recovery times and complication rates; 
however, insufficient targeting and coverage of ablation volumes have been shown to limit 
these procedures and the scope of eligible patients. This chapter is on the development and 
evaluation of a novel geometrically variable 3D ultrasound scanner, mechanically assisted 
system, and 3D-printed therapy applicator guide to provide methods for imaging and 
guiding focal ablations to the diverse anatomical locations and presentations of liver 
tumors. The system was evaluated for image reconstruction with a grid phantom, tracking 
system accuracy when compared to optical tracking, image-guidance using three different 
navigation approaches in end-to-end mock ablation phantom procedures, and clinical 
feasibility through healthy volunteer imaging.  
The system resulted in ≤3% mean geometric reconstruction errors, <7% volumetric 
reconstruction errors, and <2 mm mean tracking system errors. A combined navigation 
approach that used the scanner motors and tracking system for in-plane image corrections 
resulted in the best performing mean needle targeting errors with <4.3 mm based on 
external cone-beam CT imaging. Healthy volunteer imaging resulting in good qualitative 
images and evidence for sufficient clinical feasibility. Our system provides approaches for 
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improving liver tumor therapy targeting and has the potential for application to other 
abdominal interventions and widespread accessibility to developing countries. 
Chapter 5: Three-dimensional therapy needle applicator segmentation for 
ultrasound-guided focal liver ablation 
The 3D US system described in Chapter 4 can benefit from the addition of software tools 
to improve clinical workflow and improve localization of applicators in focal liver tumor 
ablation therapies. Local cancer recurrence remains high in these procedures and current 
limitations still exist for verifying applicator positions in 3D US liver images. This arises 
since localization accuracy is impacted by factors including the applicator insertion angle, 
depth, and size, in addition to the choice of the transducer and local anatomic acoustic 
reflections. This chapter focuses on the development and evaluation of a new 3D US semi-
automated therapy applicator segmentation algorithm for in-vivo 3D US clinically imaged 
applicators used in focal liver tumor ablations. While general needle-like segmentation 
algorithms for 3D US have been discussed in the literature and tested on tissue mimicking 
models, such as agar, chicken breast, bovine, and porcine tissues, this work is novel as it 
provides evaluation on in-vivo clinically acquired 3D US images, which has not been 
reported for the unique imaging characteristics of needle applicators used in percutaneous 
liver tumor ablations. 
The segmentation method aims to provide an intraoperative tool using a single point to 
reduce the complexity of the segmentation problem. Optimization was performed on 
homogeneous tissue-mimicking phantoms prior to a user study on clinical 3D US images.  
Trajectory, axis localization, and tip localization errors were evaluated and suggested the 
approach could be useful in a clinical environment when paired with a 3D US system. 
Chapter 6: A deep learning method for general needle and applicator segmentation 
in two-dimensional ultrasound images from multiple applications and anatomical 
regions 
Many image-guided interventions rely on the temporal resolution of 2D US to perform 
optimal needle-like tool insertions for achieving sufficient diagnoses and treatments of 
cancer. Accurate identification of tools in these images can be challenging with previously 
investigated software methods developing application-specific approaches for automatic 
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tool segmentation. This chapter is on the development of a new general deep learning-
based approach with post-processing to automatically segment tools in 2D US images for 
a wide range of clinical procedures. This can be paired with other interventional tools, such 
as those described in Chapters 4 and 5, to further improve the clinical workflow and 
targeting of needle-like tools. Unlike any other approach, this method was evaluated on a 
clinically diverse dataset from prostate and gynecologic brachytherapy, liver ablation, and 
kidney biopsy and ablation procedures, where tool appearance drastically varies. 
Segmentation performed the best when using a random sample consensus post-processing 
technique, but at the cost of increased segmentation time. Image-guided interventions with 
tools parallel to the US probe surface (i.e., prostate and gynecologic regions) performed 
the best due to tool contrast and decreased performance was observed as tool angulation 
increased (i.e., in liver and kidney regions). Our method was able to perform predictions 
of these tools in near real-time and provides the potential for improving image guidance 
during a broad range of cancer interventions. 
Chapter 7: Conclusions and future work 
This chapter focuses on the overall conclusions of the previous chapters and will discuss 
future work that could potentially address remaining unmet needs from this thesis. 
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Chapter 2  
2 Real-time registration of 3D to 2D ultrasound images for 
image-guided prostate biopsy 
Real-time registration has the potential to continuously compensate for prostate motion 
during 3D TRUS-guided biopsy and may increase the accuracy of targeted biopsy 
approaches. The purpose of Chapter 2 is to present on the development of an automatic 
registration algorithm for 2D and 3D TRUS images. 
The contents of this chapter have previously been published in Medical Physics: Gillies 
DJ, Gardi L, De Silva T, Zhao S, and Fenster A. Medical Physics 2017; 44(9):4708-4723. 
Permission to reproduce this article was granted by John Wiley and Sons and is provided 
in Appendix B – Copyright Releases. 
2.1 Introduction 
Prostate cancer is a global burden, representing the second highest incidence of 
noncutaneous cancer found in men.1 Although prostate biopsy is the current clinical 
standard for definitive diagnosis of cancer, the efficacy of the conventional procedure lacks 
sensitivity with false negative rates up to 30%.2,3 During the past decade, investigators and 
companies have developed improved prostate biopsy techniques over the conventional 
transrectal ultrasound (TRUS) based sextant biopsy.4–7 Fusion biopsy is a notable method 
that involves an image fusion pipeline, which can register and overlay pre-procedural 
magnetic resonance (MR) images and biopsy targets onto a live, intra-operative 2D TRUS 
image. This approach typically employs a multi-step image registration process and has the 
ability to guide biopsy needles to suspicious localized tissues. With the widespread interest 
in fusion biopsy, the method is becoming predominant with the availability of commercial 
fusion prostate biopsy systems (e.g., UroNav, Artemis, BiopSee, Urostation, Virtual 
Navigator, and HI RVS/Real T time Virtual Sonography). Using these devices and others 
like them, many clinical investigations and studies are currently underway to verify if there 
is an improvement in cancer diagnosis over the conventional procedure.8–12 As a result of 
increased scrutiny, image guidance during prostate fusion biopsies has been identified as a 
method to improve the detection rates of cancer and depends on accurate targeting to 
correctly grade the aggressiveness of prostate cancer.13,14 To guide biopsy needles to their 
intended targets, image fusions resulting from accurate registrations of the preoperative 3D 
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MR and 3D TRUS images to the live 2D TRUS images are critical to reap the benefits of 
multimodal imaging. Any image misregistration between these planning and intraoperative 
images can prevent correct localization or display of intended targets, which can lead to 
missed cancer diagnoses.  
Methods to improve image guidance have been focused on refining different algorithms 
used in the multi-step image fusion pipeline. Previous studies have investigated how to 
accurately register preoperative 3D MR images to 3D TRUS images for biopsy target 
planning15–17 and also for 3D TRUS to 3D TRUS registration for preprocedural 
initialization and intraoperative correction.18,19 However, in an ideal situation where these 
registration techniques reduce the error to a negligible amount, needle guidance error 
remains hindered by external influences, such as prostate motion. Prostate motion due to 
TRUS transducer pressure and patient motion due to needle pain unrelieved by local 
anesthesia will cause misregistration of the intended MR identified targets with their actual 
locations. In these instances, motion of the prostate can be in the form of sudden, random 
reflexes or slow, systematic shifts and develops as procedural time increases. It is during 
the live 2D TRUS image registration step when the current image fusion pipeline can fail. 
Since the final stage of the current fusion pipeline aims to link all prior data to the live 2D 
TRUS image, it is crucial that this registration performs with sufficient accuracy. 
Misalignment between live 2D TRUS images and preoperative MR or 3D TRUS images 
has been observed up to 10 mm after initialization.19 It has also been shown that the number 
of attempts required to sample a clinically significant tumor increases as needle delivery 
error of a biopsy system increases.20 Among other techniques, 3D to 2D registration is 
invaluable to reduce needle delivery error and has been investigated in a broad spectrum 
of interventions.21,22 Therefore, to compensate for misalignment error caused by prostate 
motion, two correction methods are feasible: 1) performing a single, intermittent user 
initiated registration correction before firing the biopsy needle, and 2) automatic, 
continuous correcting for any prostate motion throughout the biopsy procedure. With the 
first solution, image fusion would be displayed throughout the procedure, but a user would 
determine when to perform a correction based on observed image dissimilarities. Although 
a short registration time is acceptable, decreasing the computational time to less than 1 or 
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2 seconds is not a priority. Since this approach requires user interaction, current registration 
procedures are performed in an acceptable amount of time while the user focuses on 
preparation of the biopsy gun and biopsy sample. With a continuous scheme, corrections 
can be performed in the background without any user interaction, registering preoperative 
image data, targets, and segmentations automatically. Procedures can be completed more 
effectively by reducing the number of steps that require user attention, which can reduce 
procedure times and patient discomfort. These proposed motion correction methods for the 
prostate should not exceed a registration error of 2.5 mm, which has been previously 
suggested based on the smallest clinically significant tumors with an approximate 5 mm 
radius.19,23 Keeping in mind that clinical translation is the key objective, image corrections 
performed at a real-time rate are also necessary to improve overall usability since user 
distraction can result if display lag is present. Thus, in the context of a TRUS-guided 
biopsy, we define real-time to be at or near the approximate frame rate of a conventional 
ultrasound system (i.e., greater than 15 Hz or a new frame less than every 67 ms) typically 
used for a prostate biopsy procedure. However, real-time corrections for prostate motion 
requires fast and robust live 2D TRUS registration to the 3D TRUS image acquired at the 
beginning of the procedure, which contains the MR identified targets. Occasional mis-
registrations due to lack of robustness may cause large aggregated misalignments in a 
continuous approach, whereas in a user-initiated, interactive approach, any unsatisfactory 
registrations could be disregarded and repeated at the user’s discretion, possibly acquiring 
more useful data.24 Therefore, real-time 2D TRUS to 3D TRUS registration to correct for 
any prostate motion while using an automatic, continuous strategy remains a challenging 
problem to solve.  
Recent work addressing 3D to 2D registration for prostate interventions has been focused 
on reducing registration error and improving image guidance by incorporating MR images 
and deformation estimation. With the use of a preprocedural 3D TRUS image to manually 
initialize the approximate location of a preoperative MRI, Zhang et al.25 proposed an 
automatic rigid registration method to fuse preoperative MR images directly to live 2D 
TRUS images during brachytherapy. Promising registration results were shown with target 
registration errors (TREs) of 1.37 mm and 2.52 mm for phantom and patient studies, 
respectively, corresponding to registration times of approximately 1 and 3 seconds 
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following their 3D TRUS manual initialization step. Although these registration times were 
shorter than previous attempts,7 this is still too slow for continuous real-time performance. 
As a solution for deformation occurring during prostate biopsy, Baumann et al.26 presented 
a 3D ultrasound based tracking system that performed a two-step registration procedure. 
First, rigid registration was performed on patient data with a TRE of 1.4 ± 0.8 mm and an 
execution time of approximately 2 seconds. Using deformation estimation to perform a 
deformable registration, they showed a reduction in registration error to a TRE of 0.8 ± 0.5 
mm with an increased total registration time of approximately 7 seconds. The authors also 
provided an excellent discussion on the tracking errors present during targeted biopsy. With 
importance focused on accuracy, intra-operative usability is lacking in these techniques 
due to computation time restrictions from increased complexity of the algorithms. 
Although patient anatomy is deformable, the majority of prostate motion is rigid.27 While 
registration error can be decreased with a deformable registration, a recent study compared 
deformable and rigid registration methods intra-operatively, concluding no significant 
differences were found when detecting clinically significant prostate cancers.28 
Considering the feasibility of a rigid registration approach and the current limitation of 
computational speed, real-time registration and improved intra-operative usability seems 
to be readily achievable through rigid registration methods since they perform at a reduced 
computational cost. 
Our group has previously shown29 a fully automated intensity-based rigid registration 
algorithm to align 3D TRUS images acquired directly before performing a biopsy 
procedure to live 2D TRUS images acquired immediately before tissue sampling. Our 
algorithm had a TRE of 1.87 ± 0.81 mm when tested on retrospective clinical images with 
total registration times of approximately 1.1 s. The algorithm was also tested when 
performed every second and was shown to have a reduced TRE of 1.63 ± 0.51 mm. By 
reducing the computation time further, it is anticipated a real-time motion compensation 
scheme would help improve targeting accuracy and smooth clinical translation when 
compared to an intermittent approach to motion compensation. With our previous results 
and clinical motivation, an objective of this work was to perform 2D TRUS to 3D TRUS 
registration in real-time, defined to be at or near the approximate frame rate of an 
ultrasound system (i.e., greater than 15 Hz). Real-time computations approaching the frame 
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rate of an ultrasound system are necessary to provide a responsive feedback system, 
capable of correcting motion without user interaction to improve image guidance intra-
operatively. In this paper, we present image registration and optimization techniques to 
reduce registration times and provide a direct comparison to our previous implementation 
with patient TRUS biopsy images. After implementing the optimized registration 
algorithm on our previously developed biopsy system,4 phantom tests were performed to 
evaluate the feasibility and potential real-time motion correction capability of the 
algorithm. 
2.2 Materials and methods 
2.2.1 2D-3D image-based registration 
The workflow for our motion compensation technique is shown in Figure 2.1 and is based 
on the assumption that preoperative MRI to 3D TRUS registration (with segmentations 
and/or annotations) has been accurately completed. Both 2D and 3D TRUS images 
acquired during the procedure are loaded into a graphics processing unit (GPU) and a 
mechanical tracker transformation30 is used to place the images in a common coordinate 
system, referred to as the world coordinate system. The origin of the world coordinate 
system is initialized at the tip of the TRUS transducer, establishing the biopsy system that 
is based on a remote center-of-motion guidance approach.30 This allows any motion of the 
3D TRUS image, 2D TRUS image, and biopsy system to be applied around the initial 
TRUS transducer tip location during registration. With the mechanical encoder readings 
on the joints of the biopsy system, the 2D image is transformed to the world coordinate 
system to initialize its pose as a plane in the 3D image prior to registration. 
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Figure 2.1 Proposed automatic image-based registration workflow. All steps in the “2D/3D 
registration” box would contribute to the total computation time of the algorithm; image 
pre-processing of the 2D image was included in “2D/3D registration” since this step would 
need to be completed as the images are being acquired during the procedure. The 
normalized cross-correlation is computed between the moving 3D image and the fixed 2D 
image for each iteration until termination criteria is reached. When the algorithm 
converges, a final rigid transform is generated and applied to the 3D image. 
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To compute 3D to 2D registration, a variation of the algorithm previously proposed by De 
Silva et al29 was developed to achieve fast and robust performance. A normalized cross-
correlation (NCC)31 similarity metric was optimized with Powell’s method,32 using the 
Insight Segmentation and Registration Toolkit (ITK)33 framework, in a rigid search space 
comprising of three rotations and three translations. Since rotations and translations 
constitute disproportionate units, the scaling between different directions in the search 
space was an important parameter during registration optimization. The scaling parameters 
were selected based on maximum observed rotational and translational displacements in 
our previous study29 such that 6° rotation and 10 mm translation attribute to the same 
amount of displacement in the 6 DoF search space. This created a common parameter 
space with uniform and unitless spacing, permitting the use of simplified and unitless 
termination criteria during optimization.  
Since Powell’s method requires multiple iterations to converge, with each iteration 
consisting of multiple line optimizations in each DoF, a one-dimensional optimization sub-
algorithm was necessary. The golden section search (GSS)32 technique was chosen since it 
does not require derivative calculations, resulting in a low computational cost. Also, the 
GSS is more computationally efficient than a conventional bisection approach since it 
recycles previous points when varying the bracketed interval in which the optimum is 
predicted to exist in a single line direction. When employing the GSS technique and 
minimizing the search space, a parameter step tolerance and an NCC metric tolerance were 
defined as termination criteria for optimization. These tolerances were compared to the 
change at each DoF (i.e., step taken during optimization) and the change in NCC metric 
values at each iteration to terminate when near or at the local optimum. Based on 
preliminary tests, parameter step tolerances were set at one-thousandth of the expected 
image displacement ranges (i.e., 0.01 mm and 0.006°) and the NCC metric tolerance was 
set to 0.0001. In certain circumstances, if the current DoF being searched is initialized at 
its optimum, the algorithm will terminate prematurely even with image dissimilarity 
present due to misalignment in the remaining DoFs. To avoid this scenario where these 
tolerances are reached prematurely due to the lack of progress along a single DoF, the 
algorithm was forced to search each DoF at least once to always complete a full cycle when 
searching the parameter space. After successful optimization, a 3D rigid transformation 
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was output and used to estimate the pose of the 3D TRUS image to correct for any prostate 
motion during the procedure, as displayed in the live 2D TRUS image. This enabled the 
resulting 2D TRUS plane from the 3D TRUS image to be displayed during the procedure. 
To provide continuous motion compensation, the algorithm initialized the 3D pose of the 
subsequent images according to the previous image’s resulting registration transformation. 
This initialization approach was performed for three reasons: (1) Powell optimization 
performs well when adjusting for small corrections near local minima since it is typically 
used on unimodal objective functions, (2) an initialization close to the function minimum 
increases the speed of convergence, and (3) it is assumed that motion will be minimal 
between real-time 2D TRUS images (< 1 mm and < 1°) acquired at 15-50 Hz. This 
procedure will henceforth be referred to as the continuous method. 
2.2.1.1 Estimating the optimal scale for registration 
The optimal amount of image information necessary to accurately perform registration can 
vary depending on the available anatomical details, while increasing image size burdens 
computational cost. Thus, the optimal scale of the images being registered is an important 
parameter considering the tradeoff between accuracy and computational cost. In our 
methods, we investigated downsampling of 2D and 3D TRUS images by factors of 2, 4, 
and 6 without any averaging (binning). The 2D images were additionally cropped, centred 
on the image, to remove information outside an area of interest (AOI) containing the 
prostate. The AOI boundaries were chosen outside the approximate prostate anatomical 
boundary for the largest prostate sizes. Computation times and registration errors were 
computed for each downsample factor to determine the optimal sampling factor that would 
decrease the registration time without increasing registration error. 
2.2.1.2 Estimating the optimal area of interest 
Since the AOI within 2D TRUS images determines the amount of anatomical detail 
included in the registration, we investigated the AOI size as a variable in the study by 
performing repeated registrations for different AOI sizes and measuring the resulting 
registration accuracy and time. After masking the template 2D TRUS images to exclude 
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embedded text/annotations, the largest AOI containing ultrasound intensity information 
was found to be 570×466 pixels. Using this size as a template and an upper AOI limit, a 
constant width to height aspect ratio (1.22:1) was maintained when cropping the 2D image. 
Beginning with the smallest AOI at 100×82 pixels, the width was iteratively increased by 
12 pixels (with the complementary height) until a final AOI was reached at 568×466 pixels. 
Computation times and errors were determined when completing the registration at each 
AOI, which included the process of masking and cropping the 2D image, as shown in 
Figure 2.1. The registration time encompassed this process to resemble a scenario when 
the 2D TRUS image would be acquired from the frame grabber directly from the ultrasound 
system during a continuous registration method.  
2.2.1.3 Direction search order of optimization 
Finding an acceptable registration between images is dependent on how an algorithm 
searches through 3D space. Conventionally in Powell’s method, search directions are 
updated after each iteration to increase the speed of convergence by predicting the direction 
containing the largest improvement of the cost function. Search direction is predicted by 
replacing the vector containing the largest improvement with the most similar direction 
from the previous iteration in an attempt to avoid linear dependence between search 
directions. With this strategy, the method can be used to optimize a continuous function 
with an unknown underlying mathematical definition.32 With subsequent iterations 
determining search directions empirically, it is generally thought that the method is 
insensitive to initial search direction order. Even though the direction search vectors are 
updated when the optimization is continued beyond the first iteration, the initial search 
vector order of optimization is an important factor that prioritizes certain directions during 
search space traversal. Increased initialization misalignments from the target alignment can 
make the algorithm more susceptible to converge at a local optima of the NCC metric.29,34 
In these instances, it is helpful to avoid these local optima by estimating the line direction 
that achieves the target extrema quickly and correctly. To study the effect of initial search 
direction order on registration accuracy, two search orders were explored: rotation vectors 
initially optimized before translation vectors (referred to as the rotations first scheme) and 
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translation vector optimization followed by rotations (henceforth called the translations 
first scheme). 
2.2.2 Experiments 
2.2.2.1 Clinical image acquisition 
The image acquisition details have been described in De Silva et al.29 and are summarized 
here. Preoperative 3D TRUS images were acquired using our mechanically assisted 3D 
TRUS-guided biopsy system. Utilizing encoders, a commercially available end-firing 5–9 
MHz TRUS transducer probe (Philips Medical Systems, Seattle, WA) was mechanically 
tracked to reconstruct a 3D TRUS image from a series of 2D views. These 2D views were 
masked to remove extraneous system information (e.g., patient information, image scale, 
etc.) by changing the image intensity data outside the TRUS image field to 0, shown in 
Figure 2.2a. After reconstruction, the 3D image was then cropped to a rectangular bounding 
box, reducing the image size to 448×448×350 voxels with dimensions of 0.18×0.18×0.19 
mm3, shown in Figure 2.2b. The coordinate system initialization and 3D image 
reconstruction occurred only once and at the beginning of the procedure, requiring 
approximately 3 seconds. After acquiring the 3D TRUS image, 2D TRUS images were 
saved before firing the biopsy gun at predefined biopsy target locations. Similar to the 3D 
TRUS image, these 2D images were masked to remove extraneous information, resulting 
in a total image size of 640×480 pixels and pixel dimensions of 0.18×0.18 mm2. These 
images were inputs for the registration algorithm running on an i7-4770 central processing 
unit (CPU) at 3.40 GHz (Intel Corporation, Santa Clara, CA) with Compute Unified Device 
Architecture (CUDA) C++ to accelerate the NCC calculation on a GeForce GTX TITAN 
GPU (NVIDIA Corporation, Santa Clara, CA). Implementation and computation speed of 
the NCC calculation was improved by parallelizing the computations by dividing the total 
image matrix into 19,200 blocks with 16 threads per block. 
2.2.2.2 Accuracy evaluation 
The target registration error (TRE)35 was assessed by calculating the RMS error between 
manually annotated corresponding fiducial pairs in the 2D and 3D TRUS images (white 
arrows shown in Figure 2.2). A total of 45 intrinsic fiducial pairs were identified from 7 
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patients (14 biopsy needles) to calculate TRE with an average of 3 fiducials per image pair. 
Since registration is performed using image intensities, the 45 fiducial pairs were chosen 
once in the original images (i.e., no downsampling) and provided the same pre-registration 
point clouds to be used for post-registration comparisons. Variability (i.e., fiducial 
localization error (FLE)) associated with manual localization of the fiducials,35 has been 
previously reported to be 0.11 mm in the 2D TRUS images30 and 0.21 mm in the 3D TRUS 
images.18,19 
 
Figure 2.2 Example (a) 2D and (b) 3D TRUS images after masking and cropping before 
registration computations. The hypoechoic bladder can be seen in the superior portion of 
the images with the prostate below containing microcalcifications indicated by the white 
arrows. 
2.2.2.3 Phantom image acquisition 
Registration method validation using clinical images was limited to the presence of 
calcifications in the 2D TRUS images to define ground truth motion. Since a subset of the 
frames in a real-time live 2D TRUS video sequence may not contain such anatomical 
landmarks, we performed a phantom study to comprehensively analyze the performance of 
the algorithm in compensating for prostate motion in real-time. An agar-based tissue-
mimicking phantom of a prostate model4 was fabricated that contained beads embedded in 
a surrounding agar background to provide texture.6,36 The prostate model, beads, and 
background were constructed by adding 7% by mass of glycerol solution with agar powder 
to produce a speed of sound similar to that of human tissue (1540 m/s).37 The prostate mold 
(a) (b) 
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model was generated from a segmented 3D TRUS image of a human prostate and enlarged 
anisotropically in anterior/posterior, superior/inferior, and left/right dimensions 
(77:50:36)38 to a volume of 60 cm3. The agar beads and background material contained 
cellulose (15% by weight) and were used to create acoustic backscattering, providing 
hyperechoic regions in the TRUS images. The agar beads were created with diameters of 
3.18 mm and 4.76 mm from standard spherical molds, cooled, and placed in the prostate 
mold before the model was filled with non-cellulose agar. The prostate model was then 
suspended in a polycarbonate box using fishing line so the surrounding background agar 
could be added in a single pour and allowed to cool for 24 hours. This was performed to 
avoid layering interfaces in the background agar typically observed when a suspension 
technique is not used.  
The primary forms of motion that were encountered during a prostate biopsy included in-
plane and out-of-plane translations relative to the 2D TRUS image, as well as rotations 
around the long axis of the ultrasound probe. The user initiated and continuous registration 
methods as described below were investigated using this phantom to assess registration 
performance when compensating for translation and rotation motions in real time. 
2.2.2.3.1 Translation range testing 
Patients are not anesthetized during a prostate biopsy and we have observed some motion 
in the form of a translational offset. To simulate these motions, the fabricated prostate 
phantom was mounted on an independent and movable stage, as shown in Figure 2.3. This 
stage was used to validate the registration accuracy of our algorithm for known in- and out-
of-plane translations since it was capable of generating 1 micrometer increments in 
translation. After positioning the TRUS probe at the centroid of the prostate phantom and 
acquiring a 3D image, 3D to 2D registration was performed incrementally (after locking 
the tracking system) by translating the phantom and registering the resulting live 2D 
images. In a first approach, the registrations were performed manually at each translation 
increment, independently of previously performed registrations; this procedure will be 
referred to as the user initiated method. The registrations were repeated at 1 mm translation 
increments until reaching a maximum measured displacement of 12 mm, which captures a 
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range comparable to translation motions observed clinically.19 This process was repeated 
over ten trials to assess variability and robustness of the user initiated motion compensation 
algorithm. To validate continuous motion correction and provide comparison to the user 
initiated method, a similar procedure was performed that added incremental initializations 
from previous registrations. At each increment, micrometer translation was paused to 
obtain 2D images, transformation matrices, and computation times before continuing to the 
subsequent translation. This process was repeated over five trials (due to length of 
experimental setup and image acquisition) to assess variability and robustness of the 
continuous motion compensation algorithm. After completing data acquisition for one 
direction (e.g., in-plane translation), the TRUS probe was rotated by 90°, a new 
initialization matrix was generated, and the entire experiment was repeated for both 
methods to perform the registration for an additional translation motion. 
As an approach to evaluate the error of the registration algorithm, the offset difference from 
the initialization matrix to the output registration result was calculated since the translation 
distance was known and thus provided a ground truth. This error metric was chosen since 
it was less labour intensive and avoided any errors due to manual fiducial selection used to 
compute a TRE calculation. Although the translation was intended for a single translation 
direction, the RMS displacement was determined from the 3-vector offset difference to 
account for any minor setup errors that would cause 3D errors in overall motion. The offset 
difference was calculated for each increment to obtain mean differences paired with 
corresponding mean computation times. Since we intended to compare the continuous 
method directly to the user initiated method, the first corrected transformation matrix 
acquired for each increment was used to compute the offset difference from the 
initialization matrix. This corrected transformation matrix was determined for each 
increment by searching for the first TRUS frame output with no observed motion, 
representing the frame when micrometer translation was paused. 
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Figure 2.3 Phantom set up during testing of in-plane translation range when using the 
continuous motion compensation method (Multimedia view online). The live experimental 
setup can be seen on the left where the live 2D TRUS image is taken from the US machine 
and shown in the bottom right. After completing 3D to 2D registration, the resulting 
registered image plane in the 3D TRUS image is displayed, seen in the upper right. 
2.2.2.3.2 Roll rotational range testing 
Rotation around the long axis of the TRUS transducer was another type of motion we 
observed during prostate biopsy and was another type of motion we simulated to test our 
registration algorithm. Since there are no suggested rotational tolerances present in the 
literature, a rotational tolerance was justified based on the previous19,23 target TRE of 2.5 
mm to determine a target rotational error. Using our image width of 448 pixels with voxel 
dimensions of 0.18 mm, if a rotation about the center of the 3D image space is assumed, 
then the region most susceptible from a rotational error will be present near the edges of 
the image. An error of 2.5 mm located at the edge of the image (i.e., 224 pixels or 40.32 
mm from the center) corresponds to a rotational tolerance of 3.55°.  
Keeping this target in mind, we performed displacement tests to determine the rotational 
motion compensation range of the algorithm. To test rotational motion, the TRUS probe 
was positioned at the center of the base of the prostate phantom to acquire a 3D image. The 
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initialization transformation matrix was recorded and the mechanical tracking encoders 
were disabled to ensure the registration algorithm was performed without updated 
initializations. Although tracking was not performed, mechanical encoder values were still 
displayed and used to track the rotation of the TRUS probe around its long axis to determine 
rotations. This probe rotation was performed instead of a phantom rotation purely for the 
ease of operability. Similar to the translation procedure in the previous section, 3D to 2D 
user initiated image registration was performed by registering the live 2D image after 
incrementally rotating the TRUS probe. After each step, the algorithm was reinitialized 
using the original mechanical encoder transformation, without using previous registration 
outputs. This reinitialization ensured that the user initiated registration started from the 
same position for each subsequent rotational increment. Similar to the translational range 
testing, we repeated this registration procedure in approximately 1° increments until 
reaching a maximum measured rotation of 15°. Although our expected clinical rotation 
was 6°, this limit was chosen to potentially reveal the point of unreliable motion 
compensation. Motion compensation was repeated over ten trials to obtain a mean 
difference error and computation time for each increment. For comparison with the 
continuous motion correction, initialization and corrections were not reset between 
registrations, consistent with the translation testing procedure. Rotational motion was 
paused at each increment to obtain 2D TRUS images, transformation matrices, and 
computation times before continuing to the subsequent increment. This protocol for 
continuous motion compensation was repeated over four trials to obtain a mean rotation 
difference paired with a mean computation time for each increment. 
Since the rotation angle was known, the difference 3 × 3 rotation matrix (𝑻𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒) 
between the corrected registration (𝑻𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑) and initialization (𝑻𝑖𝑛𝑖𝑡𝑖𝑎𝑙) rotation 
matrices was calculated by 
 𝑻𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = (𝑻𝑖𝑛𝑖𝑡𝑖𝑎𝑙)
−1 × 𝑻𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑. (2.1) 
The corresponding rotation can be calculated from 
 
𝜓 =  tan−1 (
𝑡2,1
𝑡1,1
), 
(2.2) 
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where 𝑡1,1 and 𝑡2,1 are the 𝑻𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 matrix elements in the first and second rows of the 
first column.39 
Similar to the translation experiment, we compared the continuous method to the user 
initiated method by using the first corrected transformation matrix acquired at each motion 
increment to compute the rotation difference from the initialization matrix. This corrected 
transformation matrix was determined for each increment by searching for the first TRUS 
frame output with no observed motion, representing the frame when probe rotation was 
paused. 
2.2.2.4 Statistical methods 
Statistics calculations were performed using SPSS Statistics v.24.0.0.0 (IBM Corp., 
Armonk, NY, USA). To check if our image data followed a normal distribution, normality 
was evaluated using a Shapiro-Wilk test. Nonparametric statistical tests were used where 
appropriate and are presented in parentheses for the remainder of this section. Results were 
considered significant when the probability of making a type I error was less than 5% (p < 
0.05).  
Since our previously acquired patient images were tested for every downsample factor, a 
one-way repeated measures ANOVA (Friedman) test was used as an omnibus test prior to 
any post-hoc analysis. If significance was found, a Bonferroni correction was used, 
resulting in a significance level set at p < 0.017 for our post-hoc analyses conducted using 
Tukey's honestly significant difference (Wilcoxon signed-rank) tests. To determine if there 
is an initialization distance correlation with the accuracy of registration, linear regressions 
were plotted using Prism 7.00 (Graphpad Software, Inc., La Jolla, CA, USA) to show the 
TRE trends. The user initiated and continuous correction methods were compared using t-
tests (Welch t-tests) after in-plane, out-of-plane, and roll motion corrections for error and 
computation time distributions. 
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2.3 Results 
2.3.1 3D to 2D registration optimization on clinical images 
Interaction effects during optimization of the three tested algorithm settings were 
investigated and a brief overview of the results are shown in Figure 2.4. Linear regressions 
were added to provide an estimate of the trends observed for the TRE distributions as 
initialization offset was increased.  Although more AOI comparisons were completed, the 
smallest error was observed when downsampling by a factor of 4, cropping to an AOI of 
356×292, and optimizing the search space by translations first. In the three subsequent 
sections, each parameter was investigated independently while holding the other settings 
constant. As a reminder and disclaimer for the reader, all presented TRE results in Sections 
2.3.1 and 2.3.2 are susceptible to a small bias introduced when manually selecting fiducials. 
This should be considered when comparing changes in TRE. 
2.3.1.1 Estimating the optimal scale for registration 
Estimating the optimal scale for motion compensation was performed with an input AOI 
of 356×292, while optimizing the search space by translations first. Normality was tested 
using the Shapiro-Wilk test with significance found for factors 2 and 6, for both TRE and 
time, suggesting non-normal distributions were present. Nonparametric measures are 
shown in Table 2.1 for TRE and computation times after downsampling the 2D and 3D 
clinical ultrasound images by factors of 2, 4, and 6. A repeated measures Friedman test was 
performed for both TRE and time, which failed to show a statistically significant difference 
between the distributions of downsample factors, but showed statistical significance when 
comparing computation times (p < 0.001). Post-hoc analysis with the nonparametric 
dependent-samples Wilcoxon signed-rank test was conducted between the computation 
times for the three downsampling factors. Significant differences (p < 0.01) between all 
downsample factor combinations was found. A downsampling factor of 4 was determined 
to be the optimum rate for our application since the median and third quartile were below 
the 2.5 mm target TRE in addition to a decrease in computation time. The corresponding 
median computation time of 55 ms was observed, which is a factor of 20 times smaller than 
previously achieved.29 This computation time from registering patient images converts to 
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a rate of 18.2 Hz, which is greater than our real-time definition of 15 Hz. Thus, this 
reduction in computational time enables motion compensation to be performed as a 
background software process to continuously register live, real-time streams of 2D TRUS 
images. 
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Figure 2.4 An overview of the main interactions observed when optimizing downsampling 
factor, cropping AOI, and search order. 
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Table 2.1 Effect of downsampling 2D and 3D images on TRE and computation time for 
14 patient images. 
Image Downsample  
Factor 
 Median TRE  
[Q1, Q3] (mm) 
 Median Computation Time  
[Q1, Q3] (ms) 
2  1.37 [1.08, 2.24]  97 [92, 137] 
4  1.40 [1.14, 2.31]  55 [41, 64] 
6 
 1.71 [1.17, 2.71]  30 [24, 34] 
 
2.3.1.2 Estimating the optimal area of interest  
The optimal AOI was determined with an optimal downsampling factor of 4, while 
searching translations first. The AOI in the 2D images was iteratively increased from 
100×82 pixels with results for computation time and TRE shown in Figure 2.5. A slight 
increasing trend in computation times (Figure 2.5a) was observed over the range of AOIs. 
When analyzing TRE to find the ideal AOI (Figure 2.5b), a decreasing trend was initially 
observed until reaching a minimum at approximately 356×292 pixels, followed by a slight 
increase and plateau. The observed minimum of the TRE, reduced variability, and the 
minimal change in computation time led to the selection of a 356×292 AOI for the biopsy 
application. However, due to the bias in the TRE when manually selecting fiducials, an 
AOI in the range of 316×259 to 364×298 would equally be justified. 
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Figure 2.5 Scatter plots of the mean ± standard deviation registration computation time (a) 
and median [Q1, Q3] TRE (b) as the AOI size in the 2D image was increased. The 
asymmetric area of the AOI was scaled in a width:height ratio of 1.22:1, corresponding to 
the aspect ratio of the largest AOI achievable. 
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2.3.2 Direction search order of optimization  
The main direction search order results are shown in Figure 2.4. When using the whole 
image as an input, similar TRE distributions were observed between all downsample 
factors when comparing the rotations first strategy. The translation first method was unable 
to register large initial offsets when using a downsample factor of 2, but was similar to the 
rotation method when comparing the other downsample factors. When using the cropped 
AOI input, all translation first TRE results were reduced relative to the whole image input 
for each downsample factor. However, cropping had minimal influence when optimizing 
rotations first, with an exception at a downsample factor of 4 since it was unable to register 
the largest initial offset images effectively.  
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4
0
2
4
6
8
1 0
P a t ie n t  T r ia l
T
R
E
 (
m
m
)
R o ta tio n  F irs t
T ra n s la tio n  F irs t
 
Figure 2.6 The TRE between translation first and rotation first direction search order 
schemes on 14 patient image sets. Images used for registration were downsampled by a 
factor of 4 with the 2D images cropped to an image size of 356×292. 
When comparing direction search order TREs for downsampling by a factor of 4 and 
cropping to an AOI of 356×292 (Figure 2.6), normality was tested using the Shapiro-Wilk 
test with statistical significance found for the rotations first scheme (p < 0.05). The median 
± interquartile range (IQR) for TRE computed for the rotations first search was 2.18 ± 3.82 
mm compared to the translations first median TRE of 1.40 ± 1.17 mm (previously stated 
in Section 2.3.1.1). Since we know that the algorithm is susceptible to converge 
prematurely when the initialization is further from the target alignment, both search order 
schemes were compared to identify any trends using a Spearman's rank-order correlation. 
The initialization distances between the 2D and 3D images before registration and the 
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corresponding post-registration errors had a strong, positive correlation (0.644) using the 
rotations first scheme, which was statistically significant (p < 0.05). 
The TREs calculated from fiducials before registration (i.e., following encoder pose 
initialization) and after registration for the translations first search scheme was compared 
as it yielded better registration performance. Using a Shapiro-Wilk test of normality, the 
distribution of image distances before registration was shown to be not normally distributed 
(p < 0.05). The TRE frequency distributions before and after registration is shown in Figure 
2.7 with a median RMS error before registration of 3.41 ± 3.26 mm with the corresponding 
median TRE of 1.40 ± 1.18 mm after registration. Analyzing the post-registration group 
further, 10/14 image pairs (71%) were less than a real-time computation time of 67 ms and 
13/14 image pairs (93%) were less than a TRE of 2.5 mm. Since there could be some 
variability from manual point selection, we investigated a margin around 2.5 mm equal to 
the FLE measurement for the 3D TRUS and 2D TRUS images combined in quadrature 
(i.e., 0.237 mm). This resulted in a range from 10/14 (71%) of image pairs below a 2.263 
mm error to 14/14 (100%) of image pairs below a 2.737 mm error. We used the Wilcoxon 
signed-rank test to compare medians of distances to the desired target plane before and 
after registration, which showed a statistically significant difference when correcting for 
position (p < 0.01). 
 
Figure 2.7 Histograms of the distance calculated between 2D and 3D image pairs from the 
manually chosen intrinsic fiducial markers before (a) and after (b) registration using a 
translation first search order after pose initialization. 
0 2 4 6 8 1 0
0
2
4
6
8
1 0
P re -R e g is tra t io n  D is ta n c e  (m m )
F
r
e
q
u
e
n
c
y
(a )
0 2 4 6 8 1 0
0
2
4
6
8
1 0
P o s t-R e g is tra t io n  T R E  (m m )
(b )
57 
 
2.3.3 Validation: phantom experiment 
A summary of the total mean difference from measured displacement and the mean 
computation time for both registration methods and the three types of motion is 
summarized in Table 2.2. 
Table 2.2 Mean differences and computation times of the user initiated and continuous 
registration methods for translation (in-plane and out-of-plane) and rotational motion. 
Method  Motion  Mean Difference  
Mean Computation  
Time (ms) 
Before registration 
 Trans  6.0 ± 3.7 mm  
  Rot  8.0 ± 5.2 °  
User initiated 
 In  0.4 ± 0.3 mm  108 ± 38 
 Out  0.2 ± 0.4 mm  60 ± 23 
 Rot  0.8 ± 0.5 °  89 ± 27 
Continuous 
 In  0.2 ± 0.3 mm  35 ± 8 
 Out  0.7 ± 0.4 mm  43 ± 16 
 Rot  1.2 ± 1.0 °  27 ± 5 
 
Figure 2.8 Sample prostate phantom images before and after registration for out-of-plane 
and in-plane translational motion. Images from real-time 2D TRUS are shown in the left 
column. In the middle column, the initialization 3D TRUS image planes obtained before 
registration display image misalignment when compared to the 2D TRUS view. 3D TRUS 
image planes in the right column demonstrate motion compensation capabilities after 
registration. Grid lines were superimposed following registration to provide spatial 
reference between image frames. 
In-Plane 
Out-of-Plane 
Live 2D TRUS image 
registration target 
3D TRUS image plane 
initialization 
3D TRUS image plane 
after registration 
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2.3.3.1 Translation range testing 
Sample prostate phantom images of the 2D TRUS live view, the 3D TRUS initialization 
plane, and the calculated 3D TRUS plane after registration are shown in Figure 2.8. 
Example setup and image registration results from the continuous motion compensation 
method are also presented in Figure 2.3 (Multimedia view). An error and computation time 
comparison between the user initiated method with the continuous method is shown in 
Figure 2.9 after testing the in-plane and out-of-plane translational range. The average 
difference between the corrected registration translation offset and the measured 
micrometer translation is shown for the user initiated method (Figure 2.9a) and the 
continuous method (Figure 2.9b). When observing the mean difference errors for both 
correction methods, the mean difference error metric never exceeded 1.25 mm over the 
entire translation range, falling below half of the 2.5 mm target error. When performing a 
user initiated correction, out-of-plane motion displacements were observed to be corrected 
with a smaller mean error when compared to in-plane motion. Conversely, the continuous 
registration achieved a reduced mean error when correcting in-plane motion. Comparing 
the two methods with respect to error for each motion, out-of-plane motion was corrected 
significantly better with the user initiated method (p < 0.001) and no difference was found 
for in-plane motion. In the same figure, the corresponding computation times are shown 
for the user initiated method (Figure 2.9c) and the continuous method (Figure 2.9d). For 
the user initiated method, the out-of-plane motion correction computation time had a lower 
overall variance and consistently fluctuated around 60 ms. Computation times showed an 
increasing trend when correcting for in-plane motion as the translational displacement was 
increased, plateauing around 4 mm. From the user initiated method results, all trials for 
both motions were below an error of 2.5 mm, but only 20/130 (15%) of in-plane and 97/130 
(75%) of out-of-plane trials were less than a real-time computation time of 67 ms. When 
performing a continuous registration, all trials for both motions were below an error of 2.5 
mm and computation times were significantly lower than the user initiated correction for 
in-plane (p < 0.001) and out-of-plane (p < 0.01) motions. In addition, the continuous 
method showed 65/65 (100%) of in-plane and 57/65 (88%) of out-of-plane trials less than 
a real-time computation time of 67 ms. 
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Figure 2.9 Comparison between registration procedures when testing the in-plane and out-
of-plane translation compensation range. In the top row, Euclidean translational differences 
between measured and expected values are shown for the user initiated procedure (a) and 
the continuous procedure (b). Dotted lines represent a target tolerance of 2.5 mm. The 
corresponding computation time results for the user initiated procedure (c) and the 
continuous procedure (d) are shown in the bottom row. Standard deviation error bars are 
not shown when shorter than the height of the symbol. The dashed line represents the target 
computation time of 15 Hz or 67 ms. 
2.3.3.2 Roll rotational range testing 
The comparison between the user initiated method and the continuous method is shown in 
Figure 2.10 for rotational motion compensation. The average rotation difference between 
the corrected registration and the measured encoder angles is shown for the user initiated 
method (Figure 2.10a) and the continuous method (Figure 2.10b). In both methods, all 
differences were smaller than our rotational tolerance of 3.55° with a maximum mean 
difference of 2.3 ± 0.8° observed in the continuous method at a 12° displacement. Although 
the continuous method was observed to have an increasing error near the end of the tested 
rotations, no overall significant difference was found when compared to the user initiated 
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method. This increasing trend also occurs beyond the expected rotations of 6°, making this 
finding less of a concern for clinical translation. The computation times for the user 
initiated method is shown in Figure 2.10c, and the continuous method in Figure 2.10d. The 
user initiated method had an overall computation time of 89 ± 27 ms with a much larger 
variance compared to the continuous method with 15/90 (17%) of trials less than an error 
of 3.55° and a real-time computation time of 67 ms. Similar to Sec.2.3.3.1, the computation 
time for the continuous method was observed to be significantly reduced (p < 0.001) and 
nearly constant with a mean computation time of 27 ± 5 ms. The continuous method also 
had 36/36 (100%) of trials less than an error of 3.55° and a real-time computation time of 
67 ms. 
 
Figure 2.10 Comparison between registration procedures when testing the roll rotation 
compensation around a clinically expected value of 6°. In the top row, rotational difference 
results between measured and expected values are shown for the user initiated procedure 
(a) and the continuous procedure (b). Dotted lines represent a target tolerance of 3.55°. The 
corresponding computation time results for the user initiated procedure (c) and the 
continuous procedure (d) are shown in the bottom row. Standard deviation error bars are 
not shown when shorter than the height of the symbol. The dashed line represents the target 
computation time of 15 Hz or 67 ms. 
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2.4 Discussion 
In current TRUS-guided prostate biopsies, tracking systems generate transformation 
matrices and are used to display corresponding MRI image data, as well as preoperatively 
delineated segmentations and annotations that exist in a separate volume. With the use of 
a motion compensation module, computational resources will still need to be used for the 
existing guidance system. Therefore, motion compensation registration times reported in 
this study was shown as the additional time needed for an existing a TRUS-guided 
procedure. 
2.4.1 Optimal amount of image information for registration 
With an optimal downsampling factor, the registration computation time decreased with 
statistical significance for our clinical prostate images, without an increase in error 
compared to results reported by De Silva et al.29 For our 3D image size of 448×448×350 
pixels, a downsample factor of 4 was chosen, which provided a median and third quartile 
below a 2.5 mm target TRE (1.40 [1.14, 2.31] mm) and helped to reduce the registration 
time from approximately 1.1 s to 55 [41, 64] ms. Since the comparison of TREs failed to 
show statistical significant differences, we performed an equivalence test40,41 using an 
approximate 90% confidence interval (CI) on the median of differences using GraphPad 
Prism 7.00. An equivalence interval of ±0.24 mm was determined by combining the FLE 
measurements in quadrature for the 3D TRUS (0.21 mm) and 2D TRUS (0.11 mm) images. 
The results in Table 2.3 failed to show statistical equivalence between all downsample 
factors and support the decision to determine the optimum downsample factor as 4. 
Table 2.3 Equivalence test results of TRE for downsampling factors. 
Downsample 
Factor Comparison 
 94.26% Median CI 
 Lower  Upper 
2 – 4  -0.1665  0.2815a 
2 – 6  -0.4793a  0.0550 
4 – 6  -0.3855a  -0.0742 
aGroups are not equivalent with interval = ±0.24 mm 
62 
 
Although having a downsample factor reduced the number of NCC computations, it also 
reduced the amount of information that needed to be transferred through system memory 
from the CPU to the GPU. Therefore, by reducing the amount of image data, a reduction 
in computation times arised from a reduction in data transfer from the CPU to the GPU as 
well as a reduction in the number of computations. As a reminder for the reader, only TRUS 
image data is needed to compute a transformation matrix on the GPU. Once the algorithm 
determines the correction matrix, the transformation can be applied on the CPU to any 
additional data (i.e., MRI or segmentation data) in a short amount of time that is comparable 
to what is currently performed using a tracking system. 
Although downsampling may introduce aliasing,42 this was not believed to be a 
consequential issue for our registration application since we maintained a median TRE 
below 2.5 mm as the downsampling factor was varied. However, even though our TRE 
was below an acceptable tolerance of 2.5 mm, reducing the image size used for registration 
could be removing fine detail structures and prematurely ending the registration iteration 
loop. With these features removed, the observed 1.5 mm registration error could be the 
result of emphasized local minima in the NCC cost function. Despite the fact that smaller 
downsample factors were not observed to be more accurate, a coarse-to-fine downsampling 
technique could be required to decrease the TRE since these methods are usually more 
robust to local optima.43 
Interestingly, reducing the 2D template image size used for registration to a 356×292 pixels 
AOI (64.08×52.56 mm2) showed a decrease in TRE. This AOI is larger than an average 
healthy prostate44 length and height of approximately 40×30 mm2 with a volume of 30 cm3; 
however, many prostate glands with cancer are often enlarged and can fill this region with 
anatomical information. Since there is some variability when manually selecting fiducials, 
the chosen AOI would be influenced by an unknown bias in the TRE measurement given 
that the TRE was used for AOI selection. Although more image information might 
intuitively seem necessary for a more accurate registration, having image data outside of 
the prostate seemed to hinder registration performance. This could be due to the low 
contrast edges of the bladder or perhaps a lack of acoustic coupling found on the left and 
right sides of some images. Bladder is also more prone to deformation that may challenge 
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our rigid registration approach. It should be noted that limiting the area to slightly beyond 
the average prostate size did not improve registration for every image pair. Despite the 
presence of the bladder when imaging smaller prostate volumes, the AOI reduction 
noticeably decreased the overall average error observed. 
2.4.2 Direction search order of optimization 
To increase the speed of convergence, direction search vectors are typically updated in an 
efficient manner after the first iteration of optimization in conventional Powell’s method. 
When used in our clinically acquired prostate images, a statistically significant difference 
was observed when the search order was changed in the first iteration. Searching translation 
directions first before rotational optimization was shown to be superior in terms of 
registration accuracy with an overall TRE median ± IQR of 1.40 ± 1.18 mm. A strong 
correlation (0.644) between initial misalignment and TRE was observed in the rotations 
first scheme, suggesting the registration algorithm was converging at a local optimum of 
the NCC function. A primary source of motion we witnessed during prostate biopsy 
procedures arose from patients moving away from the biopsy gun once the needle was 
inserted into the tissue. This could result in a translational offset that dominated the overall 
motion that required compensation. Moreover, if the objective function has quadratic, 
convex properties, Powell’s method should converge at the global optimum irrespective of 
the initial search direction order. The observed performance dependency on the initial 
search order, thus, implies non-convexity of the search space challenging the underlying 
assumptions of Powell’s direction set method. The non-convexity of the objective function 
could be more severe in the rotational directions and therefore these motions could be more 
susceptible to local optima driving the optimizer away from the desired solution during 
first steps in the optimization process. A translation first scheme managed to drive the 
optimizer close to the global optimum and demonstrated robust performance in our 
experiments when downsampling by a factor of 4 and cropping to an AOI of 356×292. 
However, there seems to be some interaction effects with downsampling factor, cropped 
AOI, and optimization order that are currently unpredictable in addition to the small TRE 
variability due to manual selection of fiducials. It should be noted, the manual selection 
bias introduced in the TRE can be reduced by having observers select each fiducial multiple 
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times. Since we selected each fiducial only once, we used the measured FLE as the bias 
when interpreting Figure 2.4 and Figure 2.5b. 
2.4.3 Phantom scanning 
In the user-initiated method, motion compensation is performed intermittently and the 
physician may opt to selectively disregard registration output if it is not satisfactory and 
repeat the registration. The continuous method, on other hand, provides a more streamlined 
and automatic mode of clinical implementation of the algorithm with less dependence on 
manual intervention. However, when implemented on a TRUS-guided biopsy system and 
tested on a tissue-mimicking phantom, the registration algorithm performed robustly with 
an overall sub-millimeter and sub-degree error when performing both the user initiated and 
continuous registration methods. After testing out-of-plane translation, in-plane 
translation, and roll rotation compensation, the user initiated correction computation time 
only achieved real-time performance when correcting for out-of-plane motions. During 
testing of the real-time continuous implementation on the prostate phantom, registration 
computation times were significantly lower (p < 0.01) with less variance than the phantom 
user initiated correction, overall performing at approximately 36 ± 4 ms (28 Hz). This is 
approaching the frame rate of the ultrasound system, which updates images at 51 Hz when 
using a depth of 6 cm with one focal zone, providing near real-time feedback that is 
sensitive to sudden changes. Results from the user initiated method also supports that the 
algorithm can compensate for sudden drastic displacements with a temporary increase in 
computation time of 108 ± 38 ms as a tradeoff, using in-plane motion correction as a 
reference. The reason for significant difference when testing out-of-plane motion is 
unknown, but it is likely due to a lack of image features present at the 9 mm displacement. 
Both methods experienced an increase in registration error up to approximately 1 mm from 
expected and after scrutinizing the images further, it revealed a minimal presence of agar 
beads beyond a 6 mm displacement. From this information, it appears that the user initiated 
method was more suitable to correct for motion when there were reduced image features, 
but this will need to be investigated further. Although the registration error was 
significantly lower when performing a user initiated correction during out-of-plane motion, 
continuous registration still performed with a mean registration error of 0.7 ± 0.4 mm, 
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which is still below the target error of 2.5 mm. In this case, the clinical benefits provided 
from a significantly faster computation would likely outweigh the slight decrease in 
registration error. Results from other studies25,29 have shown that an increase in registration 
error will be expected when performed on patient images and this expectation has been 
alluded to in this study. Since the methods of the clinical image registrations are 
comparable to the user initiated procedure on the phantom, it can be observed there are 
sources of error that are not completely captured in the phantom experiment that will need 
to be investigated in more detailed patient studies. For example, a lack of agar beads could 
be the underlying cause for a poor registration when performing the out-of-plane 
translation tests. With clinical images, different image features distributed throughout the 
acquired 3D TRUS image could potentially lead to different resulting motion compensation 
trends. However, these results demonstrate robust and real-time registration performance 
on a phantom and yield valuable insights, encouraging the use of a continuous method for 
prostate motion compensation during biopsy.  
When testing the continuous motion compensation method, variable speeds were not 
assessed when moving the phantom. Although this matches our minimal motion 
assumptions between image frames, this might not be realistic of what is observed 
clinically and could be a potential limitation. In addition, the phantom we fabricated was a 
rigid body and was proven to be easily compensated using a rigid registration algorithm. 
Although prostate deformation may occur and has been previously reported to not be an 
issue for a rigid registration approach,28,29 the real-time continuous method will need to be 
verified in patient studies to confirm these findings. 
2.5 Conclusions 
Real-time registration during prostate biopsy provides key advances by compensating for 
arbitrary/intermittent motion that hinder accurate targeting of potentially cancerous tissues, 
decreasing needle targeting error, and improving clinical workflow. Using image 
downsampling and image cropping with a GPU accelerated optimization, we showed that 
a significant decrease in computation time can be achieved when performing 3D to 2D 
rigid registration on human clinical prostate images without any substantial degradation of 
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registration error. The challenges due to large initialization errors was mitigated after 
updating the optimization of the conventional Powell’s method by systematically searching 
the image space to avoid local optima. When continuously performing motion 
compensation, the error of the registration algorithm was shown to have sub-millimeter 
and sub-degree accuracy with significantly lower computation times than a user initiated 
correction. Overall registration times of approximately 36 ms were observed, performing 
near the frame rate of the ultrasound system. With this utility, preoperative annotations and 
biopsy target locations can continuously be displayed and corrected on live 2D TRUS 
images, potentially increasing the prostate cancer detection rate of image guided biopsy 
procedures. 
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Chapter 3  
3 Automatic prostate segmentation using deep-learning on 
clinically diverse 3D transrectal ultrasound images 
Minimizing procedure time with an automatic 3D TRUS prostate segmentation method 
could allow for a more accurate and efficient workflow with improved patient throughput 
to enable faster patient access to care. The purpose of Chapter 3 is to present on the 
development of a general automatic prostate segmentation algorithm for image-guided 
interventions that use 3D TRUS images. 
The contents of this chapter have been accepted for publication in Medical Physics: 
Orlando N and Gillies DJ, Gyacskov I, Romagnoli C, D’Souza D, and Fenster A. Medical 
Physics 2020; 47(6):2413-2426. Permission to reproduce this article was granted by John 
Wiley and Sons and is provided in Appendix B – Copyright Releases. 
3.1 Introduction 
Diagnosing and treating prostate cancer continues to burden global populations as it is the 
second most common noncutaneous cancer among men worldwide.1 Investigation into 
methods to diagnose and treat prostate cancer has shifted towards improved needle-based 
approaches that utilize three-dimensional (3D) information intraoperatively. Magnetic 
resonance imaging (MRI)-3D transrectal ultrasound (TRUS) guided biopsy is one diagnostic 
method that fuses the superior soft-tissue contrast of MRI to accurately localize, target, and 
sample suspicious tissue regions for prostate cancer with the real-time, low-cost, and portable 
capabilities of ultrasound. In the treatment of prostate cancer, high- and low-dose-rate 
(H/LDR) brachytherapy (BT) procedures offer therapeutic benefits for patients by exploiting 
radiobiological effects and offering shorter treatment times, while minimizing adverse side 
effects. By adding 3D ultrasound intraoperatively, improved spatial context and targeting 
can be achieved to further improve the conventional clinical workflow of biopsy and 
brachytherapy procedures; however, both procedures rely on accurate segmentation of the 
prostate in 3D TRUS images to perform necessary clinical tasks. This includes surface-based 
registration approaches with MRI2 and subsequent 3D TRUS images,3 glandular volume 
measurements,4,5 and dose-volume calculations,6 especially when using a commercial 
guidance system. These segmentations are predominantly performed manually during the 
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procedure, which is time-consuming, variable, and often difficult, which can lead to 
increased patient risk due to increased anesthesia exposure.7 
Minimizing procedure time through fully or semi-automatic 3D TRUS prostate segmentation 
has been previously investigated.8–11 Many methods have been shown to be promising, but 
have lacked clinical translation due to computational complexity, computation time, and 
robustness to diverse clinical datasets. Convolutional neural networks (CNNs) have 
received widespread attention in many image processing applications with much work 
investigating their accuracy and speed in medical imaging tasks. Prostate segmentation in 
3D TRUS is an image processing task that could be an ideal candidate for the data-driven 
predictions provided by CNNs, although most existing work has investigated their 
application in MRI,12,13 as ultrasound is considered more challenging due to noise and 
image artifacts. 
Recent work has investigated and provided promising results for the use of CNNs in 2D 
TRUS14 and 3D TRUS15,16 prostate segmentation. Ghavami et al.,15 evaluated the 
performance of an adapted U-Net on 109 side-fire sagittally-reconstructed (SR) 3D TRUS 
images. Predictions were performed on acquired 2D images and varying adjacent 
neighboring slices were also investigated to evaluate accuracy due to increasing spatial 3D 
context. The best results reported for the 2D Dice similarity coefficient (DSC), 3D DSC, 
and boundary distance were 89 ± 12 %, 89 ± 5 %, and 1.68 ± 1.57 mm, respectively. Lei 
et al.,16 investigated a multidirectional deeply supervised 3D V-Net with contour 
refinement on 44 patient 3D TRUS images. Their method was shown to improve 
performance when segmenting the apex and base of the prostate, which is often difficult 
due to low image contrast, and reported overall segmentation results for a 3D DSC, 
Hausdorff distance (HD), mean surface distance (MSD), and residual mean surface 
distance (RMSD) of 92 ± 3 %, 3.94 ± 1.55 mm, 0.60 ± 0.23 mm, and 0.90 ± 0.38 mm, 
respectively. However, these methods were tested using cross-validation approaches on 3D 
TRUS images from a single ultrasound machine with matched voxel dimensions and sizes, 
so further testing is still required on an unseen and variable dataset to provide a complete 
understanding of performance while avoiding potential limitations due to information 
bleeding.17,18 Furthermore, investigations into generalizability across procedures and 
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acquisition geometries have been limited, to our knowledge, which could restrict usability 
when applying these techniques across applications. 
Our work aims to demonstrate that a diverse image dataset can train a supervised CNN to 
provide an accurate, fast, automated, and generalizable 3D prostate segmentation 
prediction. We used 206 3D TRUS patient images from two different procedures and 
acquisition geometries, two facilities, and four transducers used with three different 
ultrasound machine models to modify and train a deep learning-based 2D segmentation 
method followed by reconstruction into a 3D surface. Since deep learning approaches often 
improve in performance when using large datasets (i.e., >1000 images), we chose to reslice 
each 3D image to increase the amount of usable data for prostate segmentation training and 
prediction. Testing was performed on 40 unseen 3D TRUS patient images and 
segmentation performance was compared to state-of-the-art fully 3D approach’s for 
assessing the impact of reducing spatial context. Various metrics are reported in the 
literature, and typically vary in choice and quantity between studies, but many metrics are 
required to obtain a complete understanding of segmentation performance and to allow for 
comparison with previous studies. By using a clinically diverse dataset with variable image 
representation and image quality of the prostate, we intend to provide a thorough analysis 
of performance for a broader scope of comparison. Once this method is evaluated, 
completion of required intraoperative image-guidance tasks can be facilitated for different 
needle-based prostate cancer procedures and potentially decrease overall clinical procedure 
times and anesthesia risks to patients. 
3.2 Materials and methods 
3.2.1 Clinical dataset 
3D images of the prostate were acquired using end-fire (as used in prostate biopsy) and 
side-fire SR (as used in some HDR-BT) mechanical scanning approaches (Figure 3.1).19 
Both methods rotate a TRUS transducer around the long-axis to create geometrically 
different reconstructed 3D images that are influenced by the transducer array configuration. 
The images used in this study were acquired with the C9-5 transducer with the iU22 
(Philips, Amsterdam, the Netherlands), the C9-5 and BPTRT9-5 transducers with the ATL 
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HDI-5000 (Philips, Amsterdam, the Netherlands), and the 8848 transducer with the 
Profocus 2202 (BK Medical, Peabody, MA, United States) ultrasound machine models. 
The total dataset of 246 3D TRUS images consisted of 104 end-fire and 142 side-fire 3D 
TRUS images and was split into training, validation, and testing datasets as shown in Table 
3.1. Manual 3D prostate segmentations (excluding the seminal vesicles) were performed 
by an observer (IG) with approximately 15 years of TRUS prostate image analysis 
experience. 3D image sizes ranged from [300⨯400⨯784] to [408⨯441⨯870] voxels with 
dimensions of [0.094⨯0.154⨯0.154] to [0.183⨯0.186⨯0.186] mm3/voxel for side-fire 
images and from [448⨯350⨯448] to [692⨯520⨯692] voxels with dimensions of 
[0.115⨯0.115⨯0.115] to [0.190⨯0.195⨯0.190] mm3/voxel for end-fire images.  
 
 
Figure 3.1 Mechanical scanning approaches for acquiring 3D TRUS prostate images using 
end-fire (left) and side-fire (right) TRUS transducers. 2D images are acquired by rotating 
around the long axis of the transducer at known sample spacings to create 3D TRUS 
images. Example 3D TRUS images are shown in the bottom row, with the front face 
demonstrating the reconstructed image plane and the white lines showing representative 
acquisition planes. 
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Table 3.1 Clinical 3D TRUS dataset split based on end-fire and side-fire scan geometries 
and resulting training, validation, and testing datasets used for deep learning. 
Image Training Validation Testing Total 
End-fire 67 17 20 104 
Side-fire 98 24 20 142 
Total 165 41 40 246 
3.2.2 3D segmentation algorithm 
A workflow diagram of our proposed method is shown in Figure 3.2. This includes 3D 
TRUS prostate image input, radial sampling, prediction using a trained modified U-Net, 
3D reconstruction, and 3D prostate surface output.  
 
Figure 3.2 Proposed 3D prostate segmentation workflow. A 3D TRUS prostate image is 
used as input, followed by radial sampling to generate 12 2D image planes. Each image 
plane was used to predict a prostate boundary with a trained modified U-Net prior to 
reconstruction into the 3D prostate surface. 
3.2.2.1 Training dataset for modified U-Net 
Images from the training and validation split were used to obtain resliced 2D images of the 
prostate. These 2D images were obtained at randomized axial, sagittal, coronal, radial, and 
oblique image planes with varying rotations and zooms. This resulted in a dataset of 6,773 
2D TRUS images with matched manual contours. All 2D images were resized to 256⨯256 
pixels with no preprocessing (i.e., despeckling or bias correction) and were separated into 
an 80/20 training/validation split for deep learning, resulting in 5418 training and 1355 
validation 2D TRUS images. 
3.2.2.2 Modified U-Net 
The previously published U-Net20 was implemented using Keras21 with TensorFlow22 and 
modified by adding 50% dropouts at every block on the expansion section of the network 
to increase regularization and prevent overfitting. In addition, transpose convolutions were 
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used at each step in the expansion section instead of the standard upsampling followed by 
convolution, as this allowed for improved performance in preliminary experiments. Data 
augmentation from random combinations of horizontal flips, 2D shifts (up to 20%), 
rotations (up to 20°), and zooms (up to 20%) were employed to double the training dataset 
to 10,836 2D TRUS images. Preliminary experiments led to the selection of an Adam 
optimizer, 0.0001 learning rate, Dice-coefficient loss function, 200 epochs, and 200 steps 
per epoch. This network was trained and used for predicting unseen data on a personal 
computer with two Xeon E5645 central processing units at 2.40 GHz (Intel Corporation, 
Santa Clara, CA, USA), 24.0 GB of memory, and a 6 GB Ge-Force GTX TITAN (NVIDIA 
Corporation, Santa Clara, CA, USA) graphics processing unit (GPU). 
3.2.2.3 3D reconstruction 
Predicted 3D prostate segmentations were obtained by segmenting multiple 2D radial 
frames generated by rotation around a central axis, followed by reconstruction to a 3D 
surface following a reconstruction method similar to Qiu et al.11 Previous observations 
have noted that segmenting the prostate on slices near the apex and base of the prostate can 
be challenging due to boundary incompleteness,15 so we chose to radially slice the 3D 
prostate image as opposed to transverse slicing in an attempt to improve segmentations at 
all boundaries. This choice was motivated by the experience of segmenting the prostate 
when the center of the gland is in-plane, which typically presents as an easier image to 
accurately define and segment the boundaries on the left and right sides of the 2D image. 
In contrast to this, a transverse slicing approach would result in 2D images with the prostate 
appearing as a different size and shape, with this difference more pronounced at the prostate 
apex and base, and when comparing end-fire and side-fire image geometries. Difficulty 
arises, predominantly in side-fire geometries, when segmenting the ends of the prostate 
along the axis of acquisition (when using a 2D approach) due to the changes in prostate 
appearance and size. Thus, radially slicing and segmenting the prostate in these views 
allows for a method that can train and predict on images containing similar structural 
shapes, across different acquisition geometries.  
Reconstructing a 3D contour was accomplished by radially slicing a 3D image in equal 15° 
spacings around the approximate central axis of the prostate (Figure 3.3) to produce 12 2D 
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images for prediction. These 12 images were predicted using the trained modified U-Net 
to produce 2D prostate segmentations, and 204 equally spaced points were sampled around 
the boundary of each 2D image. Since the original spatial location of the input 2D image 
in the 3D volume was known, each predicted 2D segmentation was placed appropriately 
back into the 3D volume and the boundary points on each segmentation were connected to 
the adjacent slices. The intermediate surface was smoothed by a windowed sinc filter, 
resulting in a final reconstructed 3D contour. 
 
Figure 3.3 (a) Method for acquiring radially sliced 2D TRUS image planes (dotted lines) 
from previously acquired 3D TRUS images. The axis of rotation (red) is approximately at 
the central axis of the prostate and in the anterior-posterior direction. (b) 12 image slices 
were obtained to perform prostate segmentation. For an end-fire 3D TRUS image, 2D 
images are about the axis of image acquisition. (c) The majority of image slices obtained 
from side-fire 3D TRUS images are across many acquisition slices and are subject to 
increased interpolation, except for one slice, which matched the original acquired 2D 
TRUS image. 
3.2.3 Evaluation and comparison 
Our algorithm was evaluated on a test data set of 20 unseen end-fire and 20 unseen side-
fire 3D TRUS images of the prostate. Standard pixel map comparisons (DSC, recall, 
precision) were computed for both 2D radial slice segmentations and the reconstructed 3D 
segmentation for each prostate to obtain an understanding of the prediction quality and 
reconstruction accuracy. We also computed absolute area/volume percent differences 
(A/VPD), absolute mean surface distances (MSD), and absolute Hausdorff distances (HD), 
as well as signed A/VPD (sA/VPD), signed MSD (sMSD), and signed HD (sHD) for all 
2D predictions and reconstructed 3D segmentations. The signed metrics, while not 
commonly reported, are important as they provide information on the segmentation bias 
(a) (b) (c) 
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and whether the prostate boundary is over or underpredicted. The inclusion of these metrics 
will provide a more complete understanding of the performance of our proposed method. 
All pixel map comparisons and 2D MSD/sMSD and HD/sHD distance metrics were 
computed using MATLAB R2019a (MathWorks, Natick, MA, United States). The 3D 
MSD/sMSD and HD/sHD metrics were computed by measuring the distances between all 
points of the automatically predicted segmentation to the closest point on the manual gold-
standard segmentation (CloudCompare v2.10.2).23 For comparison purposes, the MSD 
reported here is similar to the boundary distance15 and mean surface distance16 presented 
previously. Computation times were recorded for 2D slice segmentation, 3D 
reconstruction, and overall 3D segmentation time.  
The performance of our algorithm was compared against three state-of-the-art fully 3D 
predicting CNNs (V-Net,24 Dense V-Net,25 and High-resolution 3D-Net26) using an open-
source implementation on the NiftyNet platform.27 It is often assumed that performing a 
prediction based on 3D information allows for an improved result due to increased spatial 
context, so we completed a direct comparison on the same test dataset to investigate this 
hypothesis. Similar to our proposed method, the same 165/41 3D TRUS images (Table 3.1) 
were used for training/validation, respectively. The 3D V-Net was chosen to optimize 
hyperparameters, including loss function, due to its widespread use and performance in 
preliminary experiments. For simplicity, these hyperparameters were also used for the 
Dense V-Net and High-resolution 3D-Net. Parameters were chosen to maximize the spatial 
window size and usable memory on the GPU with optimized hyperparameters shown in 
Table 3.2. Previous work has shown improved performance with a hybrid loss function,16 
so we compared performance between a Dice loss function and a Dice plus cross-entropy 
(DiceXEnt) loss function, as provided in NiftyNet, using the 3D V-Net. Although NiftyNet 
offers a patch-based analysis, preliminary experiments resulted in 3D segmentations with 
many flat surfaces throughout the prediction corresponding to patch edges. Since we had 
one structure of interest (i.e., the prostate), we did not perform a patch-based analysis and 
predictions were performed on a resized image to match the spatial window. Data 
augmentation was employed to double the training dataset to 330 3D TRUS images. The 
chosen hyperparameters for the Dense V-Net and High-resolution 3D-Net were the same 
as shown in Table 3.2 (with the DiceXEnt loss function). These networks were trained and 
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used for predicting unseen data on a personal computer with an Intel Core i7-4770 central 
processing unit at 3.40 GHz (Intel Corporation, Santa Clara, CA, USA), 32.0 GB of 
memory, and a 6 GB Ge-Force GTX TITAN (NVIDIA Corporation, Santa Clara, CA, 
USA) graphics processing unit (GPU). Training and 3D segmentation computation times 
were recorded. 
Table 3.2 Hyperparameter selection when employing the V-Net in NiftyNet. 
Hyperparameter Value 
Optimizer Adam 
Loss function Dice and Dice + cross-entropy 
Activation function PReLU 
Learning rate 0.0001 
Spatial window size [64, 64, 64] 
Mini-batch size 2 
Weighted L2-decay 0.0001 
3.2.4 Statistical analysis 
Statistical calculations were performed in GraphPad Prism 8.3 (Graphpad Software, Inc., 
San Diego, CA, USA). The normality of distributions was evaluated using the Shapiro-
Wilk test and led to the use of nonparametric statistical tests when the assumption was 
violated. The corresponding nonparametric alternative tests are presented in parentheses 
for the remainder of the section. The significance level for statistical analysis was chosen 
such that the probability of making a type I error was less than 5% (p < 0.05), with 
statistically significant differences denoted simply as significant for the remainder of this 
manuscript.  
2D radial slice segmentation and 3D reconstructed segmentation accuracy as well as Dice 
and DiceXEnt 3D V-Net loss functions were compared using two-tailed paired t-tests 
(Wilcoxon matched-pairs signed-rank tests). Comparisons between our proposed 
algorithm and three fully 3D CNNs were performed using two-tailed paired t-tests 
(Wilcoxon matched-pairs signed-rank tests) with a Bonferroni multiple-comparison 
correction, which adjusted the significance level to p < 0.0167. Comparisons between 
segmentation accuracy for end-fire and side-fire 3D TRUS images on each network were 
completed using two-tailed unpaired t-tests (Mann-Whitney tests). 
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3.3 Results 
3.3.1 Reconstructed modified U-Net 
The results of our modified U-Net for 2D prostate segmentation and the effects of 
reconstruction on 3D surface generation are shown in Table 3.3 and Table 3.4 for the 
absolute and signed evaluation metrics, respectively. Overall, our proposed method 
generated 3D surfaces with a median [first quartile (Q1), third quartile (Q3)] 3D DSC, 
recall, and precision of 94.1 [92.6, 94.9] %, 96.0 [93.1, 98.5] %, and 93.2 [88.8, 95.4] %, 
respectively, for the pixel map comparison metrics. Absolute VPD, MSD, and HD metrics 
resulted in 5.78 [2.49, 11.5] %, 0.89 [0.73, 1.09] mm, and 2.89 [2.37, 4.35] mm with signed 
metrics of 2.38 [-2.98, 11.0] %, 0.11 [-0.24, 0.58] mm, and 2.02 [-3.34, 2.88] mm, 
respectively. All metrics, aside from the absolute and signed HD metrics, showed 
significant differences between the 2D predictions and 3D reconstructed segmentations. 
Interestingly, recall and MSD metrics were observed to significantly improve in 
performance after 3D reconstruction, with the HD metric improving as well when 
evaluating all unseen images. These findings agreed when splitting the results into end-fire 
and side-fire 3D TRUS images, other than end-fire A/VPD and the signed metrics. For 
end-fire images, absolute VPD increased after 3D reconstruction, although this was not 
significant, while the signed metrics significantly improved after 3D reconstruction. For 
side-fire images, the opposite was true, with signed metrics significantly improved for 2D 
slice segmentations. When comparing the performance of our proposed method between 
end-fire and side-fire 3D TRUS images, we found there was no significant difference in 
any metric for both 2D radial segmentations and 3D reconstructed segmentations. Mean 
computation times were observed to be 0.029 s for each 2D segmentation (i.e., 12 images) 
and 0.27 s for reconstruction into a 3D surface, resulting in a total throughput time of 0.62 
s from 3D image input to generated 3D surface. 
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Table 3.3 Absolute median [Q1, Q3] results comparing 2D radial slice segmentation to 3D 
reconstructed segmentation on an unseen test dataset of 20 end-fire and 20 side-fire 3D 
TRUS images of the prostate. 
Acquisition Segmentation DSC (%) Recall (%) Precision (%) A/VPD (%) MSD (mm) HD (mm) 
End-fire 
2D Radial 95.0  
[93.6, 95.6] 
94.5  
[92.7, 97.2] 
95.9  
[92.2, 97.4] 
4.71  
[1.71, 7.32] 
1.16  
[0.95, 1.37] 
3.64  
[3.11, 4.47] 
3D Reconstruction 94.3  
[93.1, 95.2] 
96.0  
[93.2, 98.7] 
94.6  
[88.8, 95.8] 
5.18 
[1.62, 11.2] 
0.99  
[0.78, 1.18] 
3.41  
[2.49, 4.41] 
p-value 0.0052* 0.0102* <0.0001 0.0532 <0.0001* 0.5217 
Side-fire 
2D Radial 94.6  
[92.7, 95.4] 
95.3  
[90.6, 96.9] 
94.9  
[92.6, 96.4] 
4.05  
[1.07, 6.23] 
0.95  
[0.82, 1.26] 
3.15  
[2.51, 4.27] 
3D Reconstruction 93.5  
[91.1, 94.6] 
96.2  
[92.5, 98.4] 
91.6  
[87.8, 94.8] 
5.89  
[3.17, 11.9] 
0.78  
[0.67, 0.98] 
2.61  
[2.32, 4.01] 
p-value 0.0037 0.0215 <0.0001* 0.0441 <0.0001 0.3683 
Overall 
2D Radial 94.9  
[93.2, 95.5] 
94.9  
[91.9, 97.0] 
95.6  
[92.6, 96.7] 
4.34  
[1.60, 6.77] 
1.06  
[0.85, 1.32] 
3.34 
[2.61, 4.41] 
3D Reconstruction 94.1  
[92.6, 94.9] 
96.0  
[93.1, 98.5] 
93.2  
[88.8, 95.4] 
5.78  
[2.49, 11.5] 
0.89  
[0.73, 1.09] 
2.89  
[2.37, 4.35] 
p-value <0.0001 0.0005 <0.0001 0.0061 <0.0001* 0.2766 
DSC, Dice similarity coefficient; A/VPD, area/volume percent diff.; MSD, mean surface dist.; HD, Hausdorff dist. 
*Normal distribution = paired t-test; Bolded metrics highlight the method with reduced relative error. 
 
Table 3.4 Signed median [Q1, Q3] results comparing 2D radial slice segmentation to 3D 
reconstructed segmentation on an unseen test dataset of 20 end-fire and 20 side-fire 3D 
TRUS images of the prostate. 
Acquisition Segmentation sA/VPD (%) sMSD (mm) sHD (mm) 
End-fire 
2D Radial -1.39 [-3.82, 5.82] -0.13 [-0.50, 0.71] -0.91 [-2.74, 2.81] 
3D Reconstruction -0.05 [-2.98, 11.2] 0.06 [-0.38, 0.85] -0.34 [-3.82, 3.28] 
p-value 0.0011* <0.0001* 0.9563 
Side-fire 
2D Radial -0.57 [-5.24, 3.27] 0.09 [-0.46, 0.31] -0.31 [-1.83, 1.72] 
3D Reconstruction 3.20 [-2.96, 10.1] 0.20 [-0.22, 0.46] 2.25 [-2.53, 2.81] 
p-value 0.0001* <0.0001* 0.2305 
Overall 
2D Radial -0.91 [-4.93, 4.20] -0.09 [-0.46, 0.37] -0.91 [-2.15, 2.02] 
3D Reconstruction 2.38 [-2.98, 11.0] 0.11 [-0.24, 0.58] 2.02 [-3.34, 2.88] 
p-value <0.0001* <0.0001* 0.3611 
sA/VPD, signed area/volume percent diff.; sMSD, signed mean surface dist.; sHD, signed Hausdorff dist. 
*Normal distribution = paired t-test; Bolded metrics highlight the method with reduced relative error. 
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3.3.2 3D CNNs and V-Net optimization 
Table 3.5 Absolute median [Q1, Q3] results comparing a standard 3D V-Net with a Dice 
similarity coefficient loss function to a Dice similarity plus cross-entropy (DiceXEnt) loss 
function on an unseen test dataset of 20 end-fire and 20 side-fire 3D TRUS images of the 
prostate. 
Acquisition Loss function DSC (%) Recall (%) Precision (%) VPD (%) MSD (mm) HD (mm) 
End-fire 
Dice 89.5 
[84.6, 92.0] 
97.8 
[94.6, 98.3] 
83.7 
[75.1, 88.4] 
17.8 
[7.57, 30.7] 
1.79  
[1.43, 2.47] 
8.64 
[7.53, 10.8] 
DiceXEnt 91.7  
[89.0, 93.2] 
91.7  
[86.8, 94.6] 
94.3  
[87.1, 95.8] 
7.94  
[2.95, 12.5] 
1.32 
[0.99, 1.77] 
6.95 
[5.06, 9.10] 
p-value 0.0037 <0.0001 <0.0001 0.0021 0.0009 0.0172 
Side-fire 
Dice 90.6 
[89.1, 93.2] 
94.5 
[91.1, 96.0] 
92.8 
[89.9, 96.9] 
9.08 
[4.35, 14.0] 
1.16 
[0.89, 1.46] 
5.81 
[3.85, 9.61] 
DiceXEnt 91.2  
[87.4, 92.8] 
89.5  
[80.7, 92.9] 
95.0  
[90.8, 97.5] 
7.71  
[3.55, 15.9] 
1.11 
[0.84, 1.47] 
4.92 
[4.28, 6.55] 
p-value 0.2943 <0.0001 0.0001 0.7012 0.7562 0.2305 
Overall 
Dice 90.3 
[86.5, 92.1] 
95.5 
[92.5, 97.8] 
87.8 
[81.0, 91.7] 
11.4 
[4.66, 19.3] 
1.46 
[1.16, 2.07] 
7.99 
[5.34, 10.4] 
DiceXEnt 91.3  
[88.6, 93.1] 
90.0  
[85.6, 93.3] 
94.5  
[90.0, 96.5] 
7.94  
[3.55, 13.4] 
1.27 
[0.92, 1.61] 
6.18 
[4.51, 7.82] 
p-value 0.1538 <0.0001 <0.0001 0.0356 0.0147 0.0067 
DSC, Dice similarity coefficient; VPD, volume percent difference; MSD, mean surface dist.; HD, Hausdorff dist. 
*Normal distribution = paired t-test; Bolded metrics highlight the loss function with reduced relative error. 
 
Table 3.6 Signed median [Q1, Q3] results comparing a standard 3D V-Net with a Dice 
loss function to a Dice plus cross-entropy (DiceXEnt) loss function on an unseen test 
dataset of 20 end-fire and 20 side-fire 3D TRUS images of the prostate. 
Acquisition Loss function sVPD (%) sMSD (mm) sHD (mm) 
End-fire 
Dice 17.8 [7.57, 30.7] 1.51 [0.85, 2.23] 7.99 [5.37, 10.84] 
DiceXEnt -2.16 [-8.47, 6.10] -0.07 [-0.71, 0.68] -0.05 [-7.33, 6.50] 
p-value <0.0001*  <0.0001* 0.0009 
Side-fire 
Dice 5.02 [0.93, 11.5] 0.43 [0.16, 0.80] 5.34 [3.18, 9.61] 
DiceXEnt -5.50 [-15.6, -0.62] -0.30 [-0.88, 0.02] -4.52 [-6.27, -3.04] 
p-value <0.0001* <0.0001* <0.0001 
Overall 
Dice 9.63 [3.90, 18.9] 0.83 [0.35, 1.78] 6.91 [3.35, 10.31] 
DiceXEnt -3.66 [-9.25, 3.34] -0.13 [-0.73, 0.26] -4.16 [-7.04, 4.76] 
p-value <0.0001* <0.0001* <0.0001* 
sVPD, signed volume percent difference; sMSD, signed mean surface dist.; sHD, signed Hausdorff dist. 
*Normal distribution = paired t-test; Bolded metrics highlight the loss function with reduced relative error. 
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Results of the NiftyNet 3D V-Net with a Dice and DiceXEnt loss function on 20 unseen 
end-fire and 20 unseen side-fire 3D TRUS images are shown in Table 3.5 and Table 3.6 
for the absolute and signed evaluation metrics, respectively. When comparing 3D V-Net 
performance with Dice and DiceXEnt loss functions on the full testing dataset, all metrics, 
aside from DSC, showed significant differences. Precision, VPD/sVPD, MSD/sMSD, and 
HD/sHD were significantly improved with the DiceXEnt loss function, while recall was 
significantly improved with the Dice loss function. Although there was no significant 
difference in the DSC metric, the DiceXEnt loss function showed an improved median 
DSC. When considering end-fire and side-fire images individually, identical trends were 
observed for precision, recall, sMSD, and sHD. For the DSC, VPD, MSD, and HD metrics, 
we observed a significant and nonsignificant increase in performance with the DiceXEnt 
loss function for end-fire images and side-fire images, respectively. For end-fire images, 
the sVPD metric improved significantly with the DiceXEnt loss function, while the sVPD 
metric improved significantly with the Dice loss function for side-fire images. When 
comparing the 3D V-Net performance with DiceXEnt between end-fire and side-fire 3D 
TRUS images, we found no significant differences in any metric except HD, where side-
fire images had a significantly reduced median value compared to end-fire images. Overall, 
the 3D V-Net showed improved performance with the DiceXEnt loss function and 
produced 3D segmentations with median [Q1, Q3] 3D DSC, recall, and precision results 
of 91.3 [88.6, 93.1] %, 90.0 [85.6, 93.3] %, and 94.5 [90.0, 96.5] %, respectively, for the 
pixel map comparison metrics. Absolute VPD, MSD, and HD metrics resulted in 7.94 
[3.55, 13.4] %, 1.27 [0.92, 1.61] mm, and 6.18 [4.51, 7.82] mm with signed variants of -
3.66 [-9.25, 3.34] %, -0.13 [-0.73, 0.26] mm, and -4.16 [-7.04, 4.76] mm, respectively. 
Mean computation times were observed to be 3.43 s for a full 3D segmentation. 
Results of the Dense V-Net and High-resolution 3D-Net with a DiceXEnt loss function on 
20 unseen end-fire and 20 unseen side-fire 3D TRUS images are shown in Table 3.A1 and 
Table 3.A2 in Supplement A for the absolute and signed evaluation metrics, respectively. 
Compared to the 3D V-Net, the High-resolution 3D-Net showed a reduction in median 
performance for all metrics, while the Dense V-Net showed a reduction in performance for 
all metrics except recall. In contrast with our proposed method and the 3D V-Net, we 
observed significant differences in segmentation performance for several metrics when 
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comparing end-fire and side-fire 3D TRUS images using the Dense V-Net and High-
resolution 3D-Net. For the Dense V-Net, improved performance was observed on side-fire 
images for every metric except recall, with significant differences observed for the 
precision, recall, VPD/sVPD, and sMSD metrics. For the High-resolution 3D-Net, 
improved performance was observed on end-fire images for every metric except precision 
and HD, with significant differences observed for the DSC, precision, recall, VPD/sVPD, 
and sMSD metrics. Mean 3D segmentation times for the Dense V-Net and High-resolution 
3D-Net were observed to be 2.98 s and 2.83 s, respectively. 
3.3.3 Comparison of reconstructed modified U-Net and 3D CNNs 
Sample segmentation results from the 20 unseen end-fire and 20 unseen side-fire 3D TRUS 
images from our proposed method compared against the 3D V-Net with a DiceXEnt loss 
function and manual segmentations are shown in Figure 3.4 and Figure 3.5, respectively. 
A comparison of segmentation performance between our proposed method and a standard 
3D V-Net is shown in Table 3.7 and Table 3.8 for the absolute and signed evaluation 
metrics, respectively. Overall, our proposed method had significantly improved DSC, 
Recall, sVPD, MSD/sMSD, and HD when compared to the 3D V-Net. Absolute VPD and 
sHD, while not significantly different, were reduced for our proposed method. The only 
evaluation metric where the 3D V-Net outperformed our proposed method was precision, 
where the 3D V-Net showed a nonsignificant increase. Considering segmentation 
performance for end-fire and side-fire 3D TRUS images separately, similar trends hold. 
For end-fire images, our proposed method had better performance in all metrics except 
sHD, with DSC, recall, sVPD, MSD, and HD showing significant differences, and 
precision, VPD, and sMSD showing nonsignificant improvements. However, for side-fire 
images our proposed method was superior in all metrics except precision. Significant 
improvements were shown for DSC, recall, sVPD, MSD/sMSD, and HD/sHD, while the 
3D V-Net had significantly improved precision. As was observed in the overall case, our 
proposed method showed a nonsignificant decrease in VPD compared to the 3D V-Net for 
both end-fire and side-fire images.  
Overall, our proposed method significantly improved performance on all metrics when 
compared to the Dense V-Net and showed improved performance on all metrics when 
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compared to the High-resolution 3D-Net, with significant differences observed for all 
metrics except precision, sMSD, and sHD, where our method showed a nonsignificant 
improvement. 
Table 3.7 Absolute median [Q1, Q3] results comparing a standard 3D V-Net to our 
proposed reconstructed modified (rm) U-Net on an unseen test dataset of 20 end-fire and 
20 side-fire 3D TRUS images of the prostate.  
Acquisition Segmentation DSC (%) Recall (%) Precision (%) VPD (%) MSD (mm) HD (mm) 
End-fire 
V-Net 91.7  
[89.0, 93.2] 
91.7  
[86.8, 94.6] 
94.3  
[87.1, 95.8] 
7.94  
[2.95, 12.5] 
1.32 
[0.99, 1.77] 
6.95 
[5.06, 9.10] 
rmU-Net 94.3  
[93.1, 95.2] 
96.0  
[93.2, 98.7] 
94.6  
[88.8, 95.8] 
5.18  
[1.62, 11.2] 
0.99  
[0.78, 1.18] 
3.41  
[2.49, 4.41] 
p-value 0.0003* <0.0001* 0.5459 0.4980 0.0003* <0.0001 
Side-fire 
V-Net 91.2  
[87.4, 92.8] 
89.5  
[80.7, 92.9] 
95.0  
[90.8, 97.5] 
7.71  
[3.55, 15.9] 
1.11 
[0.84, 1.47] 
4.92 
[4.28, 6.55] 
rmU-Net 93.5  
[91.1, 94.6] 
96.2  
[92.5, 98.4] 
91.6  
[87.8, 94.8] 
5.89  
[3.17, 11.9] 
0.78  
[0.67, 0.98] 
2.61  
[2.32, 4.01] 
p-value 0.0073 0.0002 0.0153 0.2611 0.0027 0.0001 
Overall 
V-Net 91.3  
[88.6, 93.1] 
90.0  
[85.6, 93.3] 
94.5  
[90.0, 96.5] 
7.94  
[3.55, 13.4] 
1.27 
[0.92, 1.61] 
6.18 
[4.51, 7.82] 
rmU-Net 94.1  
[92.6 , 94.9] 
96.0  
[93.1, 98.5] 
93.2  
[88.8, 95.4] 
5.78 
[2.49, 11.5] 
0.89  
[0.73, 1.09] 
2.89  
[2.37, 4.35] 
p-value <0.0001 <0.0001 0.1499 0.1701 <0.0001* <0.0001 
DSC, Dice similarity coefficient; VPD, volume percent difference; MSD, mean surface dist.; HD, Hausdorff dist. 
*Normal distribution = paired t-test; Bolded metrics highlight the method with reduced relative error. 
Table 3.8 Signed median [Q1, Q3] results comparing a standard 3D V-Net to our proposed 
reconstructed modified (rm) U-Net on an unseen test dataset of 20 end-fire and 20 side-fire 
3D TRUS images of the prostate. 
Acquisition Segmentation sVPD (%) sMSD (mm) sHD (mm) 
End-fire 
V-Net -2.16 [-8.47, 6.10] -0.07 [-0.71, 0.68] -0.05 [-7.33, 6.50] 
rmU-Net -0.05 [-2.98, 11.2] 0.06 [-0.38, 0.85] -0.34 [-3.82, 3.28] 
p-value 0.0030* 0.0444* 0.7942* 
Side-fire 
V-Net -5.50 [-15.6, -0.62] -0.30 [-0.88, 0.02] -4.52 [-6.27, -3.04] 
rmU-Net 3.20 [-2.96, 10.1] 0.20 [-0.22, 0.46] 2.25 [-2.53, 2.81] 
p-value 0.0001* 0.0025* 0.0107 
Overall 
V-Net -3.66 [-9.25, 3.34] -0.13 [-0.73, 0.26] -4.16 [-7.04, 4.76] 
rmU-Net 2.38 [-2.98, 11.0] 0.11 [-0.24, 0.58] 2.02 [-3.34, 2.88] 
p-value <0.0001* 0.0003* 0.0408 
sVPD, signed volume percent difference; sMSD, signed mean surface dist.; sHD, signed Hausdorff dist. 
*Normal distribution = paired t-test; Bolded metrics highlight the method with reduced relative error. 
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Figure 3.4 End-fire prostate segmentation results comparing manual (red), our proposed 
reconstructed modified (rm) U-Net (blue), and V-Net (yellow) 3D surfaces. The columns 
from left to right show the 25th, 50th, and 75th percentile results, respectively, based on DSC 
metrics. Segmentations in the axial plane, sagittal plane, 45° oblique radial plane, and 
reconstructed 3D surface error are shown in the respective rows from top to bottom. 
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Figure 3.5 Side-fire prostate segmentation results comparing manual (red), our proposed 
reconstructed modified (rm) U-Net (blue), and V-Net (yellow) 3D surfaces. The columns 
from left to right show the 25th, 50th, and 75th percentile results, respectively, based on DSC 
metrics. Segmentations in the axial plane, sagittal plane, 45° oblique radial plane, and 
reconstructed 3D surface error are shown in the respective rows from top to bottom. 
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3.4 Discussion 
3.4.1 Reconstructed modified U-Net 
We proposed a new 3D TRUS prostate segmentation method, which utilizes a modified U-
Net to segment 12 2D radial slices, which are then reconstructed into a 3D surface. We 
first compared segmentation accuracy in these 2D radial slices to segmentation accuracy 
following 3D reconstruction. In general, the performance was better on the 2D radial slice 
segmentations compared to the reconstructed 3D surface, but interestingly, our 
reconstruction method improved recall, MSD, and HD metrics when compared to 2D slice 
segmentation. When considered in combination, the reduced MSD and HD metrics showed 
better mean and irregular boundary accuracy, with the improved recall metric implying a 
reduction in underprediction (since decreasing underpredicted pixels, i.e., false negatives, 
will increase recall). The reduction in underprediction is contrasted with our method 
tending to overpredict, supported by the slight positive bias in the signed metrics and 
reduced precision. In the metrics where performance was worse for our 3D reconstructed 
segmentations, such as DSC and VPD, the difference in median values were less than 1% 
and 1.5% respectively. Thus, we saw that our 3D reconstruction method did not drastically 
reduce performance of the evaluation metrics when compared to our 2D segmentations, 
with the 3D reconstruction improving performance on select metrics. Examining the signed 
metrics shown in Table 3.4, we observed that sVPD, sMSD, and sHD are reduced 
compared to their absolute metrics, with median sVPD reduced to only 2.38 %, median 
sMSD reduced to 0.11 mm, and median sHD reduced to 2.02 mm. This demonstrated that 
our algorithm was not significantly biased to over or underpredict the prostate boundary.  
As our proposed network was trained and tested on both end-fire and side-fire 3D TRUS 
images, we directly compared the performance of our method on each image type 
observing no significant difference between performance for end-fire and side-fire images 
on any metric. Both independent image geometries also followed the same trends as the 
total dataset, aside from a reduced signed bias in the end-fire images following 
reconstruction. These results demonstrated the effectiveness of radially sampling 3D 
TRUS prostate images to produce similar 2D images for prediction and the ability to 
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accurately segment the prostate in different 3D TRUS image geometries without the need 
for multiple trained networks, which, to our knowledge, is the first time this has been 
shown. 
3.4.2 3D CNNs and V-Net Optimization 
The initial publication describing the V-Net architecture by Milletari et al.24 proposed the 
use of a Dice coefficient-based loss function, but recent leave-one-out validation, described 
in Lei et al.,16 has advocated for the use of hybrid loss functions that combine standard 
logistic loss, such as the cross-entropy loss metric,20 with the Dice loss metric. We 
implemented a 3D V-Net with both a Dice loss function and a hybrid DiceXEnt loss 
function in order to compare performance between loss functions, as well as to directly 
compare performance to previously published V-Net implementations16 on an unseen 
dataset. Our results reiterate what has been previously reported, with the hybrid DiceXEnt 
loss function significantly improving performance on all metrics except DSC and recall, 
where we observed a nonsignificant increase in performance and a significant decrease in 
performance, respectively. Similar trends held when examining the results for end-fire and 
side-fire 3D TRUS images individually. Comparing 3D V-Net performance when using a 
DiceXEnt loss function between end-fire and side-fire 3D TRUS images showed similar 
results to our proposed network, as there was no significant difference in any metric except 
HD.  
Similar segmentation performance on end-fire and side-fire 3D TRUS images for all three 
3D CNNs and our proposed 3D segmentation method demonstrated that we could 
potentially train a single network to accurately segment the prostate in geometrically 
variable 3D TRUS images. This was demonstrated predominantly with our approach and 
the 3D V-Net as the Dense V-Net and High-resolution 3D-Net were observed to have 
significant differences between several metrics when comparing end-fire and side-fire 
segmentation performance. Interestingly, performance differed between the Dense V-Net 
and High-resolution 3D-Net for different image geometries, with better predictions 
performed on side-fire and end-fires images, respectively. Although our method performed 
the best, the 3D V-Net outperformed the other two 3D CNNs investigated in this study. 
This improved performance on 3D US prostate segmentation could be due to the number 
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of parameters trained by the network since the 3D V-Net has approximately two orders of 
magnitude more parameters relative to the Dense V-Net and High-resolution 3D-Net. 
Although the latter networks are more efficient and required less computation time, we 
found this did not benefit performance. 
Although Lei et al.16 reported on a deep supervision method with contour refinement, they 
also reported on the use of a standard 3D V-Net with a hybrid DiceXEnt loss function to 
segment the prostate in side-fire 3D TRUS images, showing a 3D DSC, precision, recall, 
HD, MSD, and RMSD of 90.5 ± 3.0 %, 88.1 ± 6.0 %, 93.5 ± 3.5 %, 4.643 ± 1.926 mm, 
0.657 ± 0.270 mm, and 0.977 ± 0.410 mm, respectively. Comparatively, a standard 3D V-
Net with a DiceXEnt loss function trained on our dataset and predicted on side-fire images 
resulted in a 3D DSC, precision, recall, HD, and MSD of 91.2 [87.4, 92.8] %, 95.0 [90.8, 
97.5] %, 89.5 [80.7, 92.9] %, 4.92 [4.28, 6.55] mm, and 1.11 [0.84, 1.47] mm, showing 
very similar performance. Investigating the differences between mean and median values 
showed our V-Net implementation demonstrated improved 3D DSC and precision, while 
Lei et al.16 demonstrated improved recall, HD, and MSD. Although VDP or any signed 
metrics were not reported, this demonstrated similarity in performance. Thus, we suggest 
future comparisons should use a standardized V-Net, like the NiftyNet open-source 
implementation, to provide a baseline for comparing network performance on different 
datasets. 
3.4.3 Comparison with 3D V-Net and previously published methods 
For an identical training and testing dataset, our proposed method performed significantly 
better than the standard 3D V-Net with a hybrid loss function, with DSC, recall, sVPD, 
MSD/sMSD, and HD/sHD showing significant improvement. Our proposed method also 
demonstrated a reduced median VPD, although this difference was not significant. Similar 
differences in performance were observed when considering end-fire and side-fire 3D 
TRUS images separately. Figure 3.4 and Figure 3.5 show this difference in performance 
qualitatively for both image geometries, with the 3D V-Net often over or underpredicting 
the correct prostate boundary. This difference is readily apparent in the side-fire middle 
50th percentile column of Figure 3.5. The V-Net is shown to have incorrectly contoured 
part of the bladder as the prostate, drastically affecting the overall segmentation accuracy. 
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In contrast, our proposed method was able to correctly avoid the bladder, resulting in a 
more accurate segmentation. A similar result is shown in the left column of Figure 3.4 as 
well as in Figure 3.6, where we show that the 3D V-Net mistakenly underpredicted the 
prostate boundary due to the presence of a hyperechoic calcification artifact in the TRUS 
image, whereas our proposed method was typically able to avoid artifacts of this nature. 
We demonstrated a mean 3D segmentation time of 0.62 s with our proposed method, over 
five times faster than the 3D V-Net, which required an average of 3.43 s per segmentation. 
All segmentations were completed with the same NVIDIA GeForce GTX TITAN GPU 
with 6 GB of memory. 
 
Figure 3.6 A sample end-fire prostate segmentation result comparing manual (red), our 
proposed algorithm (blue), and V-Net (yellow) 3D surfaces in the presence of a 
hyperechoic calcification image artifact. 
Recent work by Ghavami et al.15 and Lei et al.16 report on automatic prostate segmentation 
in 3D TRUS images, with Ghavami et al.15 reporting best results for 2D DSC, 3D DSC, 
and boundary distance of 89 ± 12 %, 89 ± 5 %, and 1.68 ± 1.57 mm, respectively, and Lei 
et al.16 reporting overall segmentation results for 3D DSC, precision, recall, HD, MSD, and 
RMSD of 91.9 ± 2.8 %, 90.6 ± 5.5 %, 93.8 ± 4.3 %, 3.938 ± 1.550 mm, 0.599 ± 0.225 mm, 
and 0.900 ± 0.377 mm, respectively. Our proposed method demonstrated overall 
segmentation results for 2D DSC, 3D DSC, precision, recall, HD, and MSD of 94.9 [93.2, 
95.5] %, 94.1 [92.6, 94.9] %, 93.2 [88.08, 95.4] %, 96.0 [93.1, 98.5] %, 2.89 [2.37, 4.35] 
mm, and 0.89 [0.73, 1.09] mm, respectively, outperforming the network reported by 
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Ghavami et al.15 on all reported metrics, and outperforming the network reported by Lei et 
al.16 on all metrics except MSD. In addition, our paper reports on metrics not used in the 
studies described here, including VPD, and signed variants of VPD, MSD, and HD, 
providing additional insight into the performance of our network that is otherwise not 
present when these metrics are excluded. Lei et al.16 reported segmentation times of 
approximately 1-2 s for a U-Net, V-Net, and their proposed network, with segmentations 
completed using an NVIDIA TITAN XP GPU with 12 GB of memory. Comparatively, our 
V-Net implementation in NiftyNet had a mean segmentation time of 3.43 s, while our 
proposed method had a mean segmentation time of 0.62 s, with segmentations completed 
using an NVIDIA GeForce GTX TITAN GPU with 6 GB of memory. Although our V-Net 
had slower segmentation times, our proposed method was one and a half to three times 
faster, using a GPU with half the memory, demonstrating the advantage of our proposed 
method regarding segmentation time.  
Studies reported by Ghavami et al.15 and Lei et al.16 are also limited by their use of cross-
validation approaches, in addition to their dataset consisting of only one image geometry 
and a single ultrasound machine with matched voxel dimensions and sizes. In contrast, we 
used a clinically diverse dataset of 3D TRUS images of different image geometries, 
generated by several different ultrasound transducers used with different machine models, 
and used in distinct procedures. This dataset contains images with varying voxel 
dimensions, size, and image quality, and we have employed no pre-processing before 
training to reduce process complexity. To our knowledge, the use of a dataset with different 
image geometries, ultrasound transducers, ultrasound machine models, voxel dimensions, 
and image sizes for 3D TRUS prostate segmentation is unique and may allow for a more 
robust and generalizable segmentation method. In addition, we have not used a cross-
validation approach, instead testing our algorithm on 3D TRUS images that were 
completely unseen by the network, which we believe strengthens the significance of our 
results and may result in improved generalizability. 
3.4.4 Limitations and future work 
Although we have demonstrated excellent performance with our proposed algorithm, a 
parameter that may be interesting to explore in future work is the step angle for radial slice 
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generation. Specifically, it would be interesting to investigate whether a decreased step 
angle and thus an increased number of radial slices would significantly increase 
performance, or whether a decreased number of slices could be used while maintaining 
similar performance. An increased number of radial slices would increase computation 
time, which motivated our choice of a 15° step angle for the proposed method. When 
training the 3D CNNs for performance comparison, hyperparameters were optimized on 
the V-Net and were used for the other two networks. Even though we investigated other 
combinations and found these hyperparameters to perform the best on the Dense V-Net 
and High-resolution 3D-Net, a rigorous optimization was not performed and has the 
potential to increase performance. Another limitation of our study is the use of only one 
observer for providing ground truth segmentations. This meant we could not directly assess 
inter-observer variability for our dataset. In addition, we did not directly assess intra-
observer variability over several time points. Inter- and intra-observer variability in end-
fire 3D TRUS images were previously assessed by our group,11 and are summarized here. 
To assess intra-observer variability, one observer segmented 15 3D images five times each, 
resulting in a 3D DSC of 93.0 ± 2.1 %. To assess inter-observer variability, three untrained 
observers segmented 15 3D images three times each, resulting in a DSC of 93.5 ± 2.1 %, 
92.6 ± 3.1 %, and 92.3 ± 3.2 %, with an ANOVA demonstrating no significant difference. 
Inter- and intra-observer variability in side-fire 3D TRUS images were also assessed by 
our group,28 reporting 5.1 % variability and 99 % reliability in intra-observer prostate 
volume estimates, and 11.4 % variability and 96 % reliability in inter-observer estimates, 
for a study of eight observers measuring 15 prostate images twice. This variability is 
comparable to the reported DSC of our proposed method in this work, showing that our 
algorithm is performing at the level of intra-observer variability in the ground truth 
segmentations. Due to the demonstrated variability between different observers when 
segmenting 3D TRUS images, segmentations from other observers should be incorporated 
into our testing dataset to further improve the robustness of our proposed method. 
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3.5 Conclusions 
This study investigated the development of a 2D deep learning with 3D reconstruction 
approach for automatic prostate segmentation in 3D TRUS images. Multiple facilities, 
ultrasound machine models, and acquisition geometries were investigated to evaluate 
robustness and generalizability, with comparisons performed against multiple 3D CNNs. 
A fast, accurate, and generalizable automatic prostate segmentation algorithm could reduce 
physician burden and procedure time, offering potential workflow benefits for fusion-
guided prostate biopsy, tumor-targeted HDR-BT, and TRUS-guided whole-gland BT. 
Reducing the time a patient is under anesthesia, as in HDR-BT, also promotes a potentially 
safer procedure with fewer adverse side effects.  
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3.7 Supplement A 
Table 3.A1 Absolute median [Q1, Q3] results comparing a Dense V-Net (DenseNet) and 
High-resolution 3D Network (HighRes3dNet) on an unseen test dataset of 20 end-fire and 
20 side-fire 3D TRUS images of the prostate. 
Acquisition Segmentation DSC (%) Recall (%) Precision (%) VPD (%) MSD (mm) HD (mm) 
End-fire 
DenseNet 
87.9  
[84.9, 90.4] 
95.4  
[92.9, 97.0] 
82.2  
[77.4, 86.5] 
15.6  
[9.42, 20.8] 
2.11  
[1.55, 2.85] 
10.0  
[7.82, 12.5] 
HighRes3dNet 
90.0  
[87.3, 91.4] 
91.7  
[84.6, 94.9] 
89.3  
[87.0, 93.7] 
6.88  
[4.30, 15.7] 
1.62  
[1.41, 2.08] 
8.95  
[7.56, 11.2] 
Side-fire 
DenseNet 
88.7  
[81.6, 90.7] 
89.1  
[86.0, 95.1] 
89.6  
[82.8, 91.9] 
6.38  
[4.22, 12.6] 
1.47  
[1.26, 2.56] 
8.96  
[5.93, 13.8] 
HighRes3dNet 
86.2  
[84.3, 88.7] 
80.5  
[76.8, 86.0] 
94.9  
[90.9, 96.1] 
15.3  
[9.77, 20.0] 
1.64  
[1.36, 1.93] 
7.82  
[6.67, 9.31] 
Overall 
DenseNet 
88.2  
[84.3, 90.6] 
93.0  
[88.9, 96.1] 
84.8  
[79.2, 90.2] 
11.0  
[5.96, 19.3] 
2.00  
[1.36, 2.63] 
9.23  
[7.00, 13.2] 
HighRes3dNet 
87.5  
[85.5, 90.3] 
85.4  
[79.8, 92.1] 
92.3  
[88.4, 95.8] 
11.8  
[4.68, 18.0] 
1.63  
[1.40, 1.97] 
8.37  
[6.89, 10.9] 
DSC, Dice similarity coefficient; VPD, volume percent difference; MSD, mean surface dist.; HD, Hausdorff dist. 
 
Table 3.A2 Signed median [Q1, Q3] results comparing a Dense V-Net (DenseNet) and 
High-resolution 3D Network (HighRes3dNet) on an unseen test dataset of 20 end-fire and 
20 side-fire 3D TRUS images of the prostate. 
Acquisition Segmentation sVPD (%) sMSD (mm) sHD (mm) 
End-fire 
DenseNet 15.6 [9.42, 20.8] 1.44 [0.92, 2.18] 9.13 [7.19, 12.3] 
HighRes3dNet 2.86 [-6.42, 8.86] 0.37 [-0.46, 0.93]] 6.47 [-8.97, 9.71] 
Side-fire 
DenseNet 0.36 [-4.91, 7.07] 0.38 [-0.15, 1.03] 8.67 [-2.86, 13.8] 
HighRes3dNet -13.8 [-20.0, -7.55] -0.76 [-1.23, -0.08] -6.69 [-8.40, 4.38] 
Overall 
DenseNet 8.77 [-2.84, 18.3] 0.95 [0.29, 1.61] 8.87 [5.72, 13.2] 
HighRes3dNet -6.89 [-16.4, 4.09] -0.24 [-1.15, 0.58] -5.84 [-8.46, 8.32] 
sVPD, signed volume percent difference; sMSD, signed mean surface dist.; sHD, signed Hausdorff dist. 
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Chapter 4  
4 Geometrically variable three-dimensional ultrasound for 
mechanically assisted image-guided therapy of focal liver 
cancer tumors 
The use of 3D information during interventional procedures has the potential to improve 
the accuracy needed for sufficient clinical outcomes. The purpose of Chapter 4 is to present 
on the development of a novel 3D US system to provide a safe, cost-effective, and accurate 
intraoperative approach for focal liver tumor therapies. 
The contents of this chapter have been accepted for publication on June 28, 2020 in Medical 
Physics: Gillies DJ, Bax J, Barker K, Gardi L, Tessier D, Kakani N, and Fenster A. 
4.1 Introduction 
Liver cancer is the second and sixth most frequent cause of cancer mortality in men and 
women, respectively, and its incidence is continuing to increase globally.1 The high 
prevalence of this disease is observed in underdeveloped and developing countries due to 
the increased incidence of Hepatitis B and C, but rates are also increasing globally from 
factors including exposure to aflatoxins, metabolic syndrome, and alcohol.1 Without 
accessible and practical therapy options, the prognosis for the majority of patients 
diagnosed with liver cancer remains grave. Conventional therapy is often provided in the 
forms of transplantation and hepatic resection, but patient eligibility is often low due to 
disease exclusion criteria such as the number of tumors, size, location, and presence of 
metastases.2,3 Even in circumstances when a patient is eligible, serious complications can 
occur in up to 26-33% of procedures.4  
Image-guided interventions are less invasive alternatives to open surgery that focus on 
relating preoperative data and images of a patient in an intraoperative setting.5 Smaller 
surgical incisions often lead to reduced recovery times and complication rates, which 
directly benefit a patient’s quality-of-life and healthcare costs. Three main techniques for 
image-guided interventions in the treatment of liver cancer have been investigated: 
embolization, irreversible electroporation, and ablation, such as cryoablation, ethanol 
injection, microwave ablation (MWA), and radiofrequency ablation (RFA). In recent years, 
MWA and RFA have been regarded as the best treatment options for small and 
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unresectable liver tumors,6,7 which use needle-like therapy applicators guided to the tumor 
location to deliver a lethal thermal dose to the tumor.  
Image-guidance during ablation procedures varies globally and has been predominantly 
performed using x-ray computed tomography (CT), magnetic resonance imaging (MRI), 
and ultrasound (US). In many developed countries, access to CT provides a good depiction 
of liver tumors and the ablation applicators, but the limited access to the patient in the CT 
gantry often extends procedure time and can limit complex applicator access angles.8 Since 
MR guidance is often limited to institutions with compatible equipment, US is regarded as 
the most efficient modality for tumors that can be targeted adequately8 with developing 
countries often using this approach.9 Conventional US guidance is a real-time, two-handed 
approach using a plan based on preoperative CT or MR images where one hand positions 
and orients a conventional US probe while the other hand performs therapy applicator 
insertion. However, this approach requires extensive training as the physician must: (1) 
mentally integrate two-dimensional (2D) imaging to form an appreciation of the complex 
3D anatomy of the liver, (2) approximate the tumor volume and spatial extent, (3) align the 
2D image plane directly with the applicator to detect and track its placement at the tumor 
location, and (4) be cognizant of the surrounding anatomy to avoid puncturing unnecessary 
anatomical structures and organs-at-risk, such as the gallbladder. This time-consuming and 
challenging task with its compounding forms of mental burden can lead to increased 
variability in applicator placement and ultimately insufficient tumor ablation. In addition 
to the high local tumor recurrence that has been observed when ablation margins are less 
than 5 mm,10–12 tumors with diameters larger than 5 cm are often avoided as the incidence 
of local tumor progression is higher due to the accuracy required for placing and 
repositioning multiple applicators with overlapping ablation volumes.13 Therefore, there is 
a clinical need to improve the imaging guidance and placement verification of needle 
applicators during MWA and RFA procedures. 
Investigations into guidance techniques for planning, targeting, monitoring, and controlling 
ablation therapies and other needle-like procedures have focused on incorporating CT 
image guidance,14 MR image guidance,15 and tracking systems16,17 into the intraoperative 
clinical workflow. Incorporating three-dimensional (3D) visualizations can lead to 
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complete ablations and higher clinical success rates on the first ablation attempt, as well as 
fewer sessions overall relative to 2D US when subsequent attempts are required.16,18 CT 
images can provide 3D multiplanar images to visualize the needle-like applicators, but 
repeated CT scans are performed at the cost of increased procedure time and radiation dose 
to the patient. MR imaging has been used as it offers advantages such as improved soft-
tissue contrast and the potential for real-time treatment monitoring, but can again increase 
procedure time and is not readily accessible in many countries due to the sophisticated 
technology required.19 Electromagnetic tracking systems have been used to place multiple 
needle applicators by registering and fusing preoperative CT images with live 2D US 
images;20 however, these systems do not often rely on the intraoperative imaging data and 
are susceptible to environmental limitations that can degrade targeting accuracy. 
An alternative approach for real-time image-guided therapy is the use of three-dimensional 
(3D) US.21 This approach includes 2D US freehand scanning with optical or 
electromagnetic position tracking,22 2D array probes,23 or 2D US with mechanical 
scanners.24 These images can offer real-time or near real-time multiplanar imaging in an 
accessible and portable manner, which is an important consideration for widespread 
dissemination. If combined or fused with preoperative CT images using image registration 
methods, lesion identification and procedural plans25 can be incorporated into the 
intraoperative workflow for an augmented and targeted image-guided procedure. Needle 
guides can improve placement of applicators over freehand approaches22 and repeat 3D US 
images can be obtained safely to inform the physician if the therapy applicator placement 
is sufficient or repositioning is required with the use of segmentation algorithms,26 without 
the need for ionizing radiation exposure and a significant increase in procedure time. When 
performing guided insertions, 3D US imaging can improve the targeting accuracy of needle 
applicator placements over freehand 2D US22,27 and has been observed to detect 
unacceptable applicator placements in up to 45% of procedures.28 Additionally, 3D US has 
been observed to improve operator confidence and visualization of the positional 
relationship between needle applicators and nearby critical structures.29 Although therapy 
monitoring can be difficult on conventional B-mode imaging, intraoperative ultrasound 
elasticity imaging has the potential to provide real-time monitoring and verification of 
thermal ablation volumes.30 
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We propose the use of 3D US imaging to provide guidance and localization of ablation 
applicators in current focal liver tumor ablation therapies. We have previously developed 
a system capable of providing 3D US images using a mechanical scanning approach for 
linear, tilt, and hybrid motions of the US probe, which resulted in accurate geometric 3D 
reconstruction and good agreement with clinical CT patient liver images when assessing 
tip and trajectory errors.24 Since the liver is a large internal organ that is partly sheltered by 
the ribs, flexibility in 3D US acquisition geometries can allow for small physical footprints 
(i.e., tilt scanning) that are beneficial for intercostal imaging, as well as wide field-of-view 
(FOV) subcostal imaging (i.e., hybrid scanning) to capture large volumes of the liver. We 
chose to pursue a mechanical scanning approach as it is cost-effective since any clinically 
available US system can be used with this approach, the motor assembly can predefine and 
control probe motion with high accuracy, environmental constraints are minimal, and 
advances in US imaging probes can be easily integrated into the system without any 
changes in the scanning mechanism. This work will further expand the design and use of 
the system by incorporating and evaluating a novel scanning mechanism for increased 
image size and improved usability, a mechanical tracking system for probe placement 
reproducibility and freehand needle applicator guidance, and a needle applicator insertion 
workflow using a custom needle applicator guide for targeted image-guided procedures. 
Evaluation of the new scanner has been previously discussed briefly,31,32 but is expanded 
here to provide context for evaluation of the tracking system and needle applicator insertion 
workflow performed on 48 phantom 3D US images. A healthy volunteer was also imaged 
to provide evidence for clinical feasibility. These evaluations aim to give insights on 
clinical utility for improving applicator placement and reducing local cancer recurrence 
during interventional procedures treating liver cancer. 
4.2 Materials and methods 
Our proposed 3D US system (Figure 4.1) consists of four components: (1) a three-motor 
3D US scanner, (2) a counterbalanced tracking system, (3) a 3D-printed applicator guide, 
and (4) software for image acquisition, visualization, and guidance. The stabilizing system 
also contains electromagnetic brakes, which are disengaged using a foot pedal to improve 
clinical usability and workflow, for locking the system to limit device motion during 3D 
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US acquisition and insertion of therapy applicators. The stabilizing system is mounted on 
a portable cart, which contains a foot-released vertical motion column to accommodate 
large differences in patient sizes, a power supply, and a personal computer with a monitor 
to interface with custom visualization and guidance software. 
 
Figure 4.1 Proposed 3D US system consisting of a three-motor 3D US scanner and a 
counterbalanced stabilizing system mounted on a portable cart. A 3D-printed needle 
applicator guide and custom visualization and guidance software were developed for this 
system to perform targeted needle applicator insertions. 
4.2.1 3D US scanner design and validation 
The proposed 3D US system has been previously discussed and is summarized here.31 
Custom 3D-printed holders were designed to match 2D US probe casings and provide a 
universal male mating connection for any commercially available US probe. A standard 
clinical workflow requirement when performing US-guided procedures is the need for 
patient scout imaging to localize the tumor using freehand US imaging. Once the tumor is 
localized, a beneficial clinical utility would allow the 2D US probe to maintain its 
localization position while a 3D enabling scanner is brought to the probe. For this reason, 
the scanner was created with a female mating spring-loaded quick connection and used 
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three-motors to manipulate the attached 2D US probe. The configuration of the motors was 
designed such that the bulk of the scanner was away from the probe face, which maintained 
the physician’s conventional hand position used during freehand US imaging. The 
connection and scanner design choices allowed for accessibility for any healthcare facility 
using commercial US systems, easy transition to freehand US (which is often important for 
patient scout imaging), and a scanner design that provided a more natural feel for the 
physician as it was able to accommodate their experience and training with regard to hand 
positioning and the 2D imaging technique. Three-motors were used to manipulate the probe 
in two linear degrees-of-freedom (DoF) and one rotational DoF to provide a large scanning 
FOV with consistent image spacing for repeatable 3D US image generation. The large FOV 
allows for more anatomical landmarks and targets to be captured for reference and potential 
registration to a planning CT image. These motors controlled horizontal, vertical, and 
rotational motions up to extents of 98 mm, 19 mm, and 90°, respectively, to form different 
acquisition geometries, including linear, tilt, and or hybrid. Linear refers to the activation 
of a single motor for translation of the probe, whereas tilt and hybrid incorporate all three 
motors to either form a 3D image by rotating a 2D probe about the face of the probe (i.e., 
tilt) or during translation (i.e., hybrid) to form a wide FOV acquisition, similar to previous 
methods.24 3D image reconstruction was performed by moving the probe in the desired 
geometry while images were acquired from the US system using a Digital Visual Interface 
(DVI) to Universal Serial Bus (USB) video frame grabber (Epiphan Systems Inc., Ottawa, 
Canada). Current implementation focused on clinical simplicity and offers a set of pre-
defined 3D scanning directions and ranges, but variable control of each independent motor 
is possible. 
The three-motor scanner used to perform 3D image reconstruction was previously 
validated for geometric error and volumetric error. Geometric imaging experiments were 
performed on a grid phantom of known geometry, which resulted in mean geometric errors 
of ≤0.2%, ≤2.3%, and ≤3.0% for lateral, axial, and elevational image dimensions 
respectively.31 Volumetric imaging experiments were performed to further evaluate image 
reconstruction to assess the combined error contributions of each image dimension. Tissue-
mimicking phantoms with spherical structures were used to compute mean volumetric 
errors of -5.85 ± 6.18%, -6.12 ± 4.82%, and -6.82 ± 3.56% for linear (range: 65 mm to 98 
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mm scans), tilt (60° scans), and hybrid (range: 40 mm + 40° to 80 mm 60°) image 
geometries respectively.33 
4.2.2 Mechanical tracking system and evaluation 
The scanner was mounted on a spring-loaded counterbalanced stabilizing system that 
included a “wrist” with three rotational DoF via a gimbal design and an “arm” with two 
links for 29.3 cm vertical motion and 115º horizontal rotational range (arc length of 27.2 
cm), improving the overall range of motion and working space. The arm incorporated a 
four-bar parallelogram linkage to avoid an arcing path and provide parallel vertical motion, 
which limits the propagation of error to downstream joint axes as motion is limited to one 
Cartesian axis. These components provide a total of five DoF, which are tracked using five 
electromagnetic encoders, which allow tracking of the US probe in space by detecting joint 
angles necessary to compute forward kinematics. To compute the orientation of the 
tracking system end-effector (i.e., 2D US probe), a known position with corresponding 
joint encoder values was required to initialize the coordinate system of the tracking system. 
This position was achieved by forcing the joints into a known reference position using a 
mechanical jig (Figure 4.2A) to obtain the initialization encoder readings on the tracked 
joints (Figure 4.2B). Forward kinematics of the mechanical stabilizing system are given in 
Table 4.1 using the Denavit-Hartenberg convention. 
Table 4.1 Denavit-Hartenberg parameters of the mechanical stabilizing system using 
electromagnetic encoders (i). 
Link 
ai 
(mm) 
i 
(º) 
i 
 (º) 
d i 
(mm) 
Parallelogram 
(Adjacent) 
254 0 0 0 
Parallelogram 
(Vertical) 
0 -/2 0 0 
Sway 135.7 -/2 1 0 
Wrist Roll 0 -/2 2 0 
Wrist Pitch 0 -/2 3 0 
Wrist Yaw 0 0 4 366.4 
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Figure 4.2 (A) A jig (dashed box) was used to place the stabilizing system into a reference 
position to produce the initialization encoder positions. (B) Axes of rotations that are 
tracked using the electromagnetic encoders (i) and used to compute forward kinematics 
using the Denavit-Hartenberg parameters. 
Assessing the accuracy of the tracking system was completed by comparing displacements 
computed by the system to displacements observed by an independent external Polaris 
Vicra optical tracking system (NDI, Waterloo, Canada). An optical tracking system was 
chosen as an external method for comparison due to its high accuracy, ease of use with a 
setup that avoided line-of-sight limitations, and it avoided the need to disassemble the 
system, which is typically necessary for conventional joint analysis. Since forward 
kinematics were computed by choosing the 2D US probe tip as the termination point of the 
tracking system, comparisons were achieved by replacing the 2D US probe with a 
commercial stylus via a 3D printed attachment that maintained the 2D US probe tip 
termination point using the tip of the stylus. The position of the stylus was set using a height 
gauge and was confirmed by optically tracking the probe while only the gimbal wrist was 
manipulated. This generated a spherical cloud of points that could be fit34 and used to 
compare the radius and the expected stylus height.  
The five electromagnetically tracked joints were evaluated independently prior to a 
compound joint motion assessment. After determining an initial position in space near the 
center of the system’s range of motion, a single joint was advanced and stopped to allow 
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for matched data collection between the mechanical and optical tracking systems. Since 
the initialization position of each joint was in the center of its range of motion, 
measurements were acquired on either side of the initialization position to assess the entire 
range of the joint (Table 4.2). The vertical and horizontal joints on the arm were able to be 
manipulated without engaging other joints, but the gimbal wrist always incorporated and 
released all three rotation axes due to the manual locking mechanism used. The benefit of 
using optical tracking as an evaluation tool was that the 3D displacements could be easily 
and readily measured, allowing for a direct method of comparison to our system without 
the need for disassembly or additional manufactured tools for restricting the gimbal wrist 
axes. Although this method was valuable for evaluation, the manual locking mechanism 
prevented perfect suppression of the other gimbal joints during investigations of the 
independent wrist motions. However, due to the range of motions and displacements 
investigated (Table 4.2), error assessments for each wrist axes were assumed to be 
independent with minimal contributions from other axes. Since liver diameters are 
typically less than 15 cm but can range up to approximately 21 cm,35 we evaluated our 
system with motion up to 25 cm when testing the compound joint kinematics to ensure the 
typical working volume of the tracking system was tested.  
Quantification of the tracking system error was performed by computing the difference in 
displacements determined by our mechanical system and the optical tracking system. The 
center of the system’s range of motion was used to create a reference position for 
computing displacements during subsequent manipulations. Simultaneous transformation 
matrices were computed by our mechanical system and optical tracking, which determined 
the moving tip location in their respective coordinate systems as our system was 
manipulated. Euclidean distances between the new tip location and the initialization 
position were computed in each tracking system’s coordinate system and the difference 
was used for error quantification. 
4.2.3 Mock applicator insertion 
The expected clinical accuracy of our 3D US guidance system was evaluated using an end-
to-end workflow from 3D US image acquisition for target planning to targeted placement 
of a needle-like object with errors validated from CT imaging external to our system. A 
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tissue-mimicking phantom was made using a mixture of agar and glycerol diluted in 
deionized water (35 g/LH2O and 80 mL/LH2O, respectively) to create a speed-of-sound of 
approximately 1540 m/s.36 This mixture was heated to approximately 65°C and provided 
an approximately hypoechoic background under US imaging once cooled. Agar spheres 
were fabricated using molds with diameters of 3.18 mm, 4.76 mm, and 9.53 mm to provide 
visible fiducials for image-based registration. The spheres contained 10 g/LH2O of 
SigmaCell cellulose to provide acoustic backscatter for US imaging and 10 g/LH2O of 
Tungsten (monocrystalline powder, 0.6-1 micron, 99.9+%) to create CT contrast. These 
spheres provided a unique spatial distribution for image registration without any shadowing 
artifacts or speed-of-sound distortions. A 3D-printed needle guide was made to provide our 
guidance software with a known geometry that could be used in a targeting workflow 
(Figure 4.3). This guide was fabricated to match the casing of a C5-1 US probe (Philips, 
Eindhoven, The Netherlands) and provided known trajectories in a range from 15-60° from 
the long-axis of the probe and in the plane of the image. 
 
Figure 4.3 A custom 3D-printed needle guide provided known insertion trajectories over 
a 15-60° range relative to the US probe axis. A detachable face (top-left) allows for the 
removal of the guide after insertion of a needle into a volume, enabling 3D US imaging 
without affecting the inserted needle. 
Needle targeting was achieved by acquiring a pre-insertion 3D US image, selecting a target 
in the image, navigating to the target using our system, and inserting a needle. A 
commercially available iU22 US system with a C5-1 US probe (Philips, Eindhoven, The 
Netherlands) was attached to the system to acquire a 60° tilt scan or a 60 mm + 60° hybrid 
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scan. The fabricated phantom allowed for relevant imaging up to a depth of 14 cm, which 
resulted in image and voxel sizes of 692 × 542 × 542 voxels and 0.25 × 0.25 × 0.25 mm3, 
respectively, for the tilt geometry and 692 × 542 × 584 voxels and 0.25 × 0.25 × 0.34 mm3 
for the hybrid geometry.  
Three different modes of navigation were investigated that required varying levels of user 
interaction: (1) relying predominantly on the system by using only the motors on the 
scanner for US probe navigation, (2) a freehand approach that only used the mechanical 
tracking system for navigation, and (3) a mixed navigation approach that used the scanner 
motors for image plane navigation and the tracking system for in-plane correction. The 
targeting accuracy of the system was evaluated using eight independent stainless steel 
needle insertions per 3D US acquisition geometry (i.e., tilt or hybrid) paired with a target 
navigation technique (i.e., motors only, tracking system only, or a mixed motor plus in-
plane tracking system correction) for a total of 48 needle insertions using the 3D US 
system. 
 
Figure 4.4 Experimental set-up for a 3D US image-guided needle insertion with an O-arm 
providing external imaging comparison for targeted needle placements. 
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3D US needle image-guidance was evaluated using a post-insertion 3D US scan and an 
external cone-beam computed tomography (CBCT) O-arm imaging system (Medtronic, 
Dublin, Ireland). The portable CBCT scanner (Figure 4.4) was used to acquire images 
using imaging parameters of 100 kV, 20 mA, and 150 mAs using a high definition preset. 
Higher resolution images of 1024 × 1024 × 384 voxels with voxel dimension of  
0.22 × 0.22 × 0.43 mm3 were generated by post-processing the raw images.37 
Analyzing the needle targeting accuracy was completed by registering all images to the 
same coordinate system and comparing the needle identified in the 3D US and CT images 
to the intended target location giving 3D US tip error and CT tip error, respectively. 3D 
fiducial registration was performed by manually selecting five agar sphere centroids in the 
pre-insertion 3D US image (i.e., containing the target coordinates) and transforming the 
post-insertion 3D US image and post-insertion CT image using the matched unique 
fiducials. This enabled computation of the fiducial registration error (FRE). Needle tips 
were manually identified in the post-insertion images prior to fiducial registration to reduce 
any user bias on targeting error. Euclidean distances between the target location and 
transformed needle tip locations were computed to assess targeting tip errors when using 
the system, but the distance between needle tips identified in 3D US and CT were also 
compared to verify image modality agreement (i.e., tip agreement). 
4.2.4 Clinical feasibility 
Our system was used to acquire images of a volunteer under a study approved by the 
Institutional Review Board of Western University to qualitatively assess expected clinical 
image quality and usability. This was performed using a breath-hold technique to reduce 
respiratory motion artifacts during image acquisition and improve liver visibility while 
reducing the amount of shadowing artifacts produced from the volunteer’s ribs. A 2D US 
image depth of 14 cm was chosen to visualize the liver from the surface of the skin to the 
subject’s diaphragm and compared against 3D images generated using a commercial X6-1 
3D US probe (Philips, Eindhoven, The Netherlands). 
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4.2.5 Statistical analysis 
Statistical calculations were performed in GraphPad Prism 8.4.0 (Graphpad Software, Inc., 
CA, USA). The normality of distributions were evaluated using the Shapiro-Wilk test and 
were followed by unpaired t-tests or Mann-Whitney tests, depending on the normality of 
the error distributions. Linear regressions were performed to determine any spatial 
dependencies on targeting errors using the 3D US and CBCT images. The three navigation 
approaches were also compared using a one-way analysis of variance (ANOVA) with 
multiple comparisons performed using a Tukey’s test if a significant difference was 
computed. The significance level for statistical analysis was chosen such that the 
probability of making a type I error was less than 5% (p < 0.05). 
4.3 Results 
4.3.1 Tracking system accuracy 
 
Figure 4.5 Optical tracking stylus height assessment. (A) An optical tracking stylus was 
mounted to our system using a 3D-printed holder with a slight tilt to avoid collision with 
the three-motor scanner. (B) A sphere was fit to the point cloud generated during 
manipulation of the mechanical system gimbal joint to confirm the stylus’ height and tip 
location. 
The height of the stylus (Figure 4.5A) was confirmed by fitting a sphere to the point cloud 
generated during manipulation of the three DoF gimbal joint on the mechanical tracking 
A B 
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system (Figure 4.5B). The radius of the sphere was computed to be 366.0 mm, resulting in 
a difference of 0.4 mm (0.1 %) from the expected 366.4 mm. Following confirmation of 
the stylus tip location, each joint on the tracking system was manipulated independently 
and in compound joint motions with errors shown in Table 4.2. 
Table 4.2 Mean ± standard deviation of Euclidean distance differences between our 
mechanical tracking system and an optical tracking system. The five tracking system joints 
were evaluated using independent ranges prior to compound joint motions in a 25 cm range 
of evaluation. 
Joint Joint Range (º) Displacement Range (mm) Mean Error (mm) 
Vertical ±30º 6.9, 128.1 0.81 ± 0.55 
Sway ±30º 9.9, 119.1 0.22 ± 0.18 
Wrist Pitch -45º, 60º 42.2, 172.5 2.06 ± 2.63 
Wrist Roll ±30º 20.3, 33.0 2.40 ± 1.16 
Wrist Yaw ±90º 137.4, 421.3 2.69 ± 1.62 
Compound — 52.4, 346.0 1.85 ± 1.33 
4.3.2 Applicator insertion into phantoms 
4.3.2.1 Motor navigation 
An example phantom needle insertion with registered 3D US and CBCT images resliced 
to display the entire needle trajectory is shown in Figure 4.6. When using the three-motor 
scanner for needle targeting, mean ± standard deviation (SD) tip errors based on the US 
and CT images were 4.44 ± 3.08 mm and 4.04 ± 2.79 mm, respectively (Table 4.3). Due 
to the consistency of the motorized approach returning to the image origin, manual 
registrations were not necessary between the pre-insertion and post-insertion 3D US 
images. Although navigation when using a hybrid geometry appeared to result in larger tip 
errors, no statistically significant differences (p > 0.05) were observed between the tilt and 
hybrid scan geometries for FRE, 3D US/CT tip agreement, 3D US tip error, and CT tip 
error. However, there was a significant, moderate correlation between image depth and 
error based on tip identification in both the 3D US (Figure 4.7A) and CT images (Figure 
4.7D). Each image geometry was investigated separately for the CT tip errors and after 
removal of a low tip error outlier for the tilt geometry, strong correlations were observed 
for the hybrid geometry (p = 0.0079, r2 = 0.72) and tilt geometry (p = 0.0196, r2 = 0.78). 
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Table 4.3 Needle tip targeting errors when using a motor, tracking system, and mixed 
motor with in-plane correction navigation approaches. Mean ± SD are reported for fiducial 
registration error (FRE) between the pre-insertion 3D US and post-insertion 3D US image, 
FRE between the pre-insertion 3D US and CT image, post-insertion 3D US to CT manual 
tip location distance (agreement), needle tip to pre-insertion target distance error based on 
the US image, and needle tip to pre-insertion target distance error based on the CT image 
as the gold standard. 
Navigation 
Approach 
Acquisition 
Geometry 
US/US FRE 
(mm) 
US/CT FRE 
(mm) 
Tip Agreement 
(mm) 
  3D US Tip 
Error (mm) 
CT Tip  
Error (mm) 
Motor 
Tilt — 1.12 ± 0.29 1.37 ± 0.49 3.36 ± 1.93 2.73 ± 1.74 
Hybrid — 0.93 ± 0.36 1.27 ± 0.86 5.01 ± 3.77 5.19 ± 3.13 
Total — 1.02 ± 0.33 1.32 ± 0.69 4.44 ± 3.08 4.04 ± 2.79 
Tracking  
System 
Tilt 0.52 ± 0.16 0.62 ± 0.15 2.76 ± 1.45 5.71 ± 1.86 7.00 ± 1.49 
Hybrid 0.71 ± 0.26 0.76 ± 0.21 1.78 ± 0.61 8.46 ± 2.94 8.68 ± 2.87 
Total 0.61 ± 0.23 0.69 ± 0.19 2.27 ± 1.19 7.08 ± 2.86 7.84 ± 2.37 
Mixed 
Tilt 0.34 ± 0.09 0.65 ± 0.16 1.73 ± 0.42 3.40 ± 1.94 4.28 ± 2.02 
Hybrid 0.33 ± 0.10 0.50 ± 0.14 1.74 ± 0.34 4.14 ± 2.64 4.25 ± 3.00 
Total 0.33 ± 0.09 0.58 ± 0.17 1.73 ± 0.37 3.77 ± 2.27 4.27 ± 2.47 
 
Figure 4.6 Manually registered 3D US (A) and CBCT (B) images of needles inserted into 
an agar-based tissue-mimicking phantom. The agar spheres contained cellulose and 
tungsten to provide targets for fiducial registration. 
4.3.2.2 Tracking system navigation 
Errors associated with needle targeting using the tracking system navigation are shown in 
Table 4.3. The total mean ± SD tip targeting errors using the 3D US and CT images were 
7.08 ± 2.86 mm and 7.84 ± 2.37 mm, respectively. Aside from a statistically significant 
difference (p < 0.05) observed for the 3D US tip error, no statistically significant 
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differences were observed between tilt and hybrid geometries. However, a statistically 
significant larger error was observed for the 3D US (p < 0.05) and CT (p < 0.001) tip errors 
using the tracking approach compared to the motorized navigation approach (Sec. 4.3.2.1). 
No significant correlations were observed between tip errors and image depth (Figure 
4.7B&E). 
4.3.2.3 Mixed navigation 
Table 4.3 also shows the needle targeting errors for the combined motor and tracking 
system navigation approach. Total mean ± SD tip targeting errors using the 3D US and CT 
images were 3.77 ± 2.27 mm and 4.27 ± 2.47 mm, respectively. No statistically significant 
differences (p  0.05) were observed between tilt and hybrid geometries for any of the 
recorded metrics. ANOVA of the tip errors for the motorized navigation approach (Sec. 
4.3.2.1), the tracking system approach (Sec. 4.3.2.2), and the mixed navigation method 
showed a statistically significant difference calculated using 3D US (p < 0.01) and CT 
images (p < 0.0001). Tukey’s multiple comparisons test showed a significantly larger error 
when using the tracking system compared to the motor approach (p < 0.001) and the mixed 
navigation approach (p < 0.001), but no statistically significant differences were observed 
between the motorized approach and the mixed navigation method. Unlike the motor only 
approach, no statistically significant correlation was observed between 3D US (Figure 
4.7C) or CT (Figure 4.7F) tip error and image depth. However, strong correlations were 
observed for the hybrid geometry when 3D US (p = 0.0316, r2 = 0.56) and CT (p = 0.0122, 
r2 = 0.68) tip errors were separated by acquisition geometry. 
4.3.3 Clinical feasibility 
Example 3D US images of a healthy volunteer are shown in Figure 4.8. Important 
anatomical structures, including the portal vein, diaphragm, gallbladder, and right kidney, 
were clearly reconstructed with few artifacts due to uncorrected scanner or tissue motion. 
The full inspiration breath-hold was a successful approach for this volunteer as shadowing 
artifacts from the rib cage were avoided in the reconstructed 3D US images, generating 
clinically useful images as assessed by an interventional radiologist (N.K). Hybrid (60 mm 
+ 60º) and tilt (60º) images were acquired in 12 s. 
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Figure 4.7 Scatter plots showing the 3D US (A-C) and CT (D-F) needle tip targeting error 
as image depth increases for motor (A, D), tracking system (B, E), and mixed motor with 
in-plane correction navigation approaches (C, F). Hybrid and tilt image acquisition 
geometries were used for targeting experiments and linear regressions (solid) are shown 
with 95% confidence bands (dotted). 
 
 
Figure 4.8 3D US images of a volunteer’s liver using (A) a commercial X6-1 probe, (B) a 
hybrid scan geometry using our proposed system, and (C) a tilt scan geometry using our 
proposed system. 
4.4 Discussion 
4.4.1 Tracking system accuracy 
The mechanical tracking system was assessed using optical tracking to evaluate the error 
associated with determining a US probe orientation relative to our proposed system. After 
evaluating the error of each joint independently, a mean positioning error of 1.85 ± 1.33 
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mm was observed when performing compound joint manipulations in motions expected 
during interventional focal ablation of liver tumors. Since this error encompasses the 
tracking system error from the system cart to the 2D US probe, this has the potential to 
provide sufficient accuracy for initializing position dependent algorithms, such as a 3D US 
image stitching algorithm to generate a larger view of the liver. This also motivated 
targeted needle insertions, so a 95% confidence interval was computed to assess the 
maximum tumor diameter that could reliably be targeted using 
 
𝑑𝑚𝑎𝑥 = 2 (?̅? +
1.96𝜎
√𝑁
) [𝑚𝑚], 
(4.1) 
where ?̅? is the mean positioning error, 𝜎 is the standard deviation, and 𝑁 is the number of 
measurements. This resulted in a tumor diameter of 5.54 mm with 95% confidence if no 
other errors were present. Thus, we believe this diameter to be sufficient for clinical use as 
most treated liver tumors are between 20 mm and 50 mm. However, since we chose to use 
magnetic encoders in the tracking system that detect the perpendicular component of the 
magnetic field of the rotary shaft in the radial-transverse cylindrical plane (for a reduced 
size advantage), any manufacturing error in the magnetic field alignment with the rotary 
encoder shafts would increase the measured joint errors due to the nonlinear nature of the 
detected magnetic field. Although we believe the accuracy we achieved to be sufficient, 
calibration of each encoded joint could be completed during assembly of the system38 to 
reduce this error as the off-axis magnetic field is still extremely consistent and repeatable. 
4.4.2 Mock applicator insertion 
The motor-only navigation method approach resulted in a needle tip guidance error of 4.04 
± 2.79 mm when evaluated with a registered CT image and was observed to have the lowest 
mean error of the three approaches, although not statistically significant. Tip targeting 
errors when using the three-motor scanner approach are likely acceptable for targets 
located at a depth <75 mm, but the main source of error was likely due to the custom needle 
guide. Moderate correlations were observed with image depth and tip error, with a strong 
correlation specifically for the hybrid imaging geometry. Since angular sampling will result 
in larger distances between available needle guide trajectories proportional to depth, this 
observation possibly suggested that the needle guide increments of 5° were too large for 
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deeper targets without an in-plane correction. Since no adjustment was performed to align 
the target with one of the nearest projected needle guide tracks, an error of 2.5° (i.e., 
directly in between needle guide trajectories) was assumed to be the maximum error 
contribution from the needle guide. Taking into account the 10.69 mm template height 
offset from the US probe tip, a maximum error contribution from the needle guide alone 
(shown in Figure 4.9) for an image depth of 𝑥 mm was determined (Eq. 4.2). 
 𝑀𝑎𝑥𝑇𝑒𝑚𝑝𝑙𝑎𝑡𝑒𝐸𝑟𝑟𝑜𝑟 =  0.0436𝑥 + 0.466 (4.2) 
 
Figure 4.9 Scatter plot showing the needle targeting error using the three-motor approach. 
The maximum possible error due to the needle template geometry is shown as a dashed 
line. 
Performing guided needle insertion with the tracking system was the worst approach with 
a statistically significantly higher tip error of 7.84 ± 2.37 mm when compared against the 
other two methods. Although the mean positioning error reported using optical tracking 
was less than 3 mm, the increased error observed with needle insertion suggests that there 
is a small angular miscalibration in the tracking system as the needle tip point of 
measurement is much further from the US probe tip. In addition, some error from the three-
motor scanner could contribute to tracking system error since the scanner must return to 
the assumed final axis of the tracking system after image acquisition, but this additional 
source of misalignment is likely minimal. Since no correlations were observed with depth, 
the needle guide appears to perform as expected as the user could place the target directly 
on a projected needle trajectory.  
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A combined approach for navigation that incorporated the motorized movement for out-
of-plane motion and the tracking system for in-plane correction resulted in a mean tip error 
of 4.27 ± 2.47 mm. This approach was not statistically significantly different from a motor 
only approach and the in-plane correction did not appear to account for the observed 
correlation between image depth and tip error when using a hybrid image geometry. This 
mean error and SD suggests a target with a diameter of 10.96 mm can be hit with a 95% 
confidence, which is on the order of the recommended 5-10 mm margins for image-guided 
interventions in the liver.39–41 One caveat of the navigation errors reported in this study is 
the ideal nature of the needle insertion experiments, which did not contain expected clinical 
issues such as liver motion. Image registration methods have been investigated for other 
3D US-guided procedures42,43 and could be incorporated into our proposed system to 
perform coordinate system corrections required to maintain targeting accuracy. 
Nevertheless, the combined US-based navigation approach could provide an accessible 
method to motivate further development of stereotactic interventional radiology 
approaches that use multiple applicator insertions for treating tumor diameters larger than 
50 mm. 
4.4.3 Clinical feasibility 
The healthy volunteer images provided good feedback about anatomical structures relevant 
for focal liver tumor therapies. The increasing need and potential for accurate image 
guidance during minimally invasive therapy is also supported by the need for accurate 
tissue sampling during biopsy procedures. Since cancer is complex and often comprises of 
multiple genotypic pathologies, more accurate diagnostic biopsy procedures in the 
abdominal area could likely improve the information given to the clinician and provide 
more specific pathology data for better informed therapeutic decision trees. Therefore, our 
system has the potential to improve a wide range of minimally invasive procedures. 
One downside of using US imaging for guiding needle applicator insertions in the 
abdominal area is the low image contrast of some tumors. This can be challenging using 
conventional clinical workflows using 2D US as insertions must be performed using other 
anatomical landmarks for approximating tumor locations. A beneficial approach would be 
to perform an image registration between pre-operative CT images containing tumor 
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locations with real-time intra-operative US images for guidance, but the multi-modality 
and difference between 2D and 3D imaging present as a challenge. In addition, patient 
positioning may change and US probe pressure could introduce deformations, requiring 
deformable image corrections. With the incorporation of 3D US and our system, a multi-
modal 3D image registration could be facilitated as the additional spatial context is 
available relative to conventional 2D US imaging. By registering the CT image to the 3D 
US image domain, the navigation approaches presented could be used to target low contrast 
tumors in US using CT-derived tumor localization.  
Avoiding critical structures and organs-at-risk, like the gallbladder, is also an important 
clinical constraint for maintaining low complication rates. A registration process between 
pre-operative CT and intra-operative 3D US could allow for pre-operative planning where 
tumor locations and critical structures can be identified for optimizing the optimal needle 
applicator trajectories.25 Model views can be generated intra-operatively using 
segmentation software available on our system31 and used with our needle guide predicted 
trajectory for real-time avoidance of critical structures. If a freehand insertion is performed 
without a needle guide, an alternative solution could include a 2D US real-time needle 
segmentation method for comparing tip and trajectory information to the identified 
structures. 
4.5 Conclusions 
A mechanically tracked system with geometrically variable 3D US during minimally 
invasive liver cancer diagnostic or therapeutic procedures provides a utility that enables 
enhanced applicator guidance, placement verification, and improved clinical workflow 
without the need for additional radiation exposure. With this device, intraoperative 
assessment and applicator adjustments can be performed to potentially decrease the liver 
cancer recurrence rates associated with minimally invasive procedures and demonstrate a 
step towards stereotactic interventional approaches.  
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Chapter 5  
5 Three-dimensional therapy needle applicator 
segmentation for ultrasound-guided focal liver ablation 
The use of 3D information during interventional procedures has the potential to improve 
the accuracy needed for sufficient clinical outcomes, but increased procedure times, patient 
radiation dose, and costly interventional suites can limit widespread adoption. The purpose 
of Chapter 5 is to present on the development of a novel 3D US system to provide a safe, 
cost-effective, and accurate intraoperative approach for focal liver tumor therapies. 
The contents of this chapter have previously been published in Medical Physics: Gillies 
DJ, Awad J, Rodgers JR, Edirisinghe C, Kakani N, and Fenster A. Medical Physics 2019; 
46(6):2646-2658. Permission to reproduce this article was granted by John Wiley and Sons 
and is provided in Appendix B – Copyright Releases. 
5.1 Introduction 
Minimally invasive percutaneous interventional techniques are increasingly being adopted 
throughout the body for a wide range of diagnostic and therapeutic procedures, such as 
aspiration, biopsy, brachytherapy, and ablation. These techniques are often image-guided 
procedures and offer promising alternatives to open surgical practices as they have shown 
decreased patient recovery times and complications due to more localized treatments.1,2 
Minimally invasive focal ablation of liver tumors has received significant attention as liver 
cancer is the second and sixth most frequent cause of cancer mortality worldwide in men 
and women, respectively, with high prevalence in under developed and developing 
countries.3 Although liver transplantation and resection are the gold standard curative 
therapy options for cancer with a 5-year survival rate of approximately 40%,4 these open 
surgical procedures are often followed by long patient recovery times. Occasionally, 
serious problems can arise, including organ (graft) rejection, infection, bile duct 
complications, and immunosuppression related issues, leading to a traumatic 
hospitalization experience for approximately 26% of liver resection patients and 33% of 
liver transplant patients.5 In addition, only 10 to 20% of patients are candidates for surgery 
based on strict inclusion criteria including the number and location of tumors, malignant 
spread of the disease or lymph node involvement, and a range of patient factors (e.g., size, 
age, and existing medical conditions such as cirrhosis of the liver).6,7 Minimally invasive 
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techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and 
irreversible electroporation (IRE), have become alternative therapies for early-stage liver 
cancer with the most common treatment performed on hepatocellular carcinoma.8 Due to 
availability of commercial ablation systems, e.g., the EvidentTM MWA system (Medtronic, 
Dublin, Ireland), the StarBurst RFA system (AngioDynamics, Inc., NY, USA), and the 
Nanoknife IRE system (AngioDynamics, Inc., NY, USA), these procedures have become 
more clinically feasible and are increasingly being regarded as primary treatment options. 
Although a minimally invasive technique offers advantages relative to open surgery, some 
procedural limitations have prevented its adoption as the gold standard. A majority of the 
operators using these percutaneous techniques use x-ray computed tomography (CT) 
images for planning, two-dimensional (2D) ultrasound (US) for intraoperative guidance of 
the ablation needle applicator(s) into the center of the tumor, and either additional CT or 
2D US images to perform further modifications and verify needle applicator placements. 
Depending on the number and size of tumors, which can typically range from 1 cm to 5 cm 
in diameter,8 as well as the type of ablation (radiofrequency vs. microwave), one to four 
needle applicators are typically required to cause the ablation zone to completely cover the 
borders of the tumor and allow for adequate treatment coverage. Unfortunately, these 
procedures have higher local recurrence rates than resection due to insufficient or 
inaccurate local tumor ablation.9 One cause for poor ablation coverage has been associated 
with subjective 2D US guidance and verification, which leads to variability in needle 
applicator targeting accuracy due to high operator dependence when using 2D US images 
for 3D spatial localization. Important anatomical markers and structures are difficult to 
visualize in a single frame when using 2D imaging,10 which increases complexity and 
requires the physician to track both the ablation needle applicator and surrounding 
structures to avoid unnecessary damage.11 Malposition of the needle applicators can not 
only lead to unwanted complications, but can increase procedure times and patient 
radiation dose, from the additional US and CT needed to correct the positions. Thus, if 
needle applicator targeting accuracy is to be increased without increasing procedure time 
and minimizing excess radiation dose, a non-ionizing radiation intraoperative imaging 
workflow is needed to improve upon the conventional 2D US spatial localization method. 
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Intraoperative magnetic resonance (MR) and three-dimensional (3D) US imaging 
techniques have been investigated to reduce complexity for the physician, increase 
visualization of surrounding tissues, and enable accurate localization of the ablation needle 
applicator into the liver.12–14 Although MR images can provide superior soft-tissue contrast, 
3D US techniques have the advantage of providing real-time or near real-time imaging 
with an imaging system that is portable and affordable, ultimately addressing major 
concerns for centres in developing countries where liver cancer incidence is high.3 Since 
preoperative contrasted CT images provide a sufficient method for lesion identification and 
planning, image registration can be performed to transfer the locations of the cancerous 
tissues to the 3D US image.15 These resulting fusion images can then allow for accurate 
planning and verification of the needle applicators’ location. Unfortunately, current 
limitations still exist for visualizing and verifying needle applicator positions in 3D US 
liver images as the visibility can change with needle applicator insertion angle, depth, and 
size, in addition to the choice of transducer (i.e., curvilinear) and local anatomical acoustic 
reflections that result in complicated images containing shadows and reverberation artifacts 
with unclear line-like interfaces.16,17 Attempts have been made using a variety of needle 
applicator enhancing techniques to address these localization concerns for the physician by 
incorporating additional features like echogenic coatings,18 magnetic or optical tracking 
systems,19 robotic needle steering,20 augmented reality,21 and US beam steering.22 
Although many options seem promising, all of the above choices add increased cost and 
complexity relative to the conventional procedure, which can be a limiting factor for 
widespread dissemination.  
Image-based needle applicator segmentation is an alternative option that aims to localize 
inserted needle applicators to provide an efficient and low-cost method to inform 
physicians when needle applicator adjustments are required. By employing a segmentation 
algorithm, the time for intraoperative identification of the needle applicators can be reduced 
to improve the overall efficiency of the clinical workflow and reduce mental demand of 
the physician when trying to accurately ablate the cancerous lesions. Segmenting needle-
like objects in 3D US has been used in a broad range of interventional procedures with 
varying requirements influenced by object orientation with respect to the US probe, object 
flexibility, and US image quality, which in turn is affected by a variety of sources, including 
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the commercial system, acquisition settings, imaging artifacts from the medical tools,23 and 
anatomical imaging challenges (e.g. depth of lesion and acoustically visible internal 
structures contributing to image clutter).  
Applications for 3D US needle-like segmentation have been focused on procedures in 
prostate,24–28 breast,29–31 heart32,33 and anesthetic administration,34 but these approaches do 
not readily translate to liver interventions. This is primarily due to deep insertions into the 
liver that require needle applicators up to 30 cm in length and large angles relative to the 
transducer face resulting in poor specular reflections back to the transducer. More specific 
to liver imaging, Zhao et al.35 have investigated a four-dimensional (4D) US micro-tool 
localization approach by employing a region-of-interest strategy to a random sample 
consensus (RANSAC) and Kalman filter localization algorithm. When imaging ex vivo 
porcine liver, they reported root-mean-squared tip errors between 0.6 and 2.4 mm with 
maximum component trajectory errors less than 3.5°. For needle steering approaches, 2D 
power Doppler has been used with a vibration module20,36 for 3D segmentation of curved 
needles. Experiments performed on ex vivo bovine liver20 showed mean tip errors of 0.92 
± 0.93 mm for a centred, orthogonal, straight needle at a 600 Hz vibration frequency. Beigi 
et al.37 reported on a 3D needle segmentation from multiple images to detect intensity 
variations while using a moving stylus inside a hollow cannula. Trajectory errors of 1.4 ± 
0.7° and tip identification errors of 0.8 ± 1.1 mm were found when imaged on ex vivo 
bovine liver. While general needle-like segmentation algorithms for 3D US have been 
discussed in the literature and tested on tissue mimicking models, such as agar, chicken 
breast, bovine, and porcine tissues, evaluation on in-vivo clinically acquired 3D US images 
has not been reported for the unique imaging characteristics of needle applicators used in 
percutaneous liver tumor ablations. 
We propose the use of 3D US imaging paired with an intraoperative image-based needle 
applicator segmentation algorithm to provide localization of ablation needle applicators in 
current focal liver tumor ablation therapies. Needle applicators for these procedures 
typically have a diameter of 1.5 to 2.8 mm (12 to 17 gauge) and range in length from 12 to 
30 cm to accommodate for the variety of patient thicknesses and depth of lesions.38 These 
procedures are most commonly performed as a two-handed approach where one hand is 
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used for positioning and orienting the US transducer and the other is used for needle 
applicator insertion. Due to the free-hand nature of the conventional approach, a wide range 
of needle applicator insertion angles with respect to the US transducer are observed, 
ranging from 10 to 80° from the transducer face. In our approach, we assume needle 
applicators to be rigid and straight, relying on the assumption of minimal bending within 
the tissue. This assumption was chosen based on a recent clinical CT study where 93% of 
ablation applicators (inserted in a range from 32 – 182 mm) were observed to have less 
than 3 mm of deflection with an overall average deflection of 1.3 mm.39 Since the majority 
of these deflection measurements are less than the diameter of the ablation applicators (i.e., 
1.5 to 2.8 mm), a straight assumption would likely be appropriate to capture the trajectory, 
and more importantly tip location, for the majority of observed clinical cases. Furthermore, 
we used a supervised approach to reduce the complexity of the algorithm and provide a 
method for the physician to control the algorithm. Our algorithm was optimized and 
evaluated against manual segmentations of an EvidentTM MWA antenna (Medtronic, 
Dublin, Ireland) needle applicator inserted in plain homogeneous agar phantoms to test 
idealized imaging conditions. This optimization was followed by needle applicator 
segmentations in 16 retrospective patient 3D US images to evaluate performance on a 
clinical dataset. Multiple users with a range of US experience performed segmentations 
with the algorithm to assess robustness and inter-operator variability of the algorithm. 
These evaluations aim to provide insights on clinical utility and represent an opportunity 
for improving needle applicator localization for interventional procedures treating liver 
cancer. 
5.2 Materials and methods 
5.2.1 3D therapy needle applicator segmentation algorithm 
The overall workflow of the 3D needle applicator segmentation algorithm is shown in 
Figure 5.1, which is primarily based on voxel intensity thresholding and clustering. After 
acquiring a 3D US image, the user provides the location of a single point to the algorithm, 
which is assumed to fall along the trajectory of a visible needle applicator in the 3D US 
image with unknown insertion angle 𝜃 (Figure 5.2a). This initial seed point is used to 
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generate test points in a spherical coordinate system and creates the search space of 
potential needle applicator trajectories. Since the locations of the generated test points in 
the search space coordinate system (b) are influenced by the radius of the sphere and the 
number of points in the longitudinal (polar angle spacing ∆𝜃) and latitudinal (azimuthal 
angle spacing ∆𝜑) axes, investigation of these parameters are discussed in Sec. 5.2.2. 
 
Figure 5.1 Proposed 3D US-based therapy needle applicator segmentation workflow. Line 
segments are created from a spherical search space to compute the most probable trajectory 
using a signal-to-background intensity threshold. The Otsu threshold is computed for the 
most probable trajectory to determine the needle applicator’s tip, completing the 
segmentation. 
The second step to find the most probable needle applicator trajectory requires the 
generation of testable trajectories. Line segments are created for each test point on the 
sphere and drawn through the initial user seed point to span the diameter of the sphere. 
Searching diameters of the sphere reduced the testable search space in half as anything 
beyond the superior hemisphere would result in redundant line segments. Since 
interventional liver procedures are typically performed with oblique insertion angles on 
either the left or right side of the US transducer, the range of possible needle applicator 
slopes was restricted to the sphere’s polar angle range 𝜃 = 10-80° from the longitudinal 
axis (i.e., axial axis of the 3D US image). In addition, we also assumed the needle 
applicators were visualized in the 3D US image approximately in-plane and thus 
constrained the sphere’s azimuthal angle range (i.e., lateral axis of the 3D US image) to 𝜑 
= 0 ± 60° and 180 ± 60°, as shown in Figure 5.2c. 
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Figure 5.2 (a) Sample 3D US image plane of a needle applicator inserted in a homogeneous 
phantom with the needle applicator insertion angle (θ) and 2D US axes labelled. (b) 
Spherical 3D coordinate system to generate test points with 3D US axes labelled for 
reference. (c) Generated spherical test points used to determine the most probable needle 
applicator trajectory after incorporating intraoperative assumptions overlaid on the sample 
3D US image plane in (a) displayed with a 45° rotation. 
The needle applicator’s trajectory is determined by maximizing the sum and number of 
voxels along a line segment that exceeds an intensity threshold. The chosen intensity 
threshold was selected as the signal-to-background intensity ratio (SBR) that minimized 
the trajectory error when segmenting needle applicators in phantom images, as described 
in Sec. 5.2.2. Each potential line segment in the search space is sampled at a spacing 
equivalent to the average of the lateral and axial in-plane voxel dimensions of the 3D 
image, which was approximately 0.37 mm. The sum (𝑆𝑢𝑚𝑖) and total count (𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑖) 
of all voxels on a line segment 𝑖 that are greater than the intensity threshold are saved and 
used as the metrics to determine the most probable line segment for the needle applicator. 
The most probable needle applicator trajectory (𝑇) is computed from all possible line 
segments (𝑛) after normalizing all line segment parameters to the maximum of the 
computed metric values (i.e., 𝑆𝑢𝑚𝑚𝑎𝑥 and 𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑚𝑎𝑥) as: 
 𝑇 = max
𝑖∈𝑛
{(
𝑆𝑢𝑚𝑖
𝑆𝑢𝑚𝑚𝑎𝑥
) + (
𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑖
𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑚𝑎𝑥
)}. (5.1) 
Once the trajectory is selected, the needle applicator tip is determined by employing a 
second intensity threshold along the computed one-dimensional vector starting from the 
manually selected seed point. Under the assumption that a needle applicator (hyper-
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intense) and background (hypo-intense) could be represented with a bi-modal histogram of 
intensities, the Otsu threshold40 is determined to maximize the interclass variance between 
the intensity populations. Since the line segment chosen for the needle applicator trajectory 
would mostly contain voxels corresponding to the needle applicator, the selected line 
segment is extended by an additional 10 mm to increase the number of background voxels. 
This aims to approximately equalize the needle applicator and background voxel 
populations in the intensity distributions, which minimizes uncertainty when determining 
the Otsu threshold.41 After determining the Otsu intensity threshold, all voxels along the 
entire extended needle applicator trajectory with intensity values below the threshold are 
eliminated. Finally, the last remaining voxel along the trajectory is selected as the tip 
location.  
This complete algorithm was compiled using C++ and ran on an i7-6700K central 
processing unit (CPU) at 4.0 GHz (Intel Corporation, CA, USA) with the trajectory 
localization parallelized on 8 threads using OpenMP. This utilized a 3D Slicer42 user 
interface to allow for selection of points and passing of voxel coordinates to the 
segmentation algorithm. Completed segmentations were displayed using the physical 
dimensions of a 13-gauge ablation needle applicator with a length of 17 cm (Medtronic, 
Dublin, Ireland). 
5.2.2 Phantom images 
Since we only had access to 16 patient 3D US images, we used images of needle applicators 
inserted in phantoms to optimize various parameters required for the algorithm. These 
optimized parameters were then used to perform segmentations of needle applicators in the 
patient image dataset. Homogeneous block phantoms were made with distilled water 
(87.7% by mass), glycerol (8.8% by mass; Sigma-Aldrich, MO, USA), agar (3.1% by mass; 
Sigma-Aldrich, MO, USA), and cellulose (0.4% by mass; Sigma-Aldrich, MO, USA) for 
acoustic backscatter.43 An EvidentTM MWA antenna (Medtronic, Dublin, Ireland) was 
inserted through a custom-made template,14 which allowed for insertions with one degree 
of rotational freedom when seated in a compatible box (Figure 5.3). The needle applicators 
with a length of 17 cm (containing a 3.7 cm radiating tip) and a diameter of 2.1 mm (13 
gauge) were inserted through the template into the phantom in a clinically relevant range 
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of oblique insertion angles with a mounted protractor for approximating visual guidance, 
but not used for evaluation. 3D US images were captured by employing a freehand 
approach using the commercially available iU22 US machine with an X6-1 matrix probe 
(Philips, Amsterdam, NL). The freehand approach was chosen to resemble an 
interventional procedure where the physician tries to visualize the applicator in the imaging 
plane while inserting the applicator at various angles depending on the location of the 
tumor. Since the task of imaging in a single plane is difficult, 3D trajectories were assessed 
in two degrees of freedom and required the 3D image to be resliced on oblique trajectories 
to visualize the entire needle. 3D US images containing needle applicators were acquired 
with a 30% gain, depth of 10 cm, and a 55° angular field of view that resulted in an image 
size of 512 × 407 × 220 voxels with voxel dimensions of 0.314 × 0.258 × 0.461 mm3. The 
needle applicator insertion angles (Figure 5.2a) and insertion depths are provided in Table 
5.1. These imaging details were manually determined using the voxel corresponding to the 
entrance of the needle applicator in the US image and the voxel at the needle applicator’s 
tip location across 10 different insertions.  
 
Figure 5.3 (a) Sample MWA needle applicator inserted in a homogeneous phantom 
through a custom-made template with one degree-of-freedom. (b) Close up perspective on 
the needle applicator’s insertion angle approximated by an attached protractor. 
Following 3D image acquisition, manual segmentations of the needle applicators were 
performed to provide a comparison to the algorithm. The manual segmentations were 
completed prior to the algorithmic method to ensure an unbiased comparison was provided 
when quantifying the error of the segmentation algorithm. Manual segmentations were 
acquired by selecting one point at the visible tip of the needle applicator and a second point 
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located approximately halfway along the visible shaft. Manual tip locations were 
repeatedly selected over five different time points, separated by a minimum of 24 hours, to 
obtain a manual user variability and an average tip location. The second point selected was 
chosen at the approximate centre of the needle applicator’s shaft to ensure the computed 
trajectory was through the core of the needle applicator. This second point not only 
provided the necessary information to compute a manual trajectory, but also provided the 
seed point required to initialize and generate the segmentation from the semi-automated 
algorithm. Five of these seed points were selected for each phantom 3D US image to 
investigate if initialization variability affected segmentation performance. With this 
workflow, a direct comparison between the two methods of segmentation could be 
achieved to optimize and assess the segmentation algorithm. 
Table 5.1 Visualized needle applicators in 3D US images of a homogenous agar phantom. 
 
 Imaged Insertion  
Anglea (°) 
 Imaged Insertion 
Depth (mm) 
Mean  41.1  68.6 
Standard Deviation  16.2  8.4 
Minimum  17.4  55.5 
Maximum  65.9  81.1 
aInsertion angle was measured from the axial axis of the US image. 
The phantom image dataset was first used to perform optimization of parameters for the 
trajectory selection component of the segmentation algorithm. The test point spacing, 
which can be influenced by the spherical radius of the search space, was a major factor to 
consider when searching for the best trajectory (Figure 5.4). One option could be to choose 
a large spherical radius to capture all the needle applicator voxels in the image to maximize 
the trajectory metric in Eq. (5.1). This would also be beneficial since the needle applicator 
has a non-negligible thickness and capturing points further apart could result in fewer 
probable trajectories that would maximize the trajectory metric, resulting in a better 
approximation for the trajectory. However, employing a radius too large could 
unnecessarily increase computation time and potential for failure on shallow insertions 
since there would be an increased probability of background voxels that could exceed the 
static SBR threshold, creating maxima in the trajectory metric. Conversely, choosing a 
small radius would reduce the number of samples acquired and computation time, but could 
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result in an increased number of incorrect probable trajectories. Therefore, we optimized 
for test point spacing by investigating the interaction between coarse, medium, and fine 
uniformly distributed test point spacings (i.e., ∆𝜃 and ∆𝜑) of 2.4°, 1.2°, and 0.6° with small, 
intermediate, and large spherical search spaces represented by radii of 15, 30, and 45 mm. 
The choice of these three radii was influenced by the average appearance of needle 
applicators (i.e., mean insertion depths of approximately 70 mm) in the patient dataset 
(Table 5.2). 
 
Figure 5.4 Spherical radius influence on most probable trajectory. (a) Since the applicator 
appearance has a non-negligible thickness, the range and number of potentially acceptable 
trajectories from the seed point (red) decreases as the spherical search space radius 
increases from small (purple) to large (green). (b) If a radius search space is too large, an 
increased probability exists to choose an incorrect trajectory for shallow needle insertions 
using a larger SBR threshold as the most probably trajectory metric can be increased with 
larger pixels quantities. 
After creating the spherical search space, a background intensity threshold was used as a 
coarse method to enhance the needle visibility in the 3D US images. Since the user selects 
a seed point along the shaft of the needle applicator, a single intensity of the needle 
applicator is known and can be used as an approximation for the entire needle applicator 
mean intensity level, 𝜇𝑎𝑝𝑝. Using an SBR ratio defined as: 
 𝑆𝐵𝑅 =  
𝜇𝑎𝑝𝑝
𝜇𝑏𝑔
, (5.2) 
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the background image intensity, 𝜇𝑏𝑔, can be solved for a chosen SBR, thus, determining 
the required intensity threshold (𝜇𝑏𝑔).  The SBR was used as an optimization variable to 
investigate the influence of different background intensity thresholds when determining 
the needle applicator’s most probable trajectory.  
After optimizing the trajectory parameters, tip localization error and variability were 
investigated resulting from the Otsu threshold. As described in Sec. 5.2.1, an extension was 
added to the selected trajectory to approximately equalize voxel populations of the needle 
applicator and background. However, since the locations of the manual initialization seed 
points and the insertion depths of the needle applicators were variable, preliminary 
observations suggested the distribution of the needle applicator’s voxel intensities were 
overrepresented on average. This overrepresentation led to computation of larger than 
desired intensity thresholds, which led to shallow predictions of the needle applicator’s tip 
location. Thus, preliminary experiments led to a threshold adjustment that reduced the 
computed Otsu threshold by 5. 
5.2.3 Retrospective patient images 
After determining the optimal parameters for the segmentation algorithm from the phantom 
images, 15 3D US images were acquired on six patients undergoing MWA in the liver. 
These images were acquired using an iU22 US machine and X6-1 matrix transducer 
(Philips, Amsterdam, NL) in a study approved by the Human Subjects Research Ethics 
Board of Western University. All images were acquired post needle applicator insertion, 
but prior to ablation. Since the physical size of patients was variable, chosen US imaging 
depths were also variable and resulted in an image size range of 480 × 372 × 218 to 512 × 
404 × 222 voxels with a range in voxel dimensions from 0.248 × 0.194 × 0.336 mm3 to 
0.428 × 0.386 × 0.630 mm3. 14 3D images contained only one needle applicator prior to 
ablation with 13 images showing a needle applicator approximately in the axial-lateral US 
plane and one image showing a needle applicator approximately in the axial-elevational 
US plane. The fifteenth 3D image contained two needle applicators visualized 
approximately in the axial-lateral US plane, resulting in sixteen needle applicators in total 
that were visualized and segmented. Needle applicator insertion angle and insertion depth 
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in the US image are provided in Table 5.2. Similar to the phantom images, these 
characteristics were manually determined using the voxel corresponding to the entrance of 
the needle applicator in the US image and the voxel at the needle applicator’s tip location. 
Table 5.2 Visualized needle applicators in 3D US images of patients undergoing liver 
tumor MWA. 
 
 Imaged Insertion  
Anglea (°) 
 Imaged Insertion  
Depth (mm) 
Mean  44.1  71.7 
Standard Deviation  14.1  20.9 
Minimum  23.3  30.4 
Maximum  77.2  99.0 
aInsertion angle was measured from the axial axis of the US image. 
Since our algorithm required initialization, performance is influenced by the location of the 
user selected seed point. Variability of the algorithm between four trained users of varying 
US image analysis experience was assessed on these images. The users included: a trained 
user with four years experience (TU1), a trained user with three years experience (TU2) 
supervised by the interventional radiologist (N. K.) that acquired the clinical 3D US 
images, an interventional radiologist 2 years post-fellowship (IR1), and an interventional 
radiologist 10 years post-fellowship (IR2). All users performed manual identification of the 
tip prior to generating the algorithm segmentations and determined the mean manual tip 
locations. Following tip identification from all users, the mean consensus applicator tip 
location from two or more users was used as the manual annotation for quantifying error, 
as described in Sec. 5.2.4. All users were instructed to select the shaft seed points near the 
tip to ensure the location would fall within the spherical search space of the algorithm. 
5.2.4 Determination of needle applicator tip and axis errors 
The performance of the segmentation algorithm was compared to the manually segmented 
needle applicator to determine the algorithm segmentation error. The manual trajectory 
was determined by creating a vector between the user-selected seed point on the shaft and 
the manually determined mean consensus tip location. Variability in tip localization was 
calculated by a fiducial localization error (FLE)44 for all users selected when determining 
the consensus tip location to characterize inter-subject variability (𝐹𝐿𝐸̅̅ ̅̅ ̅̅ 𝑖𝑛𝑡𝑒𝑟) and for two 
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users (i.e., TU1 and TU2) to characterize intra-subject variability (𝐹𝐿𝐸̅̅ ̅̅ ̅̅ 𝑖𝑛𝑡𝑟𝑎). This was 
calculated by using the variance (𝜎2) for the 𝑥, 𝑦, and 𝑧 coordinates of the selected tips (𝑖) 
in all images (𝑁) over the users in agreement for inter-subject variability and over five 
trials with 24 hour intervals for the intra-subject variability. Using the definition for FLE 
of one needle applicator tip as:  
 𝐹𝐿𝐸𝑖
2 =  𝜎2(𝑥𝑖) + 𝜎
2(𝑦𝑖) + 𝜎
2(𝑧𝑖), (5.3) 
the mean FLE for all tips was computed as: 
 
𝐹𝐿𝐸̅̅ ̅̅ ̅̅ =  √∑ 𝐹𝐿𝐸𝑖
2 𝑁⁄𝑁𝑖  [𝑚𝑚]. 
(5.4) 
Variability in the manual identification of the applicator’s trajectory was computed across 
all users after determining the 3D trajectories created between the consensus tip location 
and the user-specific shaft locations for all patient images.  
Three metrics were used to quantify the algorithm’s segmentation error when compared to 
the manual segmentations. The angular difference (∆𝑇) between the algorithm (?⃑?𝑎𝑙𝑔) and 
manually (?⃑?𝑚𝑎𝑛) segmented trajectories was quantified as:  
 
∆𝑇 = cos−1 (
?⃑?𝑎𝑙𝑔 ∙ ?⃑?𝑚𝑎𝑛
‖?⃑?𝑎𝑙𝑔‖ ∙ ‖?⃑?𝑚𝑎𝑛‖
) [°]. 
(5.5) 
The second metric to describe segmentation error has been previously defined by Uherčík 
et al.29 as the axis localization accuracy (ALA). This metric measures the orthogonal 
projected distances of the entrance (E) and tip (T) points from the manual to the algorithm 
segmentation trajectory axes, and reports the maximum of the two distances (i.e., DE or 
DT), as shown in Figure 5.5. The needle applicator tip error (ATE) between manual 
(?⃑?𝑚𝑎𝑛,𝑡𝑖𝑝) and segmented (?⃑?𝑎𝑙𝑔,𝑡𝑖𝑝) needle applicator tips was quantified as the Euclidean 
distance between their coordinates: 
 𝐴𝑇𝐸 =  ‖?⃑?𝑎𝑙𝑔,𝑡𝑖𝑝 − ?⃑?𝑚𝑎𝑛,𝑡𝑖𝑝‖ [𝑚𝑚]. (5.6) 
5.2.5 Statistical analysis 
Statistical calculations were performed in GraphPad Prism 7.00 (Graphpad Software, Inc., 
CA, USA). Normality of distributions were evaluated using the Shapiro-Wilk test and led 
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to the use of nonparametric statistical tests when the assumption was violated. The 
corresponding nonparametric alternative tests are presented in parentheses for the 
remainder of the section. The significance level for statistical analysis was chosen such that 
the probability of making a type I error was less than 5% (P < 0.05). The multi-user error 
distributions from the patient dataset for trajectory, ALA, and ATE were compared using 
a one-way repeated measures ANOVA (Friedman) omnibus test, followed by post-hoc 
analysis using Tukey’s honestly significant difference (Dunn’s) tests if the omnibus test 
was significant. 
 
Figure 5.5 Illustration of the axis localization accuracy (ALA) metric simplified to a 2D 
example for clarity. The entrance and tip locations of the needle applicator from the manual 
segmentation are used to compute orthogonal distances to the algorithm segmentation axis, 
which produces the entrance-to-axis distance DE and the tip-to-axis distance DT. The 
maximum of these distances is reported as the axis localization accuracy (ALA). 
 
Figure 5.6 Sample oblique plane in a 3D US image of a needle applicator obliquely 
inserted at 44⁰ in a homogeneous tissue mimicking agar phantom before (a) and after (b) 
segmentation. The 3D US image was resliced to visualize the entire segmentation for 
clarity. 
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5.3 Results 
5.3.1 Phantom testing 
The imaging characteristics of the needle applicators in the phantom images is shown in 
Table 5.3 with a sample phantom image and segmentation shown in Figure 5.6. Using the 
five trials of manually localizing the tips in the 3D US images, the mean FLE was found 
to be 0.43 ± 0.09 mm, which corresponds to approximately one or two voxels. 
Table 5.3 Needle applicator imaging characteristics in phantom 3D US images. 
Image Characteristic  Mean ± Standard Deviation 
Applicator Intensity  178 ± 10 
Background Intensity  145 ± 5 
SBR  1.22 ± 0.08 
The influence of intensity thresholding for three radii sizes and three test point spacings 
are shown in Figure 5.7. For the largest radius (i.e., 45 mm), ∆𝑇 increased as the SBR 
threshold was increased and resulted in mean errors greater than 5° for SBR thresholds 
greater than 1.3 for all test point spacings. The trends observed for radii of 15 mm and 30 
mm were similar across all spacings. These results led to the choice of a 30 mm radius and 
an SBR threshold of 1.2 for further experiments as it was the combination that led to one 
of the lowest trajectory errors while still allowing for some variability in the needle 
applicator’s voxel intensity range. A less restrictive intensity threshold was considered 
useful and potentially more robust in the patient images as there were more observed 
artifacts and increased variability in the needle applicator intensities, as shown in Sec. 
5.3.2. The mean trajectory computation times for spacings of 2.4°, 1.2°, and 0.6° were 
0.233 ± 0.006 s, 0.506 ± 0.043 s, and 1.61 ± 0.04 s, respectively. Since a 30 mm radius and 
an SBR threshold of 1.2 resulted in similar trajectory errors across all spacing sizes, a 2.4° 
spacing was chosen since it was associated with the lowest computation time. Using the 
three selected trajectory parameters, the corresponding ALA failed to pass a normality test 
(P = 0.0005) and was observed to have a median [first quartile (Q1), third quartile (Q3)] 
value of 1.3 [0.8, 2.1] mm. 
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Figure 5.7 The influence of different spherical search space radii and test point spacings 
on segmentation trajectory error for varying signal-to-background intensity ratio 
thresholds. Standard deviation error bars are shown for each measurement. 
The optimal parameters determined from the phantom images are summarized in Table 
5.4. These parameters resulted in an overall mean algorithm segmentation time of 0.246 ± 
0.007 s on the phantom images, which encompassed input of the user selected point to the 
algorithm until display of the segmentation. This sub-second computation time was 
considered acceptable for intraoperative use and the phantom optimized parameters were 
used to create segmentations for the clinical dataset as described in Sec. 5.3.2. 
Table 5.4 Needle applicator segmentation parameters optimized on phantom images. 
Parameter  Value 
Test Point Spacing  2.4° 
Spherical Radius  30 mm 
SBR Threshold  1.2 
Tip Threshold  Otsu - 5 
5.3.2 Retrospective patient experiments 
Table 5.5 Needle applicator imaging characteristics in patient 3D US images. 
Image Characteristic  Mean ± Standard Deviation 
Applicator Intensity  159 ± 34 
Background Intensity  75 ± 21 
SBR  2.2 ± 0.5 
We first evaluated the imaging characteristics and appearances of the needle applicators in 
the patient images, shown in Table 5.5. Compared to the phantom images, the standard 
deviation of mean intensities along the needle applicator was three times greater with an 
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approximate two-fold increase in the SBR. A sample oblique plane taken from a patient 
3D US image with the corresponding segmentation is shown in Figure 5.8. Intensity 
profiles of a needle applicator taken from a phantom image (Figure 5.9a) and patient image 
(Figure 5.9b) are shown to further emphasize the appearance differences of the observed 
needle applicators in-vivo. 
 
Figure 5.8 Sample oblique plane in a 3D US image of an MWA needle applicator inserted 
in a patient’s liver before (a) and after (b) segmentation. The 3D US image was resliced to 
visualize the entire segmentation for clarity. 
 
Figure 5.9 Sample intensity profiles of the manually segmented needle applicator 
trajectory in a phantom image (a) and patient image (b). These line profiles of needle 
applicators in the phantom and patient images correspond to the images in Figure 5.6 and 
Figure 5.8, respectively. 
Figure 5.10 shows the needle applicator trajectory, axis localization, and tip segmentation 
errors of the four users and all the patient 3D US images. Error distributions for ∆𝑇 for 
TU1, ALA for TU2, and ATE across all users failed to pass a Shapiro-Wilk normality 
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test, so non-parametric statistical testing was performed for the remainder of the analysis. 
A Friedman omnibus test was first performed on the ∆𝑇 distributions (Figure 5.10a) and 
showed a statistically significant difference (p < 0.0001) between the users. Investigating 
multiple comparisons revealed significant differences between TU1-TU2 (p < 0.05) and 
TU2-IR2 (p < 0.0001). Median ∆𝑇s of 4.1 °, 1.6 °, 3.9 °, and 4.9 ° were observed for the 
TU1, TU2, IR1, and IR2 users, respectively. The ALA measurements (Figure 5.10b) also 
showed a statistically significant difference (p < 0.01) between users when performing a 
Friedman test with multiple comparisons revealing a significant difference between TU2-
IR2 (p < 0.05). Median ALA measurements of 1.4 mm, 1.2 mm, 2.0 mm, and 2.0 mm 
were observed. ATE measurements (Figure 5.10c) also showed a statistical significant 
difference (p < 0.05) between users when performing a Friedman omnibus test with 
multiple comparisons repeating significant differences between TU1-TU2 (p < 0.05) and 
TU2-IR2 (p < 0.05). Median ATEs of 3.6 mm, 1.0 mm, 1.8 mm, and 3.7 mm were 
observed for the TU1, TU2, IR1, and IR2 users, respectively. The mean intra-subject FLE 
values over five trials for the TU1 and TU2 users and mean inter-subject for all users in 
consensus agreement are provided in Table 5.6. Finally, the overall segmentation 
computation time across all users (Table 5.6) was 0.303 ± 0.026 s, which was similar to 
segmentations performed in the phantom images. 
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Figure 5.10 Box plots for the resulting trajectory (a), axis localization (c), and tip (b) errors 
after using the needle applicator segmentation algorithm. These results were performed on 
16 patient images for two trained users (TU) and two interventional radiologists (IR). The 
centre lines represent the distribution median value with the boxes showing the 25% and 
75% percentiles. 
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Table 5.6 Inter- and intra-subject manual applicator tip localization, manual trajectory 
variability, and algorithm segmentation computation times in 16 patient 3D US images. 
User 
 
𝐹𝐿𝐸̅̅ ̅̅ ̅̅ 𝑖𝑛𝑡𝑟𝑎 ± std (mm) 
 
𝐹𝐿𝐸̅̅ ̅̅ ̅̅ 𝑖𝑛𝑡𝑒𝑟  ± std (mm) 
 Manual Trajectory  
Variability ± std (°) 
 Segmentation  
Time ± std (s) 
TU1  0.99 ± 1.40  
1.37 ± 1.19 
 
1.56 ± 0.75 
 0.308 ± 0.025 
TU2  0.89 ± 0.77    0.296 ± 0.022 
IR1  —    0.310 ± 0.028 
IR2  —    0.303 ± 0.029 
5.4 Discussion 
5.4.1 Phantom experiments 
Since access to patient 3D US images containing needle applicators was limited, we 
performed optimization of the proposed segmentation algorithm on phantom images to 
utilize all available clinical images for evaluation. The selected parameters optimized on 
the homogenous agar phantom images (Table 5.4) with seed points selected by an expert 
user resulted in ∆𝑇, ALA, and ATE median [Q1, Q3] measurements of 2.1 [1.1, 3.6] °, 1.3 
[0.8, 2.1] mm, and 1.3 [0.7, 2.5] mm, respectively, with an overall algorithmic computation 
time of 0.246 ± 0.007 s. The manual variability in localizing the needle applicator tip 
locations in the phantom images (i.e., 𝐹𝐿𝐸̅̅ ̅̅ ̅̅ ) was 0.43 ± 0.09 mm, which was less than two 
voxels when referenced against the in-plane voxel dimensions of our 3D US images. This 
could represent a major cause of the observed variability for the three metrics as it is 
approximately equal to the measured interquartile ranges. However, since we used the 
average tip location over five trials when performing comparisons to manual 
segmentations, we believe the impact of FLE on the measured metrics is reduced with 
minor contributions to the overall errors observed. This belief still falls under the caveat 
that comparisons are performed to manual segmentations, which assumes that the tip 
position is visible and can be accurately estimated. Nonetheless, since the phantom images 
were primarily used for parameter tuning, the visibility of the applicator in ultrasound is 
adequate for manual segmentation accuracy evaluation. 
The investigated test point spacings of 2.4°, 1.2°, and 0.6° did not have a large effect on 
trajectory error when observing the interaction between different radii and SBR thresholds. 
Although the fine test point spacing of 0.6° yielded the smallest median observed trajectory 
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error (i.e., 1.9 [1.2, 3.4]°) with a radius of 30 mm and SBR threshold of 1.1, computation 
time increased by approximately 6.5 times (i.e., 1.58 ± 0.04 s) and was considered too large 
for only a minor decrease in observed error. A radius of 45 mm performed the worst across 
all test point spacings when increasing the SBR thresholds beyond 1.3, which is most likely 
due to the increasing number of voxels contributing to the most probable trajectory metric 
in Eq. 5.1. When searching with a radius of 45 mm, line segments along the needle 
applicator trajectory would be more likely to extend beyond the imaging limits, thus, 
negatively impacting the 𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑖 measurement in the most probable trajectory metric 
(Eq. 5.1). 
Determining the tip location was performed with the Otsu threshold since we assumed a 
bimodal intensity distribution when assessing the selected most probable trajectory. Based 
on the small standard deviation in needle applicator and background intensity values (Table 
5.3) and the appearance of the observed line profiles (Figure 5.9a), we believe this was a 
good approximation for needle applicators in the acquired phantom images. When 
computing the Otsu threshold without adjustment, thresholds were often determined too 
high and resulted in needle tip identifications that fell short of the actual position. Shifting 
the computed threshold by 5 intensity units was chosen as the ideal threshold to determine 
the tip location as it was observed to have a significantly reduced tip error. Since the Otsu 
threshold determines a threshold based on the histogram of the intensity distribution to 
maximize interclass variance, this implied that the maximum interclass variance along the 
line profile did not encompass enough needle applicator voxel intensities to accurately 
determine the tip location. Although an extension to the most probable trajectory was added 
to equalize the intensity population distributions of the needle applicator and background, 
overlap of the populations may be too great in low SBR imaging conditions to rely on 
interclass variance alone. Providing an adjustment to the Otsu threshold therefore captured 
more of the needle applicator’s intensity distribution, which appears to be necessary for tip 
localization. We have shown acceptable results using a fixed adjustment of 5 intensity 
units, but it is possible the adjustment is influenced by the needle applicator’s SBR in the 
US images and could warrant further investigation. 
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The visibility and tool SBR in 3D US can greatly influence the success of a segmentation 
algorithm and typically gets worse as SBR decreases.45 The effect of background noise has 
been previously investigated by Barva et al.31 for an automated parallel integral projection 
(PIP) algorithm to segment straight electrodes in 3D US. They used a signal-to-noise 
(SNR) ratio defined as: 
 𝑆𝑁𝑅 =  10 log
𝜇𝑒𝑙
2 +𝜎𝑒𝑙
2
𝜇𝑏𝑔
2 +𝜎𝑏𝑔
2  [𝑑𝐵], 
(5.7) 
which used the mean 𝜇𝑒𝑙 and variance 𝜎𝑒𝑙
2  of simulated electrode voxels and the mean 𝜇𝑏𝑔 
and variance 𝜎𝑏𝑔
2  of background voxels. Using this definition with needle applicator voxels 
in lieu of electrode voxels, the SNR observed for our needle applicators in the phantom 
images was 1.8 ± 0.5 dB. This was of particular interest since previous work31 had observed 
rapid increases in ATE as SNR decreased below 10 dB, which reported an ATE of 2.7 mm 
at a minimum reported SNR of 7 dB. In comparison to our measured ATE of 1.3 mm at an 
SNR of 1.8 dB, our algorithm appears to perform well and provide added utility at low 
SNR levels. 
In more recent methods using simulated data,29 the SBR has been investigated to observe 
trends in the performance of automated segmentation algorithms. Since an acceptable error 
has never been strictly defined for algorithms performing segmentation of therapy 
applications used in liver ablation, previous work considered segmentations a failure if the 
tip error (i.e., ATE) or axis localization error (i.e., ALA) were greater than or equal to 3 
mm. Using these thresholds for failure, segmentations in our phantom images resulted in a 
failure rate of 26% (13/50). Since the SBR for our phantom images was 1.22 ± 0.08, our 
method appears to be useful in imaging conditions with low tool SBR since failure rates 
were observed to be greater than 80% for many recent automated methods.29 
5.4.2 Retrospective patient experiments 
Since adjustments to the US system scanning parameters (e.g., time-gain-compensation, 
depth, focal zone depth, etc.) when acquiring an US image can be subjective and often 
depend on external factors, such as experience and environment, a wide range of image 
qualities are observed in clinical settings. An increase in needle applicator SBR was shown 
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when imaging needle applicators in patients compared to the phantom images described 
previously. In addition, the visible needle applicators and background intensities were 
observed to have increases in variability, resulting from an increased number of anatomical 
structures causing image clutter and artifacts. Using the definition of SNR in Eq. 5.7, the 
needle applicator appearance across all patient images was 6.4 ± 1.9 dB, further supporting 
the increase in SBR relative to the phantom images. When comparing intensity line profiles 
between the phantom and patient images along the needle applicator trajectories, many line 
profiles contained a bimodal distribution of intensities and resulted in more consistent and 
accurate segmentations across users (Figure 5.11a). However, the time-gain compensation 
adjustment to the US machine appeared to be overlooked during acquisition in some cases, 
leading to an intensity gradient in the image background and increases in segmentation 
complexity (Figure 5.11b). More than half of all cases (9/16) violated the bimodal intensity 
distribution assumption of our segmentation algorithm and could partially explain the 
increase in resulting  ∆𝑇, ALA, and ATE median [Q1, Q3] measurements of 4.5 [2.4, 5.2]°, 
 1.9 [1.7, 2.1] mm, and 5.1 [2.2, 5.9] mm, respectively, compared to the phantom results. 
Although there were image quality differences, the overall mean computation time was 
similar to phantom experiments at 0.303 ± 0.026 s across all users, which is suitable for an 
intraoperative implementation. 
 
Figure 5.11 Examples of simple (a) and complex (b) intensity profiles of needle applicators 
for the segmentation algorithm. Line profiles were acquired from two manually segmented 
trajectories in MWA patient images. 
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Significant differences between users for all error metrics when using the segmentation 
algorithm were observed with the most consistent difference between users TU2 and IR2. 
Currently, the algorithm is not robust to poor initializations, which is a potential source of 
differences between the different users. Variability in the manual trajectories was observed 
to be 1.56 ± 0.75 ° and represents a considerable portion of the observed trajectory errors. 
This implies that localizing the central axis of the needle applicator shaft in 3D US is not 
trivial and could motivate the need for a central axis localization technique that is able to 
adjust user selected points to better approximate the applicator’s shaft coordinates. Since 
the algorithm assumes the seed point is along the trajectory of the needle applicator, if the 
initialization point was not centered correctly, the segmentation would result in an incorrect 
trajectory and subsequently cause increases in the measured tip localization error. Image 
features that were observed to cause increased errors across most users were large gaps 
along the needle applicator shaft (4/16) and the presence of arteries and veins causing 
similar acoustic reflection intensities (5/16). 
The observed user variability in localizing the needle applicator tips and trajectories further 
emphasizes the increased difficulty of identifying applicators due to image quality 
variability when performing deep and oblique needle applicator insertions in the clinical 
setting. An increase in tip localization error was observed when intra-subject variability 
(i.e., 𝐹𝐿𝐸̅̅ ̅̅ ̅̅ 𝑖𝑛𝑡𝑟𝑎) was compared against phantom experiments, which rose from 0.43 ± 0.09 
mm to 0.99 ± 1.40 mm and 0.89 ± 0.59 mm (approximately the size of 4 voxels in-plane) 
for the TU1 and TU2 users, respectively. When compared across users, the inter-subject 
tip localization variability (i.e., 𝐹𝐿𝐸̅̅ ̅̅ ̅̅ 𝑖𝑛𝑡𝑟𝑎) was observed to be larger at 1.37 ± 1.19 mm. 
Unlike the phantom segmentations, these FLE measurements are approaching the 
magnitude of the measured errors for the four users and is likely contributing a non-
negligible amount to the measured errors even though the average position of the identified 
tip was used. Nevertheless, measured median errors appear to be acceptable for 
interventional liver procedures where tumors range from 1 cm to 3 cm in diameter.  
Interventional procedures in the liver can be performed with slight alterations in workflow, 
which could offer additional usable information for the segmentation algorithm. Our 
clinical dataset in this study was obtained from a free-hand insertion approach where no 
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needle applicator guides were used, increasing the potential search space where needle 
applicators could be found. One alternative to the current approach to reduce error could 
utilize a needle applicator guide for insertions, which could increase the a priori knowledge 
that could be taken into account to reduce the potential search space for the trajectory of 
the needle applicator. By incorporating an initialization for the segmentation, a reduction 
in the search space would not only reduce computation time further, but it would likely 
reduce error since a tighter constraint would reduce potential solutions and outliers.  
Curved needle applicator segmentations in US images have been previously 
investigated36,46–49 for procedures using flexible needles and offers further potential for this 
algorithm with some investigation into workflow changes. For example, instead of creating 
a single straight line segment through the user selected point, a spline approach could be 
performed superior and inferior to the selected point. This could potentially be 
implemented with multiple, smaller spherical search spaces with searched trajectory 
solutions reduced after the first few completed line segments by constricting the search 
space around the locally determined trajectory. With increasing interest in IRE procedures, 
which use thinner diameter electrodes (16 to 19 gauge)50 that are more susceptible to 
deflection during insertion, this possible solution could provide a method for improving 
needle applicator placements with increased imaging complexity. 
5.5 Conclusions 
A semi-automated 3D US needle applicator segmentation during minimally invasive liver 
cancer diagnostic or therapeutic procedures provides a utility that enables enhanced needle 
applicator guidance, placement verification, and improved clinical workflow without the 
need for additional radiation exposure. Using a posteriori knowledge of the current 
procedural workflow, we employed constraints on a heuristic intensity-based algorithm to 
perform 3D needle applicator segmentations in less than 0.31 s. Homogeneous agar 
phantom images containing needle applicators were used to optimize the trajectory and tip 
localization parameters of the algorithm prior to investigation on retrospective 3D US 
images of patients who underwent liver MWA. Median trajectory, axis localization, and 
tip localization errors across four users were less than or equal to 5°, 2 mm, and 4 mm, 
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respectively, suggesting this approach could be useful for the clinical environment. With 
this tool, intraoperative segmentations can be performed to assess and adjust needle 
applicator placements, potentially decreasing the liver cancer recurrence rates associated 
with minimally invasive procedures. 
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Chapter 6  
6 A deep learning method for general needle and applicator 
segmentation in two-dimensional ultrasound images from 
multiple applications and anatomical regions 
2D US is widely used for real-time imaging during insertion of interventional tools, but 
accurate identification is necessary for desired clinical outcomes and is often dependent on 
subjective physician interpretation. The purpose of Chapter 6 is to present on the 
development of a general needle-like tool segmentation algorithm for improving 
intraoperative identification during interventional procedures without the need for 
additional equipment or operating room set-up. 
The contents of this chapter have been submitted for publication in Medical Physics and 
are currently under peer-review: Gillies DJ and Rodgers JR, Gyacskov I, Roy P, Kakani 
N, Cool DW, and Fenster A. 
6.1 Introduction 
Ultrasound (US) imaging is often used during interventional procedures to provide 
portable, accessible, and real-time imaging of anatomy and instruments. This is particularly 
advantageous for guidance during minimally invasive percutaneous interventional 
techniques, which offer reduced recovery times and complications relative to open surgery. 
Despite these benefits, one factor that has limited the guidance accuracy of these techniques 
is the ability to localize needle-like interventional tools, such as needles and therapy 
applicators, quickly and accurately in the standard two-dimensional (2D) US images while 
in the intraoperative environment.1,2 Diagnostic and therapeutic cancer procedures where 
accurate localization is essential include brachytherapy, solid organ ablation, and biopsy. 
High-dose-rate interstitial brachytherapy of prostate or gynecologic malignancies delivers 
internal radiation via multiple needles (typically about 5–24)3,4 that are inserted into the 
tumor and surrounding area, thereby requiring correct needle placement to deliver optimal 
treatment and reduce risks to nearby structures. In ablation procedures, commonly used in 
liver and kidney cancers, one to four applicators, such as radiofrequency electrodes or 
microwave antennae, are inserted into tumors to heat the tissue and destroy malignant cells. 
Applicators must be accurately placed within the tumor to achieve adequate therapy and 
minimize local recurrence risk.5 Similarly, during biopsy procedures, accurate insertion of 
the biopsy needle into a suspicious mass is essential to ensure proper tissue sampling for 
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histopathological assessment. In this paper, we use the term “tools” to refer generically to 
needle-like interventional instruments, including electrodes, antennae, applicators, and 
needles. Identifying these tools in 2D US images can be challenging, with their precise 
position difficult to distinguish once placed inside the tissue. Visualization requires the tool 
to be coplanar with the US probe and localization is often operator-dependent, associated 
with subjective 2D US guidance.1 Additionally, anatomical features, such as the body 
habitus of the patient, fat, and blood vessels in the liver, or artifacts, such as air gaps or 
needle reverberation in some brachytherapy images, can affect the appearance of the tool 
and obscure portions of the tool path or confound identification of the tool’s tip position. 
Implementation of a real-time or near real-time method to automatically identify and 
segment interventional tools on intraoperative live US images might improve clinicians’ 
ability to guide, adjust, and verify tool positions, allowing these positions to be refined and 
misalignments to be corrected without disrupting clinical workflow or extending procedure 
time. 
Image-based approaches for tool guidance, avoiding the requirement for additional 
equipment, signal processing, and set-up, have been proposed for general tool 
segmentation in US images, leveraging techniques based on image properties, including 
projections,6–9 random sample consensus (RANSAC),10–12 filtering,11,13–15 and Hough or 
Radon transforms,16–20 or physical properties, such as analyses of motion,20–24 beam 
steering,25 and circular wave generation.26 Many of these algorithms were developed for 
three-dimensional (3D) US images;6–13,18,19,21 however, 2D US is the clinical standard for 
image-guided minimally invasive interventions at most institutions and therefore is the 
focus of our work presented in this study. Many of the published approaches were tested 
only on phantom or ex vivo tissue images,6–22,24–26 in vivo on an anesthetized porcine 
model,18,23 or, in some cases, US images from one clinical application, such as breast 
biopsy8,10,16 or nerve block imaging.25 Therefore, the generalizability of the algorithms to 
multiple applications, particularly given the idealized nature of phantom conditions, 
requires further investigation.  
Image-based approaches may suffer from a lack of robustness and longer processing times 
when used on more complex clinical images.27 To address these limitations, recent 
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developments by Pourtaherian et al.28 and Arif et al.27 have employed convolutional neural 
networks (CNNs) for needle detection in 3D US images. The method presented by 
Pourtaherian et al.28 used patch classification and semantic segmentation techniques with 
CNN architectures, testing their approach on chicken breast and porcine leg ex vivo datasets 
with data augmentation. This method achieved tip localization errors of < 0.7 mm. Arif et 
al.27 also proposed a CNN-based method using a V-Net model to localize needles in 3D 
US phantom and liver images, demonstrating a mean tip error of 1 mm and angular error 
of 2°. Both methods demonstrated the potential of CNNs to accurately localize needles in 
US images; however, neither were assessed on 2D US images and investigation of their 
applicability on a range of clinical images has not been performed. 
In recent work, Lee et al.29 proposed segmentation of kidney biopsy needles in 2D US 
images using a deep learning approach based on a LinkNet architecture with the addition 
of a concurrent spatial and channel “Squeeze and Excitation” method to independently 
weight spatial and feature map characteristics. This method used images acquired at three 
frames per second from eight patient US videos to create a dataset for training and testing, 
achieving a Dice similarity coefficient (DSC) of 56.65 %, root-mean-square (RMS) 
distance error of 9.5 pixels, and RMS angular error of 13.3°.29 Although this approach is 
susceptible to information leakage since many images were acquired per patient, this study 
demonstrates many of the challenges associated with localizing needles in kidney images 
and the extension of this method to applications other than kidney biopsy has not been 
explored. Mwikirize et al.30 investigated an algorithm using a fully convolutional network 
with a fast region-based CNN for interventional applications requiring quick localization 
of mid-to-steeply inserted needles (40–75°) and deep insertions (up to 9 cm) in 2D US 
images. This study demonstrated accurate localization with recall and precision rates > 99 
%, a mean tip error of 0.23 mm, and a mean angular error of 0.82° with a processing time 
of 0.58 s.30 Further investigation of this approach is necessary to assess its generalizability, 
as the initial study was limited by only using in-plane (or slightly out-of-plane) insertions 
of a single tool type (17-gauge epidural needle) in ex vivo bovine/porcine tissues and 
phantoms with recall and precision only assessed on images acquired from a single US 
system and probe, matching the system used for training. 
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In this study, we have developed and evaluated a deep learning method using a CNN with 
a U-Net architecture to segment general needle-like interventional tools from 2D US 
images from multiple anatomical regions and various interventional procedures in near 
real-time. The proposed algorithm was trained and tested on augmented datasets using 2D 
US images and manual segmentations from phantom experiments and five different clinical 
cancer procedures: prostate brachytherapy, gynecologic brachytherapy, liver ablation, and 
kidney ablation and biopsy. 
6.2 Materials and methods 
6.2.1 CNN model 
The proposed CNN in the U-Net architecture was adapted from Ronneberger et al.31 and is 
shown in Figure 6.1. Accommodation of all anticipated image sizes was performed by 
resizing all images to 256⨯256 pixels. Convolution kernels were 3⨯3 pixels with a 
rectified linear unit (ReLU) activation function and optimization of network weights was 
performed using an Adam optimizer with a DSC loss function. Regularization was a key 
consideration to prevent overfitting of the CNN, especially in a small dataset application, 
so 50 % dropouts were used in the decoder section of the network, as has been previously 
shown to maximize regularization.32 Transpose convolutions were used instead of 
upsampling followed by convolution, based on preliminary experiments to improve 
performance. Final output masks were produced with a 1⨯1 convolution kernel and a 
sigmoid function. All images were used to compute the mean and standard deviation (SD) 
of intensities for data centering and normalization. Improvements in the network accuracy 
were investigated by performing experiments on the training dataset (Sec. 6.2.2) for the 
learning rate and epoch hyper-parameters. Learning rates ranged between 10-3 and 10-5 
with epochs tested from 50 to 200. Training and validation DSCs of approximately 85 % 
resulted in the selection of a 10-4 learning rate with 100 epochs. 
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Figure 6.1 A schematic of our CNN in the U-Net architecture with arrows denoting the 
different operations. The numbers above the rectangles correspond to the output filters in 
the convolution (i.e., multi-channel feature map) and the numbers along the side 
correspond to the XY image size in pixels. 
6.2.2 Datasets 
Images and manual segmentations used for training, validation, and testing of the proposed 
CNN were acquired from phantoms and five different clinical interventional procedures, 
including prostate and interstitial gynecologic brachytherapy, liver ablation, and kidney 
ablation and biopsy, with the assumption that only a single tool was present in each 2D 
image. A single trained observer generated gold standard manual segmentations by 
selecting the tool tip and a second point on the tool shaft. An assumption of a 2.1 mm tool 
diameter with a conical tip was used to create linear, needle-shaped masks (Figure 6.2) 
along the user-defined axes. In the gynecologic brachytherapy images, the needle tip was 
not always visible within the image field-of-view and therefore the deepest visible point 
along the needle path was selected as the tip in these cases and the conical tip assumption 
was removed from mask generation. This dataset, totaling 1242 images and segmentations, 
was split into a 74 % training set and a 26 % unseen testing dataset (Table 6.1). Since 
multiple tools were occasionally visualized per patient, all images for an individual were 
assigned to either the training or testing dataset to avoid potential redundancies in the 
anatomical background. This ensured that the testing dataset contained solely unseen data 
to improve the approximation of future clinical use and robustness. The training dataset 
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was further split into 80 % training and 20 % validation datasets to train and optimize the 
network weights. 
Table 6.1 Training and testing dataset distributions of 2D US images containing needle-
like tools from interventional applications, with the number of unique patients provided for 
clinical applications and the number of independent tool insertion experiments for the 
phantom. 
Image 
Background 
Images in Training Set 
(Number of Patients) 
Images in Testing Set 
(Number of Patients) 
Phantom 23 (7) 9 (3) 
Prostate 18 (4) 8 (1) 
Gynecologic 34 (4) 18 (2) 
Liver 540 (18) 256 (8) 
Kidney 302 (9) 34 (3) 
Overall 917 325 
 
 
Figure 6.2 Input 2D US images illustrating background and tool appearances (top row), 
tool masks generated from manual segmentation (middle row), and tool masks predicted 
by the CNN algorithm prior to post-processing (bottom row) for each of the applications 
tested, showing examples of various segmentation performance quality. 
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Data augmentation was investigated to increase the number of images used for training and 
further reduce overfitting to improve the generalization of the tool segmentation CNN. 
Combined strategies used to augment our data included horizontal flips, horizontal and 
vertical shifts up to 20 % of the image size, 20° maximum rotations, and a 20 % zoom 
range. Augmentation was performed at the time of training in batches of 10, which doubled 
the dataset for each epoch, but with different augmentations on subsequent epochs. 
Training and testing of the CNN were performed using a Python implementation of Keras 
on Windows 10 (Microsoft, WA, USA). This was run on a personal computer with two 
Xeon E5645 central processing units (CPUs) at 2.40 GHz (Intel Corporation, CA, USA), 
24.0 GB of memory, and a GeForce GTX TITAN (NVIDIA Corporation, CA, USA) 
graphics processing unit (GPU). This hardware allowed for training to be performed in 
approximately 3.5 hours. 
To ensure the generalizability of the algorithm, images from clinical applications with 
varying tool properties and appearances were used, with examples shown in Figure 6.2. 
Phantom procedures were performed in a tissue-mimicking agar mixture and microwave 
ablation applicators with 2.1 mm outer diameters were inserted (depth range: 55.5–81.1 
mm) with oblique insertion angles relative to the probe (range: 17.4–65.9°). Phantom 
images had a pixel size of 0.2⨯0.2 mm2 and were acquired with a Philips iU22 US system 
using a C5-1 curvilinear probe (Philips Healthcare, the Netherlands). Prostate 
brachytherapy procedures used 2 mm diameter plastic needles, whereas gynecologic 
brachytherapy procedures used 1.65 mm diameter stainless steel needles. Both prostate and 
gynecologic brachytherapy images were acquired using a BK ProFocus 2202 US system 
with an 8848 endocavity probe (BK Medical, MA, USA). Pixel sizes for the brachytherapy 
images ranged between 0.126⨯0.126 mm2 and 0.212⨯0.212 mm2. Both brachytherapy 
procedures had needles inserted nearly parallel to the linear US imaging face, often 
resulting in reverberation artifacts. Other artifacts also impacted the appearance of these 
needles, as more anterior needles often appeared partially obstructed due to shadowing in 
prostate images and air artifacts occasionally created discontinuities in gynecologic 
images. Ablation and biopsy images with pixel sizes between 0.151⨯0.151 mm2 and 
0.428⨯0.386 mm2 were acquired with a Philips iU22 US system using a C5-1 curvilinear 
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probe (Philips Healthcare, the Netherlands). For ablation procedures and kidney biopsy, 
1.3 mm and 2.1 mm outer diameter applicators were inserted with widely varying depths 
and angles (depth range: 30.4–99.0 mm; insertion angle range: 23.3–77.2°) resulting from 
the free-hand nature of applicator insertion. These angles relative to the curvilinear US 
probe can create discontinuities in the intensity of the applicator with anatomical features 
creating a large amount of image clutter and making applicator visualization difficult. 
6.2.3 Post-processing and evaluation 
Smaller disconnected regions were sometimes present in the predicted segmentations. 
Since we assumed that only a single tool was present in our images, we employed two post-
processing methods to filter the predicted masks and fit a single trajectory corresponding 
to the needle-like tool. Both methods were implemented offline in MATLAB R2019a 
(MathWorks, MA, USA) using a Windows 10 (Microsoft, WA, USA) personal computer 
with an i7-5820K CPU at 3.3 GHz (Intel Corporation, CA, USA) following the prediction 
using the CNN. Neither approach was optimized for speed or for use with a GPU. 
Processing times reported included only the time for filtering and fit, excluding the time to 
read or write the predictions and results, as it was assumed that this would be incorporated 
into the pipeline when implemented as a routine part of the algorithm. 
The simpler approach to tool fitting was implemented using a largest island post-processing 
technique to save only the largest connected region of predicted pixels, as has been 
previously studied.29 A linear least-squares fit on this map was then used to predict the 
tool’s tip and trajectory. In an attempt to more robustly establish the tool axis in the 
presence of disconnected outlier regions, a RANSAC model-fitting approach10 was also 
evaluated. The RANSAC method used a linear model with a 14-pixel diameter, as nominal 
tool widths were between 5 and 14 pixels, depending on the application. The RANSAC fit 
was initially performed twice with a 90º rotation of the predicted mask between the two 
fits and the direction that maximized the number of inliers was then selected. To produce 
a more consistent result and reduce the likelihood of a poor fit resulting from the random 
nature of the RANSAC fit, the fit was run two more times in the chosen direction. From 
the three fits in the selected direction, the fit with the largest number of inliers was chosen. 
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Any pixels that were classified as part of the tool prediction but were not considered inliers 
were removed from the mask to generate the filtered mask. 
Evaluation of the predicted tool segmentations was performed using a combination of 
traditional metrics for pixel map comparisons and tool segmentation-specific error metrics. 
Since the number of pixels within the predicted tool region-of-interest (ROI) was expected 
to be small relative to the total number of pixels within the image, only pixel map 
comparison metrics that excluded true negative predictions were considered. These criteria 
included the DSC, recall (i.e., sensitivity), and precision classification statistics. Pixel map 
comparisons were performed prior to post-processing and following both filtering 
approaches. Tool segmentation-specific errors included the tip and trajectory errors of the 
predicted segmentations. Tip errors were computed by determining the Euclidean distance 
between the manual gold standard tip location and the automated segmentation tip location 
determined by linear fits for both post-processing approaches. Since two points were used 
to create the gold standard manual segmentations, vectors for the manual segmentations 
(?⃑?𝑚𝑎𝑛) and the computed vector from the algorithm (?⃑?𝐶𝑁𝑁) were used to assess trajectory 
errors by: 
 
∆𝑇 = cos−1 (
?⃑?𝐶𝑁𝑁 ∙ ?⃑?𝑚𝑎𝑛
‖?⃑?𝐶𝑁𝑁‖ ∙ ‖?⃑?𝑚𝑎𝑛‖
) [°]. 
(6.1) 
6.2.4 User variation 
While a single trained user, now denoted U1, generated the gold standard masks used for 
training and testing, two additional trained users also generated manual segmentations to 
obtain an insight into the potential variability in the gold standard masks. All users 
generated two masks per tool on over 200 images with a minimum of 24 hours between 
segmentations to allow for quantification of the intra-rater repeatability of the masks. Users 
also generated segmentations on a dataset of 211 images to compare the inter-rater 
segmentation performance. The intra-rater repeatability was assessed by calculating a tip 
localization error analogously to a fiducial localization error33 and the SD of the 
corresponding trajectories, as well as the DSC, recall, and precision. Agreement metrics 
for the inter-rater comparison were tip localization error, the SD of corresponding 
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trajectories, and a three-user DSC,34 as well as a Fleiss’ kappa,35 which determines the 
agreement between users while correcting for chance. 
6.2.5 Statistical analysis 
Statistical calculations were performed in GraphPad Prism 7.00 (GraphPad Software, Inc., 
CA, USA). The normality of distributions was evaluated using the Shapiro-Wilk test and 
led to the use of nonparametric statistical tests when the normality assumption was 
violated. The corresponding nonparametric alternative tests are presented in parentheses 
for the remainder of the section. For nonparametric distributions, descriptive statistics were 
reported using medians with interquartile ranges. The significance level for statistical 
analysis was chosen such that the probability of making a type I error was less than 5 % (p 
< 0.05). The tip and trajectory errors of tools with short visible lengths were compared to 
the tip and trajectory errors of tools with longer visible lengths using t-tests (Mann-Whitney 
tests). Intra-rater metrics were compared using a one-way analysis of variance (Kruskal-
Wallis) test with multiple comparisons performed using a Tukey (Dunn’s) test. The three-
user DSC and Fleiss’ kappa were implemented in MATLAB R2019a (MathWorks, MA, 
USA). 
6.3 Results 
6.3.1 Unfiltered predictions 
The CNN algorithm generated predicted segmentations in approximately 50 ms per image. 
Examples of the predicted masks generated by the algorithm for each application prior to 
post-processing are shown in Figure 6.2, including the corresponding background images 
and manual masks used as the gold standard. The small island in the predicted mask of the 
gynecologic brachytherapy example is a result of a reverberation artifact in the image and 
was eliminated by both post-processing methods. The algorithm identified tools in 96.9 % 
of the images in the unseen testing set with three of the ten failures in the kidney images 
and the remaining seven in the liver images. The pixel map comparison error metrics prior 
to post-processing for each application are summarized in Table 6.2. It should be noted that 
due to the large number of liver images available, the overall values reported throughout 
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this section are strongly influenced by the liver results. The kidney segmentations 
demonstrated much lower DSC and recall medians relative to the other anatomical 
backgrounds, reflecting the difficulties in distinguishing needles in kidney US images.29  
Table 6.2 Resulting medians [first quartile (Q1), third quartile (Q3)] for DSC, recall, and 
precision metrics on an unseen testing dataset prior to post-processing. 
Image  
Background 
DSC (%) Recall (%) Precision (%) 
Phantom (n = 9) 85.6 [82.1, 89.9] 94.3 [91.0, 99.0] 78.0 [73.0, 84.1] 
Prostate (n = 8) 76.2 [71.0, 84.0] 79.3 [62.8, 88.8] 76.3 [71.1, 82.1] 
Gynecologic (n = 18) 88.7 [85.8, 92.0] 91.0 [85.7, 95.2] 88.6 [80.8, 91.6] 
Liver (n = 249) 71.8 [58.0, 86.2] 72.1 [53.1, 88.5] 83.2 [69.4, 89.5] 
Kidney (n = 31) 58.0 [44.7, 70.1] 49.2 [38.6, 59.0] 83.1 [67.2, 98.9] 
Overall (n = 315) 71.9 [58.0, 86.3] 72.3 [52.4, 89.3] 83.2 [70.9, 89.8] 
6.3.2 Post-processed predictions 
The largest island filtering and linear fit were performed with a 2 ms processing time per 
tool. The median tip, trajectory, and pixel map metrics resulting from this approach are 
summarized in Table 6.3. Similarly, the error and pixel map metrics using the RANSAC 
method of fitting and filtering are summarized in Table 6.4 and performed with a 
processing time of 23 ms per tool. Overall, the RANSAC method produced lower tip and 
trajectory errors than the largest island approach with median [first quartile (Q1), third 
quartile (Q3)] tip errors of 3.5 [1.3, 13.5] mm and 4.4 [1.5, 17.8] mm, respectively, and 
median [Q1, Q3] trajectory errors of 0.8 [0.3, 1.7]° and 1.4 [0.4, 2.5]°, respectively. The 
RANSAC method also had a slightly higher DSC than the largest island method, as well 
as improved the precision to a median [Q1, Q3] of 87.5 [76.2, 95.1] % from 84.1 [73.6, 
90.4] % obtained with the largest island. Both methods improved the DSC and precision 
relative to the unfiltered predicted masks. The largest island method yielded a higher recall 
value with a median [Q1, Q3] of 72.3 [51.5, 89.3] % compared to RANSAC with a median 
[Q1, Q3] of 67.4 [48.8, 77.6] %, which is also lower than the unfiltered mask recall. 
Examples of cases from Figure 6.2, showing the performance of the fitting and filtering 
approaches are shown in Figure 6.3. The gynecologic case demonstrates the feasibility of 
both approaches to remove the smaller second island generated by the reverberation 
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artifact. The liver example shows similar performance between the two techniques but with 
the largest island and linear fit approach producing a more accurate tip position than 
RANSAC. In the kidney case, the predicted tool appeared fragmented leading to a poor 
result using the largest island and a much more accurate result using RANSAC. Kidney 
predictions demonstrated much higher tip errors than the other anatomical backgrounds. 
Particularly using the largest island approach, removing the kidney from the overall 
calculations improves the tip error from 4.4 [1.5, 17.8] mm to 3.5 [1.3, 16.6] mm and also 
improves the overall tip error from 3.5 [1.3, 13.5] mm to 3.1 [1.2, 12.7] mm with RANSAC 
post-processing. Excluding the kidney results also leads to slight improvements in the 
overall trajectory error, DSC, and recall with both post-processing methods. 
Table 6.3 After largest island filtering and linear fit, resulting medians [Q1, Q3] for tip and 
trajectory errors and DSC, recall, and precision metrics on an unseen testing dataset. 
Image  
Background 
Tip 
Error (mm) 
Trajectory 
Error (°) 
DSC (%) Recall (%) Precision (%) 
Phantom 
(n = 9) 
2.0 [0.6, 3.6] 0.8 [0.2, 1.9] 85.6 [82.1, 89.9] 94.3 [91.0, 99.0] 78.0 [73.0, 84.1] 
Prostate 
(n = 8) 
1.4 [0.9, 8.2] 0.7 [0.2, 1.3] 76.3 [72.6, 84.8] 79.3 [62.7, 88.8] 81.6 [75.5, 93.4] 
Gynecologic 
(n = 18) 
0.3 [0.2, 0.4] 0.3 [0.2, 0.6] 89.8 [86.7, 92.9] 89.9 [85.7, 95.2] 89.9 [85.7, 91.7] 
Liver 
(n = 249) 
5.0 [1.7, 18.1] 1.4 [0.5, 2.4] 71.8 [58.9, 86.4] 72.1 [52.7, 88.5] 83.9 [72.1, 89.8] 
Kidney 
(n = 31) 
10.9 [4.4, 33.4] 3.2 [1.6, 6.0] 58.4 [46.2, 70.5] 44.8 [30.0, 59.0] 87.5 [73.9, 100.0] 
Overall 
(n = 315) 
4.4 [1.5, 17.8] 1.4 [0.4, 2.5] 72.2 [59.1, 86.6] 72.3 [51.5, 89.2] 84.1 [73.6, 90.4] 
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Table 6.4 After RANSAC fitting and filtering, resulting medians [Q1, Q3] for tip and 
trajectory errors and DSC, recall, and precision metrics on an unseen testing dataset. 
Image  
Background 
Tip  
Error (mm) 
Trajectory 
Error (°) 
DSC (%) Recall (%) Precision (%) 
Phantom 
(n = 9) 
1.0 [0.6, 3.1] 0.5 [0.2, 1.9] 87.3 [83.5, 90.3] 94.2 [89.5, 98.7] 80.8 [78.9, 84.5] 
Prostate 
(n = 8) 
1.5 [0.9, 8.3] 0.4 [0.3, 0.7] 78.9 [73.8, 84.7] 73.2 [62.4, 81.9] 87.9 [84.8, 95.8] 
Gynecologic 
(n = 18) 
0.3 [0.2, 0.4] 0.4 [0.2, 0.7] 88.7 [84.6, 93.5] 85.2 [80.9, 91.1] 93.2 [89.6, 97.0] 
Liver 
(n = 249) 
3.8 [1.6, 14.3] 0.8 [0.3, 1.6] 72.4 [57.0, 81.4] 67.6 [50.2, 75.5] 87.0 [74.0, 95.0] 
Kidney 
(n = 31) 
10.1 [3.5, 33.8] 2.9 [1.3, 7.5] 55.8 [36.6, 67.9] 42.2 [33.2, 56.6] 86.1 [65.7, 98.9] 
Overall 
(n = 315) 
3.5 [1.3, 13.5] 0.8 [0.3, 1.7] 73.3 [56.2, 82.3] 67.4 [48.8, 77.6] 87.5 [76.2, 95.1] 
 
 
Figure 6.3 Cropped predicted masks of example cases from in Figure 6.2 (top row) and 
the result after filtering with the largest island approach (middle row) and RANSAC 
approach (bottom row) with the corresponding fits shown in red. Both methods performed 
similarly for the gynecologic and liver examples, but the RANSAC approach performed 
much better than the largest island in the scenario provided by the kidney image. 
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The visible length of the tool within the image appeared to influence the variability of the 
tip errors, as shown in Figure 6.4(a), and there also appeared to be a trend, illustrated in 
Figure 6.4(b), when examining the trajectory errors. This encompassed cases where the 
tool was captured in an US image when the tool and imaging plane were not coplanar. 
Based on the trajectory errors, an empirical threshold was established where tools with < 
35 mm visible within the image demonstrated larger predicted trajectory errors compared 
to those tools with ≥ 35 mm visible. Since only liver and kidney images contained tools 
with short visible lengths (i.e., < 35 mm), only those applications were included in this 
analysis. The tip and trajectory errors after RANSAC post-processing for tools on either 
side of this threshold are shown in Table 6.5. As these errors did not pass a normality test, 
Mann-Whitney tests were used to evaluate the statistical significance between the two 
groups of tools. While the tests failed to show a significant difference in the tip errors, the 
liver and kidney tools both showed significant differences between the trajectory errors for 
the longer and shorter tools; however, there were only a small number of tools meeting the 
criteria for short visible length (7 in kidney images and 26 in liver images) in this study. 
Additionally, tip error variability increased for long tools when observing liver and kidney 
images combined, but this trend was only demonstrated for liver images when investigated 
independently, as the third quartile for kidney (Table 6.5) decreased for long tools. 
 
Figure 6.4 Influence of the visible length of the tools in the liver and kidney US images 
on (a) tip error and (b) trajectory error after RANSAC fitting and filtering. There was a 
statistically significant difference in the trajectory error between tools with visible lengths 
longer and shorter than 35 mm, but no significant difference was observed in the tip error. 
The trajectory difference was only observed in kidney and liver applications as all other 
applications had all visible lengths longer than 35 mm. 
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Table 6.5 Median [Q1, Q3] tip and trajectory errors using RANSAC fitting for kidney and 
liver tools with < 35 mm visible (short) within the 2D image compared those ≥ 35 mm 
(long) with significance from Mann-Whitney tests shown. 
Image  
Background 
Number of 
Tools 
 Tip Error (mm)  Trajectory Error (°) 
Short Long  Short Long p-value  Short Long p-value 
Liver 26 223  
4.6 
[1.4, 9.2] 
3.7 
[1.6, 17.5] 
0.4505  
1.4 
[0.8, 3.0] 
0.8 
[0.3, 1.5] 
0.0007 
Kidney 7 24  
10.7 
[2.6, 71.1] 
10.0 
[3.7, 31.6] 
0.5320  
12.6 
[2.9, 27.5] 
2.0 
[0.6, 4.1] 
0.0223 
Overall 33 247  
4.9 
[1.8, 10.4] 
4.4 
[1.7, 18.5] 
0.8021  
2.1 
[1.0, 6.8] 
0.8 
[0.3, 1.7] 
< 0.0001 
6.3.3 User variation 
A subset of images was used to assess intra-rater repeatability (Table 6.6) for the three 
trained users that produced manual segmentations. Though the actual differences in user 
performance were small with all median pixel map metrics differing by < 4 %, a Kruskal-
Wallis test found significant intra-rater performance differences (p < 0.01) for the DSC and 
recall metrics. Using Dunn’s tests, significant differences (p < 0.05) were found between 
the intra-rater pixel map performance metrics of U1 and U2 and between U2 and U3, but 
not U1 and U3. This indicated that U2 was significantly more repeatable and sensitive than 
the other users. U1 and U2 had equivalent tip localization errors of 3.4 mm and median 
trajectory SDs of 0.3º, whereas U3 had slightly poorer consistency with a tip localization 
error of 4.3 mm and median trajectory SD of 0.5º. 
Table 6.6 Intra-rater repeatability for three trained users producing manual segmentations. 
Tip localization error and median [Q1, Q3] trajectory SD, DSC, recall, and precision 
metrics were determined on a repeated image subset (N) with more than 24 hours between 
segmentations. 
User [N] 
Tip 
Localization 
Error (mm) 
Trajectory SD 
(°) 
DSC (%) Recall (%) Precision (%) 
U1 [215] 3.4 0.3 [0.2, 0.7] 89.7 [84.0, 93.5] 88.9 [82.9, 93.0] 91.3 [86.2, 95.1] 
U2 [251] 3.4 0.3 [0.1, 0.6] 91.9 [83.8, 95.7] 92.2 [85.8, 95.8] 92.7 [84.7, 96.3] 
U3 [275] 4.3 0.5 [0.2, 0.9] 89.5 [82.1, 94.0] 88.5 [82.3, 93.4] 91.3 [85.7, 95.2] 
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An identical set of 211 images was used to assess the inter-rater reproducibility (Table 6.7) 
with the multi-user DSC and Fleiss’ kappa both showing very strong agreement between 
users. The tip localization error, trajectory SD, and DSC had values for the inter-rater 
agreement on the same order as the intra-rater repeatability. 
Table 6.7 Inter-rater reproducibility of the manual segmentations produced by three trained 
users. Tip localization error and the median [Q1, Q3] values of trajectory SD, DSC, and 
Fleiss’ kappa metrics are reported for a repeated image subset of 211 images. 
Tip 
Localization 
Error (mm) 
Trajectory SD 
(°) 
DSC (%) Fleiss’ Kappa (%) 
2.8 0.6 [0.3, 1.1] 90.6 [86.5, 93.8] 87.3 [82.6, 91.7] 
6.4 Discussion 
In this study, we designed and evaluated a CNN-based method for segmenting needle-like 
tools in 2D US images in near real-time (approximately 50 ms per tool), demonstrated on 
unseen data from phantoms and five different interventional applications from four 
anatomical sites. The widespread use of 2D US makes the algorithm clinically relevant for 
a large variety of minimally invasive percutaneous interventions that require accurate 
placement of tools to achieve desired diagnostic and therapeutic results. The near real-time 
segmentation of the algorithm provides the potential for live localization and better 
visualization of tools during insertion for interventional procedures. This could enable 
clinicians to immediately evaluate the tool position and trajectory and adjust accordingly, 
compensating for misalignments without disrupting the clinical workflow or adding 
additional segmentation time to the procedure. Future work will involve integrating this 
segmentation into the live video stream from the US machine to provide intraoperative 
guidance, which could potentially improve the accuracy of tool placement and clinician 
confidence in the treatment (e.g., ablation) and sampling (e.g., biopsy) of lesions. One key 
advantage of our approach over existing general tool segmentation algorithms developed 
for US is the availability of both phantom and patient images from five different clinical 
applications and different US machines for development. These images were acquired from 
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different facilities with different operators and had a variety of characteristics, including 
variable image and pixel sizes, acquisition with different US systems and probe geometries, 
and different tool types and diameters. Images from the five clinical interventions, as well 
as phantom images, were used for evaluation, whereas most current techniques have only 
been tested in phantom or ex vivo environments, occasionally with one clinical application 
included. The broad testing environment that our study leveraged for assessment of our 
proposed general algorithm provides evidence that our technique may work across many 
interventional applications. 
Overall pixel map comparisons showed good overlap and agreement between the manual 
and predicted segmentations, as described by the DSC (71.9 [58.0, 86.3] %), true positive 
rate (recall) of 72.3 [52.4, 89.3] %, and a positive predictive value (precision) of 83.2 [70.9, 
89.8] % prior to post-processing. Following post-processing, there was a minor 
improvement in the overall DSC, as well as a higher precision. These pixel map 
comparisons showed DSC > 85 % and recall rates with both post-processing methods > 85 
% for phantom and gynecologic images. Using the RANSAC approach, all applications 
had a precision > 80 % and had higher precision for every image background compared to 
the largest island approach; however, filtering with the RANSAC approach had the 
opposite effect on recall, which decreased for every background. Since the largest island 
approach doesn’t modify the predicted pixels and only keeps the largest connected region, 
these changes in the pixel map metrics indicate that the CNN had a higher chance to over-
predict pixel regions relative to the manual mask resulting from lower false-negatives and 
higher false-positives. Since the RANSAC method only keeps inlier pixels based on the 
maximum nominal tool diameters, spurious regions, such as the bump on the left side of 
the gynecologic example shown in Figure 6.3, are removed. As a result, over-predictions 
or predictions wider than this threshold diameter become slimmer, reducing the number of 
false positive pixels or increasing the false negative pixels, respectively. Aside from the 
kidney, a higher DSC also resulted when using a RANSAC approach and produced 
predictions more representative of the tool’s true shape. 
The predicted regions were sufficient to estimate the tool’s tip and trajectory using both 
post-processing methods. Overall, the RANSAC approach produced a more accurate tip 
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and trajectory identification for the tools than the largest island method but performed 
slower than the largest island approach. While neither approach has been optimized for 
speed, the chosen method for post-processing could change depending on the application 
and choice to prioritize speed or accuracy. Although currently slower, there is the potential 
to implement parallelization of the RANSAC method to improve processing time as the 
approach executes the fitting step multiple times. Limitations of both approaches are the 
assumptions that tools are linear and that there is only one tool present in the images; 
however, the type of fit selected could be modified in the future to include other variations 
and step-wise predictions with subsequent image filtering could provide a method for 
multi-tool segmentation, but both will need to be investigated further.  
Tool segmentation was not consistent across all images investigated and varied widely by 
anatomical location. Gynecologic images demonstrated the most accurate tool 
segmentation-specific metrics when compared to manual masks (median tip: 0.3 mm and 
median trajectory: 0.4°). This was likely due to the distinct needle appearance attributable 
to being nearly parallel to the linear US imaging face. However, the tip error in these 
images may not be a reflection of the true accuracy as they did not always contain the 
needle tip within the image field-of-view. In some cases, the tip point was selected to be at 
the edge of the image, which may be easier for the algorithm to detect as it removes the 
insertion direction component of error. Further investigation into the tip error for this 
application is necessary, but likely would be similar to that observed in the prostate 
brachytherapy images. The prostate images also demonstrated low tip and trajectory errors 
and the overall performance of the algorithm on brachytherapy images demonstrates 
robustness to large artifacts, such as the reverberation and shadowing observed in these 
images. Following RANSAC post-processing, phantom, prostate, and gynecologic images 
all produced median tip errors ≤ 1.5 mm and tools in these images, as well as the liver 
images, demonstrated median trajectory errors < 1º. The trajectory errors associated with 
kidney and liver ablation tools were shown to improve significantly for tools with more 
than 35 mm visible in the image field-of-view, but the spread of the tool tip error was also 
observed to increase proportionally with the tool length. Figure 6.4(a) shows that some 
liver predictions had very large tip errors, which is also reflected in the high variability in 
tip error reported in Table 6.3 and Table 6.4. These large errors were typically associated 
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with deeply inserted tools and, due to the free-hand nature of the procedure, are likely the 
result of partially visualized tools not entirely in-plane with the US image. In the reported 
analysis, we did not implement a success/failure threshold; however, in a clinical setting, 
physicians would be able to keep in mind the insertion depths of tools to interpret the 
reasonability of the provided segmentation and, in most cases, these large errors likely 
appear only for a few frames in a video sequence. Therefore, future work will involve 
investigating a method for segmenting very short visible tool lengths and improving deep 
tool tip identifications, which may be integrated into the algorithm to improve 
performance. Despite the variability in performance across anatomical location, the 
performance on the liver images had a relatively high impact on the overall metrics reported 
in this study. The negative impact of the poorer performance on kidney predictions also 
influenced the overall values reported, but this would cause reported values to be more 
conservative compared to the true performance in other anatomical locations and the 
relatively larger number of liver images minimizes this influence. 
Although the overall median tip error was slightly higher than those reported for other deep 
learning-based US tool segmentation methods,27,28 the accuracy achieved is likely 
sufficient for most clinical applications. As the other methods were developed only in ex 
vivo models28 or specifically for liver27 and kidney29 procedures, they may not reflect the 
complexity of clinical scenarios, limiting the generalizability of the approaches and 
diversity of the datasets. We demonstrated a median trajectory error for the liver tools of 
0.8°, showing an improvement over the mean error of 2° reported by Arif et al.27 Since the 
tool angle of incidence in liver images is steeper relative to the US probe than in other 
applications, visibility of the tool is reduced36 and tip identification is more challenging, 
leading to the observed median tip error of 3.8 mm. 
Our algorithm demonstrated much poorer performance in kidney images than the other 
applications in this study; however, the DSC of 58.0 % prior to post-processing is similar 
to the value of 56.65 % reported by Lee et al.29 Additionally, our median trajectory error 
of 2.9º for the kidney ablation tools may offer a substantial improvement over the trajectory 
error of 13.3º reported by Lee et al.29, though a direct comparison is not possible given the 
use of RMS error in that study. Assuming a similar pixel size, our tip error appears larger 
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than the distance error from the Lee et al.29 study; however, their value does not represent 
the tip error, which is often much higher since the largest segmentation challenge is 
typically the early truncation of the tool path in the insertion direction. The high errors 
reported by both studies on the localization of tools in kidney images shows the US 
visibility challenges associated with steep tool insertion angles and increased number of 
anatomical interfaces with similar echogenicity, emphasizing the need for further research 
in this area. 
Our precision (83.2 [70.9, 89.8] %) was much higher than that observed by Mwikirize et 
al.30 prior to pre-processing, with a similar recall rate; however, Mwikirize et al. 
emphasized the importance of pre-processing US images to reduce high-intensity artifacts 
in the image, providing a vast improvement in the recall and precision rates of their 
algorithm. While pre-processing was avoided in our study to more closely reflect the 
intraoperative clinical realities, this may be an area of future investigation to further 
improve the accuracy of our results.  
The three users in our study produced high pixel map scores on repeated segmentations of 
the same tools, all having DSCs > 89 % and recall and precision rates > 88 %, indicating 
high intra-rater repeatability in these metrics with U2 demonstrating the highest rate of 
repeatability and sensitivity. Although the median trajectory SDs were all ≤ 0.5º, variability 
in tip localizations were high with median differences ranging from 3.4 mm to 4.3 mm, 
demonstrating the difficulty of the task. This variability is also comparable with the tip 
errors produced by our method, suggesting that a large proportion of our reported algorithm 
errors are due to manual variability in tip localization. Thus, an alternative to manual 
segmentation is required to improve ground truth segmentations for further improvement 
in performance. The inter-rater comparison was consistent with intra-rater metrics and 
showed that using a single user for earlier comparisons was likely sufficient for assessing 
our method. The users also showed strong agreement with minimal effects of chance, 
demonstrated with the median Fleiss’ kappa of 89.3 %. 
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6.5 Conclusions 
We have presented a near real-time approach using deep learning techniques for 
fast and accurate segmentation of general needle-like tools in a variety of clinical cancer 
applications, demonstrating the potential to improve and ease tool localization in 
intraoperative environments during minimally invasive percutaneous interventions. 
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Chapter 7  
7 Conclusions and directions for future work 
Image-guided medical interventions that use 3D information intraoperatively may provide 
improvements to the diagnosis and treatment of cancer, but these procedures rely heavily 
on the accurate targeting, guidance, and verification of needle-like tools for planned 
outcomes. This thesis focused on the application of 3D US imaging and image processing 
methods during image-guided interventions in the prostate and liver to provide accessible, 
fast, and accurate improvements to the clinical workflow. This chapter provides the 
summary, conclusions, limitations, and future directions from the work in Chapters 2-6. 
7.1 Summary and conclusions 
In Chapter 2, an automatic 2D-3D registration method approaching the frame rate of a US 
system was investigated to compensate for prostate motion during 3D TRUS-guided 
biopsy procedures. Since patient motion can be continuous or intermittent throughout a 3D 
TRUS-guided biopsy procedure, MR-derived targets can be misaligned during biopsy 
sampling, which can result in increased needle targeting error and the chance of missing 
cancer in suspicious regions identified in the MR image. Two registration modes were 
investigated: motion compensation using a single user-initiated correction that could be 
performed before biopsy and real-time continuous motion compensation that could be 
performed automatically as a background process. A previously developed1 intensity-based 
algorithm was further optimized on retrospective patient images by implementing the 
algorithm on a GPU, downsampling the 2D and 3D TRUS images by a factor of four, 
cropping the 2D TRUS images to 356  292 pixels,  and optimizing the Powell search 
space order with translations first to avoid local optima near the registration initialization 
position. This optimization on patient images resulted in a mean ± SD TRE and 
computation time of 1.6 ± 0.6 mm and 57 ± 20 ms, respectively. After implementation in 
a 3D TRUS-guided system, a tissue-mimicking prostate phantom with embedded agar 
spheres was used to evaluate the user-initiated and continuous registration approaches with 
known displacements provided by a micrometre-driven stage. The user-initiated mode 
performed registrations with computation times of 108 ± 38 ms, 60 ± 23 ms, and 89 ± 27 
ms for in-plane, out-of-plane, and roll motions, respectively, and corresponding 
registration errors of 0.4 ± 0.3 mm, 0.2 ± 0.4 mm, and 0.8 ± 0.5°. The continuous method 
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performed registration significantly faster (p < 0.05) than the user-initiated method, with 
observed computation times of 35 ± 8 ms, 43 ± 16 ms, and 27 ± 5 ms for in-plane, out-of-
plane, and roll motions, respectively, and corresponding registration errors of 0.2 ± 0.3 
mm, 0.7 ± 0.4 mm, and 0.8 ± 1.0°. The presented method encourages implementation of 
real-time motion compensation algorithms in a prostate biopsy as registration errors are 
around the previously determined 1.6 mm requirement for sampling clinically significant 
prostate cancer with a 95 % confidence.2 Image registration approaching the frame rate of 
an ultrasound system offers a key advantage to be smoothly integrated into the clinical 
workflow and could be used further for a variety of image-guided interventions, like 
prostate brachytherapy or liver ablation, to treat and diagnose patients by improving 
targeting accuracy. 
Chapter 3 focused on automating the 3D TRUS-guided biopsy workflow further with 
additional application to 3D TRUS-guided brachytherapy by developing an algorithm 
using a deep learning-based approach for automatic 3D TRUS prostate segmentation. 
Using 3D TRUS images effectively typically requires the physician to manually segment 
the prostate to define the margins and volume used for accurate registration, targeting, and 
dose calculations. However, manual prostate segmentation is a time-consuming and 
difficult limitation on clinical workflow, often occurring while the patient is under sedation 
(biopsy) or anesthetic (brachytherapy).3 A supervised deep learning-based method was 
developed to segment the prostate in 3D TRUS images from different facilities, procedures, 
acquisition methods, and commercial ultrasound machine models to create a generalizable 
algorithm for needle-based prostate cancer procedures that avoids the development of 
procedure-specific approaches. The developed modified U-Net with 3D reconstruction 
performed with a median [Q1, Q3] absolute DSC, recall, precision, VPD, MSD, and HD 
of 94.1 [92.6, 94.9] %, 96.0 [93.1, 98.5] %, 93.2 [88.8, 95.4] %, 5.78 [2.49, 11.50] %, 0.89 
[0.73, 1.09] mm, and 2.89 [2.37, 4.35] mm, respectively, when tested on a dataset of 20 
unseen end-fire and 20 side-fire 3D TRUS images. When compared to three fully 3D 
networks (i.e., V-Net, Dense V-Net, and High-resolution 3D-Net), our proposed method 
performed with significant improvement across nearly all metrics investigated. 
Computation time of <0.7 s per prostate was observed, which is a sufficiently short 
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segmentation time for intraoperative implementation and enables a generalizable 
intraoperative solution for needle-based prostate cancer procedures. 
In Chapter 4, a new geometrically variable 3D US scanner, mechanically assisted system, 
and 3D-printed therapy applicator guide was developed to provide methods for imaging 
and guiding focal liver tumor ablations. Image guidance variabilities with 2D US imaging 
during freehand therapy applicator targeting can limit the sufficiency of ablation volumes 
and the overall potential of ablation procedures. However, US offers a safe, cheap, 
accessible, and real-time advantage over other methods of image-guidance. Proposed 
imaging solutions like CT and MRI can provide useful tools for applicator targeting, but 
often require longer procedure times, which are more complex and costly, limiting their 
widespread use. 3D US was proposed as an alternative image-guidance approach and a 
three-motor scanner was designed to be used with any commercially available US probe to 
generate accurate, consistent, and geometrically variable 3D US images. The designed 
scanner was mounted on a counterbalanced stabilizing and mechanical tracking system for 
determining the US probe position and orientation, which was assessed using optical 
tracking to have a mean positioning error of 1.85 ± 1.33 mm when performing compound 
joint manipulations. The utility of the motorized scanner enabled the development of an 
image-guidance navigation workflow that moved the probe to any identified target within 
an acquired 3D US image. The complete 3D US guidance system was used to perform 
mock targeted interventional procedures on a phantom by selecting a target in a 3D US 
image, navigating to the target, and performing needle insertion using a custom 3D-printed 
needle applicator guide. Registered post-insertion 3D US images and CBCT images were 
used to evaluate tip targeting errors when using the motors, tracking system, or mixed 
navigation approaches. A combined approach for navigation that incorporated the 
motorized movement and the in-plane tracking system corrections performed best with a 
mean tip error of 3.77 ± 2.27 mm and 4.27 ± 2.47 mm based on 3D US and CBCT images, 
respectively. 3D US image geometries used during the needle targeting experiments 
involved a small-footprint tilt scan and a large field-of-view hybrid scan, which were 
observed to have no significant differences in needle tip errors over a total of 48 targeted 
needle insertions. 3D US images were qualitatively evaluated in a healthy volunteer and 
compared to a commercially available matrix array US probe, which resulted in a clear 
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reconstruction of clinically relevant anatomy. Overall, this system provides a utility that 
enables enhanced applicator guidance, placement verification, and improved clinical 
workflow during focal liver tumor ablation procedures, potentially reducing local cancer 
recurrence rates and the feasibility of 3D US stereotactic interventional procedures. 
Chapter 5 described the development of a semi-automatic 3D US needle-like therapy 
applicator segmentation algorithm that used a single user input to augment the addition of 
3D US, like the system described in Chapter 4, to focal liver tumor ablation workflows. 
The algorithm was initialized by creating a spherical search space of line segments around 
a manually chosen seed point that was selected by a user on the needle applicator visualized 
in a 3D US image. The most probable trajectory was chosen by maximizing the count and 
intensity of threshold voxels along a line segment and was filtered using the Otsu method 
to determine the tip location. Homogeneous tissue-mimicking phantom images containing 
needle applicators with manual segmentations were used to optimize the parameters of the 
algorithm to median [Q1, Q3] trajectory, axis, and tip errors of 2.1 [1.1, 3.6]°, 1.3 [0.8, 2.1] 
mm, and 1.3 [0.7, 2.5] mm, respectively, with a mean ± SD segmentation computation time 
of 0.246 ± 0.007 s. The segmentation method was tested with a four-user study using 16 in 
vivo, retrospective 3D US patient images, which resulted in overall median [Q1, Q3] 
trajectory, axis, and tip errors of 4.5 [2.4, 5.2]°, 1.9 [1.7, 2.1] mm, and 5.1 [2.2, 5.9] mm. 
This 3D US semi-automatic tool segmentation offers the ability to quickly assess and adjust 
needle applicator placements intraoperatively, potentially improving 3D US liver ablation 
clinical workflow and adoption. 
A general needle and applicator tool segmentation algorithm was developed in Chapter 6 
for 2D US images from multiple image-guided interventions and anatomical regions. Many 
interventional procedures, like focal liver ablation, leverage the temporal resolution of 2D 
US to provide real-time feedback to aid in the accurate placement of interventional tools.  
Identifying tools in 2D US images during intraoperative insertion is necessary for correctly 
achieving planned targets for optimal diagnosis or treatment of cancer, but it is often time-
consuming with accurate position information difficult to distinguish. A deep learning-
based method, similar to Chapter 3, was used to predict tools in 2D US images in 
approximately 50 ms for multiple anatomical sites, despite the widely varying appearances 
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across interventional applications. A modified U-Net architecture was trained with real-
time data augmentation on 917 images and manual segmentations from 
prostate/gynecologic brachytherapy, liver ablation, and kidney biopsy/ablation procedures, 
as well as phantom experiments. Post-processing to identify the tool’s tip and trajectory 
was performed using two different approaches, comparing the largest island with a linear 
fit to RANSAC fitting. Comparing predictions from 315 unseen test images to manual 
segmentations, RANSAC post-processing resulted in improved performance with an 
overall median [Q1, Q3] tip error, trajectory error, and DSC of 3.5 [1.3, 13.5] mm, 0.8 [0.3, 
1.7]°, and 73.3 [56.2, 82.3] %, respectively. The predictions with the lowest median tip and 
trajectory errors were observed in gynecologic images (median tip: 0.3 mm and median 
trajectory: 0.4°) with the highest errors in kidney images (median tip: 10.1 mm and median 
trajectory: 2.9°). Although variability was observed across different anatomical 
applications, the proposed approach could accurately segment tools in 2D US images from 
multiple anatomical locations and a variety of clinical interventional procedures in near 
real-time. This avoids the need for application-specific methods and provides the potential 
to improve image guidance during a broad range of diagnostic and therapeutic cancer 
interventions. 
7.2 Limitations 
The significant limitations of this thesis are discussed in this section and provide a 
summary of the discussions presented in Chapters 2-6. 
7.2.1 General limitations 
All studies investigating patient data in this thesis were retrospective in nature, which was 
more practical for developing new methods since relevant images were previously 
acquired. However, prospective imaging studies including larger unseen patient test data 
for additional evaluation would provide stronger evidence for the clinical utility of the 
image processing methods developed. This could include additional evaluations such as 
the practicality of integration into clinical workflow, physician approval through a Likert 
scale assessment, and randomized control trials to prove the benefit over conventional, 
manual techniques. The registration and deep learning methods described in this thesis also 
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rely on the need for a GPU to perform at the reported computation speeds, which is not 
traditionally available on systems currently used clinically and could limit translation. 
However, GPUs are easily incorporated into new systems, such as the liver system 
described in Chapter 4, and offer the potential for additional software acceleration to 
processes that could benefit from real-time functionality, such as US colour flow imaging.4 
Obtaining ground-truth for accuracy assessment is often very complex and difficult, relying 
on gold standard techniques, such as manual annotations, to perform as a substitute. These 
gold-standard manual annotations include fiducials for registration, prostate 
segmentations, and needle applicator tip and shaft locations. All studies investigating 
patient data did not include external validation from other measurement sources due to the 
retrospective nature of the studies, which could provide an improved method of accuracy 
quantification. However, external system evaluation was performed during phantom 
experiments to address this need, such as a micrometre-driven translation stage, optical 
tracking, and CBCT images. 
7.2.2 Study specific limitations 
In Chapter 2, the optimization of the real-time 2D-3D TRUS registration algorithm was 
performed on a retrospective patient dataset and tested on phantom images in an ideal 
imaging scenario. Optimization on the patient images enabled an approach to refine the 
algorithm on expected clinical images, but manually identified fiducials and the TRE 
metric were used as a surrogate measure of ground truth displacement and were performed 
by a single user. Despite the variability introduced due to manual selection of 
corresponding fiducials, an improved method of evaluation would require the knowledge 
of a patient’s true displacement without the uncertainty associated with imaging error, 
which is an extremely challenging endeavour. This motivated the use of a micrometre-
driven phantom as an alternative, feasible, and accurate approach to provide ground truth 
information for evaluation. However, this approach limits extrapolation to expected 
clinical use where images might have less contrasting structures and more image artifacts. 
Three independent motions were testing with the phantom to get an impression of the 
algorithm’s performance, but complex motion combining multiple degrees-of-freedom 
was not investigated. In addition, obtaining variability in phantom motion speed was 
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difficult using a hand-driven micrometre stage, but motion speed could influence the 
performance of a continuous registration approach since inter-frame displacements would 
be larger than investigated, potentially increasing registration computation time. Although 
this was not tested, it is assumed the performance would have an upper bound at the level 
of the user-initiated results since that experiment mimicked large displacements across a 
single US image frame. Finally, the phantom fabricated was a rigid body and was shown 
to be easily compensated using a rigid registration algorithm, but the real-time continuous 
method still needs to be verified in prospective patient studies where additional motion due 
to prostate deformation may occur. 
In Chapter 3, an automatic prostate segmentation method was trained, validated, and tested 
on a clinically diverse dataset of 3D TRUS images. Although excellent performance was 
demonstrated with the proposed algorithm, a parameter that may influence computation 
time and accuracy is the step angle for radial slice generation and 2D predictions. Varying 
the step angle away from 15° would likely alter computation time since predictions would 
be performed on different amounts of image information, but the variability in accuracy is 
unknown. When training the 3D CNNs for performance comparison, hyperparameters 
were optimized on the V-Net and were used for the other two networks. Although these 
hyperparameters were found to perform the best during preliminary experiments on the 
Dense V-Net and High-resolution 3D-Net, a rigorous optimization was not performed and 
has the potential to increase performance. Another limitation of this study was the use of 
only one observer for providing gold standard manual segmentations. Although inter- and 
intra-observer variability was not assessed for the dataset used, variability in end-fire 3D 
TRUS images5 and side-fire 3D TRUS images6 were previously assessed by our group. 
Previously reported user variabilities were comparable to the reported DSC of the proposed 
segmentation method in this chapter, showing that the algorithm was performing at the 
level of variability observed in the gold standard segmentations. Due to the demonstrated 
variability between different observers when segmenting 3D TRUS images, segmentations 
from other observers should be investigated and incorporated into the testing dataset to 
further demonstrate the robustness of the proposed method. 
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In Chapter 4, a novel mechanically assisted 3D US system with geometrically variable 
image geometries was evaluated using optical tracking, phantom images, and CBCT 
images. One caveat of the navigation errors reported in the study was the ideal nature of 
the needle insertion experiments, which did not contain expected clinical issues such as 
liver motion. The imaging phantom was also limited in deformation characteristics relative 
to a patient, which could cause issues like needle deflection during needle insertion. 
Healthy volunteer images were also acquired under a breath-hold technique to evaluate 
clinical imaging feasibility. Although the images were reconstructed to visualize clinically 
relevant anatomy for liver ablation procedures, patients who are unable to hold their breath 
for 12 s would incorporate motion artifacts during 3D US acquisition. Image acquisition 
can be performed faster with this system by acquiring fewer images, but alterations to 
image reconstruction quality were not assessed. Images of healthy volunteers were only 
shown for one volunteer, so a wider range of body sizes should be investigated in the future. 
In Chapter 5, a semi-automatic 3D US needle applicator segmentation algorithm was 
developed and optimized on phantom images before evaluation on a dataset of patient 3D 
US images containing needle-like therapy applicators in the liver. This relatively small 
dataset of patient images limited potential development of the segmentation algorithm as 
images of phantoms with minimal US echogenecity were relied on for optimizing the 
approach. Although the dataset was small, this was the largest clinical liver dataset of 3D 
US images evaluated to-date for needle applicator segmentation. A fixed adjustment to the 
Otsu threshold was implemented for accurate applicator tip localization, but it is possible 
that the adjustment is influenced by the needle applicator’s SBR in the 3D US images and 
investigation into a dynamic adjustment was limited. The choice to use an Otsu threshold 
was also a potential limitation in this study as the assumption of a bimodal intensity 
distribution that was split between foreground (i.e., applicator) and background was not 
always maintain when evaluating the clinical images. Image features that were observed to 
limit the performance of the algorithm were large gaps along the needle applicator shaft 
and the presence of arteries and veins causing similar acoustic reflection intensities. 
Needle-like therapy applicators were also assumed to be linear, but this was a sufficient 
assumption for the clinical images investigated. However, this assumption limits 
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application to a broader range of procedures that include thinner diameter interventional 
tools that have a higher probability for deflection and bending. 
In Chapter 6, a deep learning-based approach compared two post-processing techniques 
for segmenting needle-like tools in 2D US images. This method was trained, validated, and 
tested on unseen data from five different interventional applications from four anatomical 
sites and phantom experiments. The advantage of this study compared to previously 
reported methods was the variability in image data used for development; however, the 
number of patients and images accessible for this study were not balanced across all 
anatomical sites investigated. Overall values of accuracy were reported, but these results 
were heavily skewed by the performance using liver images. Tip errors reported for 
gynecologic images may not be a reflection of the true accuracy for this anatomical region 
as they did not always contain the needle tip within the image field-of-view. Since the 
identification of the tip location is typically the most difficult aspect of needle-like tool 
segmentation, the complete understanding of performance on gynecologic images could be 
limited. Despite this limitation, performance is expected to be similar to the prostate 
brachytherapy images since tool trajectories are parallel to the US probe face, which 
demonstrated low tip and trajectory errors with robustness to large artifacts, such as 
reverberation and shadowing. The post-processing approaches tested with this method also 
assumed a single tool was present and that it was linear, which might limit the performance 
of the algorithm if multiple tools are visible, as in brachytherapy procedures, or if tools 
deflect within the body. However, the type of fit used in this work could be modified in the 
future to include other variations and step-wise predictions with subsequent image filtering, 
which could provide a method for multi-tool segmentation. Lastly, investigation on user 
variability when producing manual segmentations revealed large median differences for 
tip identification relative to the reported metrics on the test dataset. This limits a complete 
understanding of the segmentation performance as errors reported incorporated a non-
negligible amount of human error and did not isolate the accuracy solely due to the 
algorithm, stressing the difficulty of the segmentation problem. 
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7.3 Future directions 
7.3.1 2D-3D prostate motion compensation clinical translation 
A 2D-3D TRUS registration method was implemented on a guidance system in Chapter 2 
for evaluating the clinical feasibility of a continuous registration approach during prostate 
biopsy. To expand beyond the phantom experiments and provide additional evidence for 
clinical feasibility, a proof-of-concept prospective clinical study has been investigated with 
the implemented method in Chapter 2.7 Although the patient sample size was small (i.e., 
three patients), the registration approach was observed to have a median [Q1, Q3] 
registration error of 3.4 [1.5, 8.2] mm and a mean ± SD computation time of 27 ± 8 ms 
when evaluating 21 2D-3D image pairs acquired during the conventional biopsy 
procedure.7 Larger registration errors were observed during sampling of tissue samples on 
the lateral edges of the prostate, so a new method of navigation that emphasized US probe 
rotation was developed during continuous 2D-3D TRUS registration. This new approach 
resulted in a median [Q1, Q3] registration error of 2.0 [1.3, 2.5] mm and a mean ± SD 
computation time of 22 ± 3 ms when evaluated on 18 image pairs, providing evidence that 
clinical implementation of the registration algorithm with a workflow adjustment could 
improve prostate biopsy targeting. These results support the investigation into a larger 
clinical trial with prospective patient imaging and may require the need for external 
imaging after needle insertion to directly verify needle targeting accuracy. 
7.3.2 Multi-institutional 3D TRUS prostate segmentation 
Chapter 3 described the development and evaluation of an automatic prostate segmentation 
method on 3D TRUS image acquired using end-fire and side-fire probes. Another common 
geometry for 3D TRUS image acquisition can be achieved using biplane probes during 3D 
TRUS-guided prostate brachytherapy, which have transverse elements that can be used to 
axially-reconstruct 3D images using tracked steppers.8 A dataset including these images 
with manual 3D segmentations could easily be evaluated and would enable the proposed 
approach to have a wider potential impact and further prove the results of the method being 
image reconstruction geometry independent. Even if significant differences were to be 
observed when evaluated on this new acquisition geometry, including additional images in 
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the training set of the deep learning approach may be the only required alteration, which is 
an easily performed task. 
Providing further evidence for prospective clinical utility and impact of the automated 
segmentation approach could be performed through the use of a multi-user and multi-
institutional study. This could either provide evidence that the method is not biased to the 
single user used for training the approach or stress the need to incorporate alternatives for 
different users. The clinical impact could also be investigated across multiple users through 
the evaluation of segmentation accuracy and variability on radiation dose planning. Also, 
an editing time metric could be investigated to provide supporting evidence for benefits to 
clinical workflow and patient throughput.9 
7.3.3 CT-US fusion-guided liver ablation 
 
Figure 7.1 Proposed workflow for a CT-3D US-guided focal liver ablation. 
3D US has the potential to improve applicator targeting accuracy during focal liver tumor 
ablation therapies with the opportunity to draw many parallels to MR-TRUS fusion-guided 
prostate biopsy. Conventional liver ablation procedures are typically only performed on 
lesions with diameters less than 50 mm due to the accuracy required for placing and 
repositioning multiple applicators with overlapping ablation volumes,10 but an accurate 
image-guidance pipeline and system could provide the tools necessary to expand the 
number of patients eligible for ablation procedures. As shown in Figure 7.1, many modules 
can be incorporated into the system to plan, guide, and verify an applicator(s) placement at 
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the location of a tumor(s). Planning in the preoperative setting based on an initial CT image 
could allow for the segmentation of the tumor and provide targets for an applicator 
planning application to determine the optimal configuration, especially for multi-applicator 
treatments.11 A CT to 3D US deformable image registration12 could bring these CT-derived 
segmentations and targets into the intraoperative setting on the day of the procedure. 
Image-guidance could be performed using a motion compensation 2D-3D US registration 
algorithm, like an adaptation from the method described in Chapter 2, to adjust coordinate 
systems and allow for motorized target navigation, as described in Chapter 4. Using the 
method described in Chapter 6, 2D applicator segmentation could be performed on the live 
image sequence to help aid with applicator insertion. Lastly, verification of applicator 
guidance could be performed with subsequent and repeated 3D US images. These images 
could be used with the 3D applicator segmentation method developed in Chapter 5, or a 
fully automated deep-learning approach, for generating applicator locations and planned 
ablation volumes for therapeutic margin assessment before initiating the therapy session. 
Technology that enables a stereotactic interventional approach could exploit the low 
complication rates and recovery times of focal liver ablation procedures, while increasing 
patient eligibility, decreasing local cancer recurrence rates, and increasing overall patient 
survival. 
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